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Design and Architecture of an Ontology-driven Dialogue
System for HPV Vaccine Counseling
Abstract
Speech and conversational technologies are increasingly being used by consumers, with the inevitability
that one day they will be integrated in health care. Where this technology could be of service is in
patient-provider communication, speci cally for communicating the risks and bene ts of vaccines.
Human papillomavirus (HPV) vaccine, in particular, is a vaccine that inoculates individuals from
certain HPV viruses responsible for adulthood cancers - cervical, head and neck cancers, etc.
My research focuses on the architecture and development of speech-enabled conversational agent
that relies on series of consumer-centric health ontologies and the technology that utilizes these
ontologies. Ontologies are computable artifacts that encode and structure domain knowledge
that can be utilized by machines to provide high level capabilities, such as reasoning and sharing
information. I will focus the agent’s impact on the HPV vaccine domain to observe if users would
respond favorably towards conversational agents and the possible impact of the agent on their
beliefs of the HPV vaccine. The approach of this study involves a multi-tier structure. The rst
tier is the domain knowledge base, the second is the application interaction design tier, and the third
is the feasibility assessment of the participants. The research in this study proposes the following
questions:
1. Can ontologi support the system architecture for a spoken conversational agent for HPV
vaccine counseling?
2. How would prospective users’ perception towards an agent and towards the HPV vaccine be
impacted after using conversational agent for HPV vaccine education?
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The outcome of this study is a comprehensive assessment of a system architecture of a conversational
agent for patient-centric HPV vaccine counseling. Each layer of the agent architecture is regulated
through domain and application ontologies, and supported by the various ontology-driven sof ware
components that I developed to compose the agent architecture. Also discussed in this work, I
present preliminary evidence of high usability of the agent and improvement of the users’ health
beliefs toward the HPV vaccine. All in all, I introduce a comprehensive and feasible model for the
design and development of an open-sourced, ontology-driven conversational agent for any health
consumer domain, and corroborate the viability of a conversational agent as a health intervention
tool.
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The scariest moment

always just before you start.
Stephen King

1
Introduction

From the time we are born, we learn to interact with one another using speech to achieve a
variety of human objectives – request for food or milk, attention from another human, or to learn.
It is natural for human beings to use speech and dialogue interaction to communicate and exchange
information that could improve the quality of our lives. The research contained in this dissertation
embarks on an attempt at designing a conversational agent using a series of ontological knowledge
bases that provide the intelligence of the agent to interact with human users. The speci c use-case
is a light counseling session discussing the HPV vaccine with a patient (i.e. health consumer) that
should occur between patient and provider. This proof of concept conversational agent could
be integrated in a waiting room area of a clinic where they are free to be engaged or waiting for a

1

clinician.
Several researchers have stated the importance of vaccines to diminish the impact of death-related
disease. The HPV vaccine is no di ferent. This particular vaccine protects individuals from some
cancer-causing viruses like throat cancer and cervical cancer. The human papillomavirus (HPV)
vaccine is noted to be 99% e fective against the HPV virus (Centers for Disease Control and Prevention,
2014a), and yet the United States population uptake for HPV vaccine is at a low 37.1% (Walker et al.,
2017), short of the 80% uptake goal (US Department of Health and Human Services and O ce
of Disease Prevention and Health Promotion and others, 2012). Many life threatening cancers,
like cervical cancer, is attributed to high risk HPV viruses (Type 16 and 18). One predictive study
reported that if the population were to have 70% coverage of HPV vaccine, at least 4 million deaths
could be prevented in the next decade (Goldie et al., 2008). Misinformation relating to the safety
and importance of vaccines a fects coverage rates of all vaccines, including but not limited to the
HPV vaccine (Myers & Pineda, 2009). Closing this misinformation gap is crucial if we are to guarantee
the safety of the human population from viruses and diseases, and from diseases long-thought to be
extinguished from re-emerging in the community.
Providers are the rst and recommended line of defense to educate the consumers about the HPV
vaccine. Yet this is an added burden to the provider. One of the burdens is being a skilled communicator,
especially toward patients who have low health literacy (Go f et al., 2011; Roter et al., 2007; Evans &
Bostrom, 2002). Another burden is taking the role of being health educator (Zimet et al., 2013),
even in the di cult situation of talking about sexual-related matters with both the parent and the
teenage child (Esposito et al., 2007; Humiston et al., 2009; Daley et al., 2006). More importantly,
there is not enough time to discuss and counsel the patient about the HPV vaccine (Go f et al.,
2011; Vadaparampil et al., 2011). This work explores the possibility of delegating and automating
the communication and education task to an interactive kiosk or tablet application that is available
for patients, similar to a “Siri”-like experience. The possible bene t other than cost e fectiveness
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is facilitating the interactive dialogue that could approximate a real conversation (Migneault et al.,
2006), mimicking the personal interaction that patients and health consumers desire (Katz et al.,
2011; Ahken et al., 2015). Also using machine intelligence, the system can strategize how and when
information is provided (Migneault et al., 2006). For example, the system can implement the use of
short sentences, acknowledge the user by name, supplement the speech with pictures and gures, or
regulate the dialogue turn to ve chunks of information at a time to accommodate cognitive limits.
There is also the opportunity to reach out to multilingual patients or improve low health literate
patients’ con dence and communication (Migneault et al., 2006; Narayanan et al., 2004). Current
research have noted that face-to-face counseling between patient and provider has an in uence in
accepting vaccination for the patient or the patient’s parent (Kessels et al., 2012; Rambout et al.,
2014; Reiter et al., 2009; Anhang Price et al., 2011). Research have also shown that interactive agents
can improve educational gains of the learner compared to passive learning (Christel, 1994; Moreno
et al., 2001; Moundridou & Virvou, 2002; Hongpaisanwiwat & Lewis, 2003; Guadagno et al., 2007;
Van Mulken et al., 1999; Rickenberg & Reeves, 2000).
One of the originators of the web, Sir Tim Berners-Lee, envisioned a “web of data” in a seminal 2001
article for Scienti c American (Berners-Lee et al., 2001). The central component of the semantic web
architecture is the ontology layer. Ontologies are representational artifacts that link heterogeneous
data, describe domain knowledge, and enable reasoning capabilities for machines to consume. From
an arti cial intelligence perspective, ontologies provide machines a vehicle to represent knowledge
and share standardization of knowledge between agents. Biomedical researchers bene t from the
tools and the inherit features that ontologies have to o fer, ranging from the National Center of
Biomedical Ontologies BioPortal, the Gene Ontology (Ashburner et al., 2000), etc. Many applications
utilize biomedical ontologies for sophisticated data analysis. Yet in the age where copious health
information is available on the web, there is no dedicated ontologies or formalized knowledge
bases that target patients that can be used for knowledge acquisition or utilized for patient-centric
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applications and tools. The development of the patient-centric vaccine knowledge base would be
the rst of consumer informatics-based ontologies, which could foreseeable be used in a variety of
use-cases. Viewing the linked open data cloud (Figure 1.1), a web of connecting ontologies, most of
the “professional level” ontologies predominate the health and life science ontologies.

Figure 1.1: Linked open data cloud. Licensed under CC BY 4.0. https://lod-cloud.net/

Also, Berners-Lee had presented his vision of an intelligent agent providing interactive, aggregate
health data from the web to a casual users. While this vision has gotten closer to realization, we
propose the possibility of an ontology-based agent that can ful ll a speci c use-case, namely an
interactive system using modern day speech technology to counsel patients on the HPV vaccine.
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Such an agent, would utilize ontologies to coordinate the dialogue and visual interaction, and
provide ontologies to query from for domain knowledge. In addition, I will also test the usability
of the agent with prospective users to demonstrate some early perceptions and e fectiveness. Using
ontologies, there is a possibility to formalize knowledge, such as patient-level vaccine knowledge and
standardizing various interaction modalities, that can be shared with other agents and be linked to
other sources to expand the domain space.

Context is king

Permit me to have a candid moment. You, the reader, may be puzzled by

the discussion of ontologies and why and how it would be used for HPV vaccine counseling * .
Even from my own subjective observation, the biomedical informatics community has a limited
scope (or imagination) of how ontologies could be used in this area, much less be used in humancomputer interaction. This is evident with the massive number of expressive reference ontologies
that I mentioned. Research is so devoted to ontology-learning methods and knowledge engineering,
but what about making these semantic technology usable, for what they were envisioned to do, than
just being repositories of validated scienti c knowledge?
I present the classic knowledge triangle in Figure 1.2. This triangle describes the evolution of information,
from noise at the bottom to data (relevant) to information (processed, structured data), to knowledge
(rules about the information), and to wisdom (apex of all knowledge). Modern technology like
machine learning typically is used to classify information, occupying the information level of the
triangle. Ontologies are associated with the knowledge level of the triangle. For further explanation,
I present (again) the knowledge triangle (Figure 1.3), but oriented in a use-case that may be analogous
to what we are attempting to achieve.
Let us pretend we have a robot in a concert arena. On the lef end of the gure, the musician emits
a lot of noise, some of which might be useful. If useful, the analog to digital converter transforms
* This might make sense in the next few chapters.
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Figure 1.3: Application of knowledge pyramid for agents.
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some of the noise to a digital format for the machine (data level). Machine learning and neural
networks power the robot’s speech recognition sof ware (information level) to nd patterns from
the digital data to produce string text, e.g. “Are you gonna go my way?” (Kravitz & Ross, 1993).
At the knowledge level, given the string text of “Are you gonna go my way”, what does the robot
do? Treat this as a question? Sing with the crowd? This is what ontologies for agents do, and why
ontologies are important to not just our work but also for any system that requires rules for information
and knowledge.

1.1 Objective
Our overall objective is to certify that an ontology-driven architecture for the HPV vaccine impacts
vaccination rates. By proving that this can work, we can (i) make a case to develop and deploy –
based on the technology and lessons learned – a fully-automated conversational agent for the HPV
vaccine in a clinical environment, (ii) further explore additional impact for vaccination uptake, and
(iii) exploit the system for other health-related tasks.
The approach towards our objective is described in Figure 1.4. In that gure we have three integrated
layers of the architecture for our system. The domain layer contains the domain knowledge base
for the agent. The application layer contains application rules to automate the interface layer. The
interface layer contains the basic functional units facing the user. This would include a dialogue
manager to coordinate the counseling/conversation for the HPV vaccine, an accurate question
answering system to address user questions about the HPV vaccine, and a visual facade for nonverbal behavior (emotion, regulating turn-taking, and feedback). This layer also harnesses the domain
knowledge layer for some of its functionality. There is the user experience aspect that involve factors
that could lead to vaccination uptake. While not technically part of the system architecture, the
application and interface layer is inspired by early experimentation with a simulation agent. To
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Figure 1.4: Multi-level development for the architecture of HPV vaccine conversational agent.

further support the objective, we also need to provide evidence that a conversational agent for the
HPV vaccine is well received by the user, and that there is evidence to show that the agent may
in uence decisions for vaccine uptake.

1.2 Research Hypothesis and Specific Aims
Our research asserts the following:

Hypothesis:

Application and domain ontologies can serve as the primary facilitator for the

interaction of conversational agents for communicating and impacting vaccine knowledge in health
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consumers.

Hypothesis:

A speech-enabled conversational agent can be an e fective tool to enhance positive

HPV vaccine beliefs.
Specific Aims
1. Model patient-centric health knowledge relating to the HPV vaccine and serialize the
structure of the knowledge into standard OWL and RDF format.
2. Develop the interaction applications that harness application ontologies that can regulate
the interaction ow between user and machine.
3. Assess the di ferent tiers of the proposed conversational agent for HPV vaccine to validate
its feasibility for eld use.
• Appraise the quality of health consumer ontologies for domain knowledge
• Evaluate the system functionality of the ontology-driven application for dialogue
interaction
• Examine the overall system usability of the voice interaction interface through prospective
users
• Examine the impact of the conversational agent on the users’ health beliefs of the HPV
vaccine

1.3 Dissertation Summary
In Chapter 2, I review the background that supports this research. This chapter covers some of
the basic history and the importance of the HPV vaccine on the human population and the need
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to address the low vaccination rates, particularly provider interaction with patients and health
consumers† . Chapter 2 also reviews the eld of ontology and knowledge representation, along with
the sub elds pertaining to ontology evaluation and question answering for ontologies. Natural
language processing research will also be brie y discussed as they are interdependent with ontology
research. More importantly, dialogue systems are discussed from the perspective of utilizing ontologies,
and from the perspective of dialogue systems impacting the healthcare domain.
Chapter 3 discusses development and design of health consumer ontologies for HPV vaccines.
This includes the work that has resulted in the Vaccine Information Statement Ontology (VISO),
Vaccine Information Statement Ontology for HPV (VISO HPV), and the Vaccine Misinformation
Ontology (VAXMO). This chapter will also explore my work in ontology engineering tools that
involve using natural language generation and metrics underpinned by semiotic theory.
In Chapter 4, we review our work on applied ontologies for interaction with health consumers. This
chapter highlights some preliminary work in implementing the Wizard of OZ protocol for data
collection. Also, the chapter discuss the development and design of the Patient Health Information
Dialogue Ontology (PHIDO), an application ontology for controlling machine decision for dialogue.
Brie y, the Visualized Emotion Ontology (VEO) is mentioned in Chapter 4.
Chapter 5 embarks on assessing the di ferent layers of the architecture of a conversational agent
for HPV vaccine counseling. This chapter examines the evaluation of the rst layer, namely the
su ciency of the domain ontologies – VISO HPV and VAXMO. The chapter follows up on assessing
the second layer which is the application tier. This involves reviewing the results of the evaluation of
question answering sof ware component (harnessing VISO HPV) and the ontology-driven dialogue
engine powered by PHIDO. Also discussed in this dissertation is the evaluation of PHIDO, and
some brief notes about VEO and its own engine. The third layer pertains to the user experience
†

Throughout this document, I will use patients and health consumers interchangeably as they are
generally thought of as the same.

10

evaluation of the conversational agent where users interacted with the system and provided their
feedback. The data collected is discussed in assessing the agent’s usability and impact. Lastly, this
chapter also explains the integration of the various tiers to serve as a blueprint for ontology-driven
spoken dialogue system for HPV vaccine counseling.
Chapter 6 summarizes the contribution of this work, and its limitations and impact on future
studies.
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Health informatics

the interdisciplinary study of

the design, development, adoption, and application of
IT-based innovations in healthcare servic delivery,
management, and planning.
United States National Library of Medicine

2
Background

This work covers two basic areas - domain and application ontologies and the impact of human
papillomavirus (HPV) vaccines on health consumers. For the former, we will focus on the HPV
vaccine, which until last year, was a vaccine that targeted adolescent boys and girls to protect them
against the HPV virus. The vaccine was approved for females upon its inception in 2006 (US Food
and Drug Administration and others, 2006; Garland et al., 2007). In 2011, the Federal Drug Agency
approve of its use for young males (Castle & Scarinci, 2009). Last year, the Federal Drug Agency
approved the vaccine’s e fectiveness for up until the age of 45 (US Food and Drug Administration,
2018) (i.e. previously the vaccine had proven e fectiveness for 11 to 26 years of age). Ontologies are
electronic artifacts that codify the structure of knowledge to facilitate standardization of semantic
knowledge and to provide reasoning intelligence for sof ware agents. It is not uncommon to discuss
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ontologies and natural language processing considering the use of semantic labels assigned to concepts
and relationships. We will also discuss some subtopics of natural language processing that have a
unique and important role with our research on health consumer ontologies, including dialogue
systems. Overall, the topics in this chapter covers the background information in the later chapters
of this dissertation.

2.1 Human Papillomavirus Vaccine
At 79 million reported cases, human papillomavirus (HPV) infection is one of the most common
sexually transmitted infections, and per year, according to the Centers for Disease and Control, 14
million more infections will be reported (Centers for Disease Control and Prevention (CDC), 2013a;
Weinstock et al., 2004). Based on one report, HPV will infect 80 million women by the time they
reach 50 years of age, and about 50% of sexually active males and females will eventually contract
the HPV virus (Centers for Disease Control and Prevention (CDC), 2011). Also it is estimated that
80% of US women by the time they reach 50 will have been vulnerable to the HPV virus (Chesson
et al., 2014; Dunne et al., 2007; Weinstock et al., 2004; Centers for Disease Control and Prevention,
2016a; Chesson et al., 2014). Previous gures noted that 20 million were infected by the HPV virus,
and also projected, that 6 million more will be infected each year - a notable increase from what
was described earlier (Dunne et al., 2007; Weinstock et al., 2004; Centers for Disease Control and
Prevention, 2016a; Dunne et al., 2007; Weinstock et al., 2004; Centers for Disease Control and
Prevention, 2008).
HPV virus sub-types are classi ed as low-risk or high risk, with the low-risk attributed to genital
warts and the high risk attributed to cancer-related outcomes, such as cervical cancer, throat cancer,
and genital-a fected cancers (Centers for Disease Control and Prevention, 2014b; Palefsky, 2010).
Speci cally, the high-risk virus (HPV 16 and HPV 18) are accountable for 25-30% oral and throat
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cancers, 90% of anal cancers, and 40% of penile cancers; and HPV 6 and HPV 11, the low-risk types,
are primarily responsible for the occurrence of genital warts, which require comprehensive treatment
(Parkin & Bray, 2006; Watson et al., 2008b; Lacey et al., 2006). Though uncommon, HPV infection
can also be transmitted to children during pregnancy and delivery (Centers for Disease Control and
Prevention, 2014b; Markowitz et al., 2014).
Reports have indicated an increase in cervical and genital cancer over the last decade, with 33,000
new cases of HPV-related cancer cases (Chaturvedi et al., 2011; Munoz et al., 2004; Centers for
Disease Control and Prevention (CDC), 2012). Each year, 12,000 cervical cancer cases are reported in
the United States, with 4,000 cases of deaths resulting from cervical cancer among women each year
(U.S. Cancer Statistics Working Group, 2013; CervicalCancer.org, 2014; Centers for Disease Control
and Prevention (CDC), 2012). Worldwide, the number of new cases of cervical cancer is estimated at
471,000, and it is the 5th most common type of cancer impacting females (CervicalCancer.org, 2014;
Allen et al., 2011). While irrespective of the US region, women in the South are highly impacted
by cervical cancer, and compared to other socioeconomic levels, women belonging to lower socioeconomic strata are greatly a fected (Watson et al., 2008a; Hendry et al., 2013). Also, when compared
to Caucasians, African Americans and Hispanics su fer more from cervical cancer (Reis et al., 2005;
Newmann & Garner, 2005). In addition to cases of cervical cancers caused by HPV, a recent report
estimates that 70-90% of new cases of head and neck cancer is due to the HPV virus (Young et al.,
2015). While women can be diagnosed with head and neck cancer, non-smoking white males in their
40s and 50s are disproportionately a fected by head and neck cancers caused by HPV (Deschler et al.,
2014; Chaturvedi et al., 2011; Centers for Disease Control and Prevention (CDC), 2014; Hemminki
et al., 2000). Regardless of demographic attributes, most of the population is susceptible to the
HPV infection.

14

2.1.1

HPV Vaccine & Population Impact

In 2006, the FDA approved of a HPV vaccine that can protect patients from low and high risk
HPV viruses, speci cally for patients for teens and young adults up to the age of 26 (US Food
and Drug Administration and others, 2006; Garland et al., 2007). The HPV vaccine has shown
its e fectiveness in alleviating 70-75% of the occurrence of cervical cancer, while another study shows
a success rate of 95% against cervical lesions associated with HPV viruses (Blake et al., 2015; Garland
& Smith, 2010; Villa et al., 2007; Group et al., 2010). A few studies have also revealed e cacy of
the HPV vaccine for women over 26, even though the HPV vaccine is licensed for an age group
younger than 26 (Schwarz et al., 2011; Schiller et al., 2012; Castellsague et al., 2011). As of 2018, the
HPV vaccine is approved for use up until age 45 (US Food and Drug Administration, 2018). Despite
the success of the HPV vaccine, the United States is one of the “high income” countries to have low
HPV vaccine coverage (28%) (Hopkins & Wood, 2013; Centers for Disease Control and Prevention
(CDC), 2013c).
Irrespective of the e cacy of the HPV vaccine, it has yet to be fully embraced by the public, patients,
and even healthcare providers (Gottlieb et al., 2014). The projected goal for Healthy People 2020
is 80% coverage for the HPV vaccine, but compared to other “high income” countries, the United
States is falling behind these projections (28%)(US Department of Health and Human Services and
O ce of Disease Prevention and Health Promotion and others, 2012). Even with recommendations
by the Advisory Committee on Immunization Practices (ACIP) to vaccinate adolescents, there are
still a number of female teens and young adult females that are not completely immunized – either
they have not had the vaccine, or not completed the three dose schedule (Markowitz et al., 2014).
Infection rates for Black and Hispanic females are higher than females, resulting in greater incidence
of cervical cancer when compared to Caucasian females (Hariri et al., 2011; Watson et al., 2008b). A
few studies have pointed that non-white guardians and parents were less aware of the HPV infection
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compared to white guardians (Constantine & Jerman, 2007; Hughes et al., 2009). One study in
particular, noted that African American women were the least aware of the HPV virus (Cates et al.,
2009). These disparities are further evident in vaccination rates compared to Caucasians, where
white females have a higher vaccination coverage than African American and Hispanic. African
American teens, in general, are also lagging behind Caucasian female teens and are the least likely to
complete the 3 dose HPV vaccine routine (Rahman et al., 2014; Niccolai et al., 2011). Several studies
have revealed that minority women, speci cally black and Hispanic females were least likely to
complete the HPV vaccine schedule (Rahman et al., 2014; Laz et al., 2013; Chou et al., 2011; Gelman
et al., 2013).
Though not a representative study, one cohort group of males had 50% of the participants that have
been infected by the HPV virus, while others vary around 20% - 73% infection rate among their
samples (Giuliano et al., 2011; Dunne et al., 2006). Of concern, is that infected males tend to be
asymptotic and are expected to have more sexual partners than females (Dunne et al., 2006; Jones &
Cook, 2008; Verhoeven et al., 2006). In one study, 30% of the infected males had the type of HPV
virus that was attributed to cancer, while 38% had the genital related HPV virus (Giuliano et al.,
2011). Currently, there is no FDA-approved test to detect HPV infection in males (National Cancer
Institute, 2012).
Starting in 2009, the FDA approved the use of the HPV vaccine for males, yet current data revealed
lowered coverage of males in the United States (Centers for Disease Control and Prevention (CDC),
2010; Jemal et al., 2013; Centers for Disease Control and Prevention, 2012; Reiter et al., 2011). The
comparison with female teens (9-17) found that male teens had dramatically lowered HPV vaccination
both for vaccine invitation and completion, 24% and 5% respectively in 5 US States (Du et al., 2015).
While 2% of the boys, in another survey, had either completed or initiated the HPV vaccination
(Reiter et al., 2011). Nationwide, the vaccine initiation and completion of the HPV vaccine with
teenaged boys were 20% for initiation and 6% for completion (Rimer et al., 2014). Among the older
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male demographic (19-26), the coverage compared to female is lower than females - 2.3% for males
and 34.5% for females (Williams et al., 2014).
In one study, 80% of the teen male participants were unaware that the HPV vaccine was for males,
but this lack of awareness is common with many other than teenage boys as Liddon, et al. noted in
their review (Reiter et al., 2011; Liddon et al., 2010). However, a small percentage of parents (7%)
either wanted to delay or reject the vaccine for their sons, but nearly all of them had not spoken
to their sons about the HPV vaccine (Reiter et al., 2011). Contrasting with young adult males, a
third or close to half of young males are open to the HPV vaccination, but some were undecided
about the HPV vaccination (40%)(Ferris et al., 2008, 2009; Lenselink et al., 2008a). Liddon, et al.,
observed that the bene t of the HPV vaccine for the male’s female partner does not encourage men
for HPV vaccine uptake (Liddon et al., 2010). Health care providers and parents believe vaccinating
males would be bene cial to female patients in alleviating HPV transmission, including avoiding
stigmatizing females and advancing sexual responsibility for boys (Kahn et al., 2007; Olshen et al.,
2005; Noakes et al., 2006; Katz et al., 2009). Overall, numerous papers have suggest wide support
and advocation of male HPV vaccination by parents and health care professionals (Kahn et al., 2009;
Pearce et al., 2009; Songthap et al., 2009; Tariq et al., 2009; Katz et al., 2009; Noakes et al., 2006;
Olshen et al., 2005; Wong, 2008; Dahlström et al., 2010; Lenselink et al., 2008b; Ogilvie et al., 2008;
Podolsky et al., 2009).

2.1.2

Causes of Low HPV Vaccination Coverage

Adult female patients have lower HPV vaccine coverage and are least likely to be vaccinated during
adulthood than in their early teens (Centers for Disease Control and Prevention (CDC), 2013b;
Markowitz et al., 2012; Go f et al., 2011). Speci cally, studies show a range of 23-35% of adult aged
women (19-26) have had one or two doses of the HPV vaccine, and 13% have completed the dosing
interval (Williams et al., 2014; Laz et al., 2013). Researchers noted that college degrees, high income
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earnings (>$75000), routine health checkups, and perhaps regional locale are possible predictors of
HPV vaccination completion (Rahman et al., 2014; Chao et al., 2010; Rahman et al., 2015; Du et al.,
2015). Among women over 26, a survey indicates a majority of the women want physicians to discuss
the HPV vaccine with an older demographic, and half want to be vaccinated with the HPV vaccine
(Dempsey et al., 2015).
For patients, regardless of gender and age, factors that attribute to decisions to be vaccinated are
perceived safety issues/side e fects, recommendation from their provider, lack of vaccine knowledge,
nancial cost, and lack of vigilance (Williams et al., 2013; Kessels et al., 2012; Boehner et al., 2003;
Ferris et al., 2009; Gerend & Barley, 2009; Ferris et al., 2008; Daley et al., 2010; Hernandez et al.,
2010; Liddon et al., 2010; Reiter et al., 2010). Parents have a strong in uence, particularly their
personal perception and attitudes about the vaccine toward vaccine uptakes for their children,
and for many parents and young adults, the lack of information was barrier to HPV vaccination
uptake (Mullins et al., 2013; Rambout et al., 2014; Javanbakht et al., 2012; Perkins & Clark, 2012;
Quinn et al., 2012; Burke et al., 2010; Dahlström et al., 2010; Fang et al., 2010; Podolsky et al., 2009;
Rosenthal et al., 2008; Weisberg et al., 2009; Yeganeh et al., 2010; Kang & Moneyham, 2010).
A variety of studies have emphasized that a lack of information or knowledge gaps, regarding HPV
and the HPV vaccine, is preventing parents with children, older patients, and children from wide
regional surveys and demographics from receiving the vaccine, which ultimately may impact their
overall health and lifestyle (Downs et al., 2008; Gottlieb et al., 2009; Dorell et al., 2011b,a; Laz et al.,
2012; Stokley et al., 2011; Watkins et al., 2015; Etter et al., 2012; Fisher, 2012; Stupiansky et al., 2012;
Priest et al., 2015; Marlow et al., 2007; Lenselink et al., 2008b; Woodhall et al., 2007; Al-Naggar et al.,
2010; Bair et al., 2008; Bernard et al., 2011; Hilton & Smith, 2011; Krupp et al., 2010; Kwan et al.,
2008; To folon-Weiss et al., 2008; Robbins et al., 2010; Liddon et al., 2012a; Sotiriadis et al., 2012;
Juntasopeepun et al., 2012; Zimet et al., 2010; Mortensen, 2010; Kobetz et al., 2010a,b; Kontos et al.,
2012; Rimer et al., 2014; Blake et al., 2015; Anhang Price et al., 2011; Dahlström et al., 2010; Williams
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et al., 2011; Donadiki et al., 2014; Hendry et al., 2013). Interestingly, with patients who claim to have
extensive knowledge of HPV infection, an examination of their knowledge reveals the opposite
(Giede et al., 2010; Ahken et al., 2015). There are concerns among many parents and patients about
the safety of the vaccine (Freed et al., 2010; Kester et al., 2013; Katz et al., 2009; Marlow et al., 2009c;
Williams et al., 2011; Hopfer & Clippard, 2010; Madhivanan et al., 2009; Racktoo & Coverdale,
2009; To folon-Weiss et al., 2008; Brabin et al., 2006; Burke et al., 2010; Dahlström et al., 2010;
Fang et al., 2010; Feemster et al., 2008; Ishibashi et al., 2008; McRee et al., 2010a; Riedesel et al.,
2005; Rosenthal et al., 2008; Songthap et al., 2009; Wong, 2009; Yeganeh et al., 2010; Caskey et al.,
2009; Marlow et al., 2009b). Additionally, the e cacy of the vaccine is a common worry among
patients (Bakogianni et al., 2010; Liddon et al., 2012a; Hopfer & Clippard, 2010; Jain et al., 2009;
Ratanasiripong, 2012; Juntasopeepun et al., 2012; Weiss et al., 2011; Zimet et al., 2010; Marlow, 2011).
Globally, numerous publications have also noted that the false assumption that the onset of sexual
activity upon vaccination was a concern for parents that may have resulted in hesitancy or refusal
of the HPV vaccine (Humiston et al., 2009; Katz et al., 2009; Marlow et al., 2009c; Mays et al.,
2004; Noakes et al., 2006; Olshen et al., 2005; Waller et al., 2006; Wong, 2008; Dinh et al., 2007;
Tozzi et al., 2009; Askelson et al., 2010; Brabin et al., 2006; Marlow et al., 2009a, 2007; Brawner
et al., 2012; Bastani et al., 2011; Hendry et al., 2013; Thompson et al., 2012; Brewer & Fazekas, 2007;
Quintero Johnson et al., 2011). Because of this concern, health care providers are hesitant to discuss
the HPV vaccine because of the implication of early teen sex. In one study, some health care providers
are more comfortable discussing the sexual aspect of HPV and HPV vaccine with males than females
(Schnatz et al., 2010; Zimet et al., 2013; Kahn et al., 2012; Ko et al., 2010). There is also a misconception
among younger women and parents of daughters that if one is in a monogamous relationship,
sexually inactive, or not engaging in risky sexual behavior, then the vaccine is not needed for them,
and that they were at less risk than their counterparts (Zimet et al., 2010; Humiston et al., 2009;
Kwan et al., 2008; Wong, 2008; Hilton & Smith, 2011; Hopfer & Clippard, 2010; Marlow et al.,
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2009c; Katz et al., 2009; McClelland & Liamputtong, 2006).
For many patients and parents of patients, there is a perception of low susceptibility of HPV infection,
and hence, they would not need the HPV vaccine. Some of these perceptions include being underage
if the patient is a child, or that the HPV vaccine is not speci cally needed for them (Wong & Sam,
2010; Bastani et al., 2011; Dempsey et al., 2009; Laz et al., 2012; Forster et al., 2010; Rambout et al.,
2014; Robbins et al., 2010; Marlow et al., 2009c; Williams et al., 2011; Madden et al., 2012; Daley
et al., 2010; Hernandez et al., 2010; Liddon et al., 2010; Reiter et al., 2010; Ferris et al., 2008) . Instead,
some patients revealed certain alternative measures, like condom use, cervical screening, or being in
a monogamous relationship, precludes them from HPV vaccination (Hilton & Smith, 2011; Hopfer
& Clippard, 2010; Mays et al., 2004; Noakes et al., 2006; Williams et al., 2011; Robbins et al., 2010;
Henderson et al., 2011; Kwan et al., 2008; Leask et al., 2009; Waller et al., 2006; Caskey et al., 2009).
It is also possible that HPV vaccination itself contributes to low susceptibility of cervical screening
and protection against other sexually transmitted diseases (Henderson et al., 2011; Waller et al., 2006;
Marlow et al., 2007; Robbins et al., 2010; Vamos et al., 2008).
Another factor contributing to low coverage of HPV vaccination is the lack of health care provider
recommendation for the HPV vaccine. Of en, if there is any provider recommendation, it is weaker
compared to other vaccines that are recommended (Kester et al., 2013; Laz et al., 2012; Thompson
et al., 2012; Stokley et al., 2011; Ylitalo et al., 2013; Centers for Disease Control and Prevention (CDC),
2013c; Vadaparampil et al., 2011; Grabiel et al., 2013; Reiter et al., 2009; Zimet et al., 2010). One
possible explanation is that physicians are unaware of the preventive impact that HPV vaccine has
on cervical cancer and other cancers that result from the HPV virus (Saraiya et al., 2012; Koshiol
et al., 2009; Perkins & Clark, 2012). Another explanation is the controversial issue of discussing
the sexual activity aspect relating to the HPV vaccine, especially when the patient is a teenager
(Esposito et al., 2007; Schnatz et al., 2010; Humiston et al., 2009; Kahn et al., 2007; Krupp et al.,
2010; Sussman et al., 2007; Daley et al., 2006). Also, time constraints impede any in-depth or useful
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discussion of the HPV vaccination (Vadaparampil et al., 2011). Similar to what patients assumed,
some physicians believed that Pap tests are a preventive measure against cervical dysplasia, disregarding
the threat the HPV virus poses (Perkins & Clark, 2012; Katz et al., 2011). Possibly due to language or
cultural barriers, minority patients (African Americans and Hispanics) are least likely to receive
HPV vaccine counseling (Jeudin et al., 2014; Centers for Disease Control and Prevention (CDC),
2013d; Hughes et al., 2009; Morales-Campos et al., 2013). However, with older patients, health care
providers are likely to recommend the vaccine for adult females (Kahn et al., 2005; Riedesel et al.,
2005; Daley et al., 2006; Kahn et al., 2005; Riedesel et al., 2005). A 2007 qualitative study noted that
pediatricians believe there is greater bene t of the HPV vaccine for females than males, and that
it also be di cult to recommend the vaccine for males (Kahn et al., 2007). Though irrespective of
the health care provider recommendation, lack of access or regular checkup prevents patients from
possible HPV counseling (Blake et al., 2015).
Several studies have mentioned cost of the vaccine from the patient perspective as a determinant to
the HPV vaccine, even though the nancial cost resulting from a cancer caused by HPV is much
higher than the cost of being vaccinated (Pourat & Jones, 2012; Liddon et al., 2012a; Ratanasiripong,
2012; Juntasopeepun et al., 2012; Weiss et al., 2011; Zimet et al., 2010; Mortensen, 2010; Allen et al.,
2009; Kim & Goldie, 2009; Wei et al., 2013; Williams et al., 2013; Tiro et al., 2012; Liddon et al.,
2012b; Anhang Price et al., 2011). Notwithstanding high cost and possible insurance coverage, providers
are still less inclined to provide the HPV vaccine (Pourat & Jones, 2012; Ylitalo et al., 2013). For half
of the family physicians surveyed, the high cost of the HPV vaccine prevented purchasing them, and
with some providers, issues with private insurance coverage deterred some from vaccinating insured
patients (Freed et al., 2010; Colgrove et al., 2010; Vamos et al., 2008).
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2.1.3 Directions for Increased HPV Vaccination Uptake
In 2014, the President’s Cancer Panel suggested the need for patient-physician counseling for HPV
vaccination, and for many patients, their health care provider is their main and most trusted source
of health information to learn more about the HPV vaccine (Rimer et al., 2014; Hughes et al., 2009).
Several studies have all declared that health care provider in uence is an important factor too for
HPV vaccine uptake for their patients (Kessels et al., 2012; Rambout et al., 2014; Reiter et al., 2009;
Thomas et al., 2013; Lenehan et al., 2008; Anhang Price et al., 2011; Sundström et al., 2010; Williams
et al., 2011; Rosenthal et al., 2011; Mullins et al., 2013; Reiter et al., 2009; Caskey et al., 2009). A
few studies have noted as high as 95% vaccine acceptance whenever physician counseling occurs
between patient and physician, and in one study an 18-fold probability increase of the acceptance
as a result of health provider recommendation occurred (Hopfer & Clippard, 2010; Chow et al.,
2010; Dinh et al., 2007; Fang et al., 2010; Kang & Moneyham, 2010; Caskey et al., 2009; Lau et al.,
2012). Many patients prefer the face-to-face interaction and counseling to learn more about the HPV
vaccine in order to decide on vaccine uptake (Katz et al., 2011; Ahken et al., 2015). While there is a
strong preference for patient and physician interaction, this unfortunately forces the physician into
taking on more intensive health education than time might allow (Zimet et al., 2013). This would
involve additional professional development training and tips to address HPV vaccine barriers in
order to e fectively communicate health information to patients (Sherris et al., 2006; Valentino
& Poronsky, 2015; Zimet, 2005; Kahn et al., 2007; Leddy et al., 2009; Fang et al., 2010; Mortensen,
2010). Also, this would require health care professionals to be aware of myths surrounding HPV
vaccine, and detailing facts about HPV and the vaccine, and providing a comfortable atmosphere for
patients (Valentino & Poronsky, 2015; Ahken et al., 2015). There is also the challenge that patients
will ask few questions and interact minimally when being counseled on vaccines, as well as the health
care provider dominating the discussion and peppering their dialogue with technical jargon that
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could impede on the counseling (Go f et al., 2011; Roter et al., 2007). Yet, health care providers have
limited time to discuss the HPV vaccine with patients, which also impacts decisions for vaccination
uptake (Go f et al., 2011). In a study consisting of college males, participants noted that time and
scheduling with their provider is a barrier that prevents opportunities to learn more about the HPV
vaccine and HPV (Katz et al., 2011).
A couple of studies have noted that social interaction and support with peer and personal connection
with physicians also has an in uence on vaccine uptake (Allen et al., 2009; Hopfer & Clippard, 2010;
Boehner et al., 2003; Ferris et al., 2009; Gerend & Barley, 2009). Policy or macro-level solutions,
such as free vaccination of the HPV vaccine, does not seem to impact coverage of the population, as
evident in Greece, where 11-25% of the population are vaccinated (Bakogianni et al., 2010,?; Donadiki
et al., 2012). Mandatory vaccination policies could have a “knee-jerk” reaction in disrupting the trust
between the public and its citizens (Gostin & DeAngelis, 2007; Charo, 2007).
To address lack of extended provider counseling and lack of knowledge of the HPV vaccine, educational
intervention are needed for a wide range of patients who need to make a decision regarding HPV
vaccination, especially those in remote rural areas where the resources to provide counseling are
scarce, and minorities with lowered educational attainment (Blake et al., 2015; Herzog et al., 2010;
Fiks et al., 2013; Watkins et al., 2015; Reiter et al., 2011). While the bene ts of the HPV vaccine for
their female partner does not encourage males to vaccinate themselves of the HPV vaccine, awareness
and knowledge of how HPV infection and the vaccine impacts male health does (Jones & Cook,
2008; Boehner et al., 2003; Krawczyk et al., 2013; Gerend & Barley, 2009; Petrovic et al., 2011; Ferris
et al., 2009; Lenselink et al., 2008a). One researcher noted that repeated exposure to HPV knowledge
encouraged males to decide to receive the HPV vaccine (Daley et al., 2010). According to a review
of HPV vaccination education initiatives, most of the educational materials are written documents
that are distributed to patients (Fu et al., 2014). Most patients expressed discontent with the comprehension
level and the quality of information in order to make an informed decision for HPV vaccine uptake
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(Dempsey et al., 2009; Henderson et al., 2011; Madhivanan et al., 2009; Mays et al., 2004; To folonWeiss et al., 2008; Williams et al., 2011; Wong, 2008). And overall, providing written documentation
is insu cient to educate patients about HPV vaccination (Dempsey et al., 2006).
As far as the type of content that is needed to be communicated to patients, describing the HPV
vaccine as a cancer preventive measure is a convincing argument for patients to eventually decide on
uptake (McRee et al., 2010b; Krakow et al., 2015; Hilton & Smith, 2011; Hopfer & Clippard, 2010;
Humiston et al., 2009; Madhivanan et al., 2009; Stretch et al., 2009). Also, for men, prevention
of genital warts, protection for their partner and overall well-being as a result of being vaccinated
provides forceful justi cation, along with the basic information about HPV infection, what the
vaccine protects against, etc. (Ferris et al., 2008; Krawczyk et al., 2013). However, communication
of HPV vaccination information whether verbally or written is complex and challenging, as one
has to consider the information about sexual transmission (a sensitive topic for some patients), or
communicating subtle information about the vaccine in a clinical environment (Quintero Johnson
et al., 2011; Zimet et al., 2013). Too much information for the patient may pose some di culties in
a time constrained session or may cause fear in the patient, and caution should be considered when
relaying negative information about the vaccine as it could impede on the patient’s decision (Evans
& Bostrom, 2002; Go f et al., 2011). In a survey among male college students, any information
gathered about the HPV vaccine came from multimedia sources, even though participants preferred
face-to-face counseling for the vaccine (Katz et al., 2011). Particularly, using web-based intervention
for vaccine education and decision making has the bene t of being cost e fective, exible, interactive,
and holds the potential to positively in uence patient decisions regarding uptake (Lustria et al.,
2007; Michael & Cheuvront, 1998; Brewer & Fazekas, 2007; McRee et al., 2010a; Fabry et al., 2011;
Betsch et al., 2010). There has been no study to determine whether the web-based interventions and
education ultimately led to actual vaccine uptake (McRee et al., 2012).
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2.1.4

Health Belief Model

For any health intervention, grounding the intervention or program to any theory allows better
design of programs and strategies to a fect the behavior of the population and for improving and
validating existing theories (Migneault et al., 2006). Particularly with interventions relating to either
vaccines or vaccinations, theories of health behavior can potentially deduce beliefs that may lead to
vaccine uptakes (Brewer & Fazekas, 2007). The health belief model (HBM) is one type of theoretical
framework that aims to predict an individual’s intent to engage in a preventive health behavior
based on attitudinal and psychological factors. Simply, personally held beliefs can have an in uence
on whether one will undertake a particular preventive health behavior. HBM was introduced by
Becker (1974) in the 1970s, and, as a theoretical psychological model, it has demonstrated predictive
validity in various studies (Brewer & Fazekas, 2007; Zak-Place & Stern, 2004; Petosa & Jackson,
1991). Speci cally with HPV vaccine research, studies have revealed that the health belief model
has been shown to predict the intent to take the HPV vaccine among young females – for example
Gerend & Shepherd (2012); Patel et al. (2012) and many other studies have utilized the health belief
model to determine a subject’s intent for vaccine uptake, speci cally the HPV and in uenza vaccines
(Montgomery & Smith-Glasgow, 2012; Marlow et al., 2009b; Juntasopeepun et al., 2012; Coe et al.,
2012). The variables that comprise the health belief model include perceived susceptibility, severity,
beneﬁts, and barriers (Becker, 1974; Janz & Becker, 1984).
• perceived susceptibility is “a person’s subjective perception of the risk of contracting a particular
condition or illness (perceived personal relevance)” (Bartholomew et al., 2011). If an individual
believes he or she is of no risk of a harmful condition, they are least likely to behave in a
manner to avert the condition.
• perceived severity is “a person’s feelings concerning the seriousness of contracting an illness”
(Bartholomew et al., 2011). A patient that assumes a condition is less severe is least likely to
engage in healthy behaviors.
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• perceived beneﬁts is “a person’s belief regarding the e fectiveness of various actions available
to reduce the threat of a disease” (Bartholomew et al., 2011). A patient regarding a health
behavior as a bene cial preventive measure against a condition or illness is likely to adopt the
health behavior.
• perceived barriers is “a potential negative aspects of a particular health action” (Bartholomew
et al., 2011). This includes factors, whether external or even psychological, that prevent an
individuals’ intention towards a healthy behavior.

Figure 2.1: Adapted gure from Janz & Becker (1984) for HPV vaccine intervention.

In application to vaccination, these constructs translate to the risk associated of contracting a certain
disease or infection if not vaccinated (perceived susceptibility), the assumption of the e fectiveness
of the vaccine (perceived beneﬁts), the severity of disease or infection in absence of a vaccination
(perceived severity), and the perceived barriers related to physical, or psychological barriers that
would inhibit vaccination ( nancial or attitudes).

2.2 Ontologies
The word ontology has its roots in metaphysical philosophy, extending back to Aristotle’s Categori ,
as a “nature of being”. In the early 90s, the de nition of ontology was oriented in the computer
science eld as a “speci cation of a conceptualization.” (Gruber, 1995). At the turn of the century,
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Sir Tim Berners-Lee described his vision for the next generation web called the “semantic web”
in Scienti c America where ontologies would be the foundation for this vision (Berners-Lee et al.,
2001). Simply, an ontology is a machine-readable artifact or le that encodes a logical representation
of a domain space using vocabularies and their semantic meanings. It is the output of a knowledge
engineering process where tools and methods are used to build the ontology (Gomez-Perez et al.,
2006). Overall, ontologies are used for representing information and knowledge (Bodenreider &
Stevens, 2006; Cimino & Zhu, 2006; Yu, 2006). Worth mentioning, ontologies still rely on their
philosophical roots to help model the physical world as accurately possible in order for it to be used
for science-related research, and there are currently two philosophical schools of thought, one of
which is the realist approach, where the modeling of the physical world should be independent
of our cognitive perception (Smith, 2003). The eld of philosophy still plays an important role in
ontologies as evident in the work of the Basic Formal Ontology (Smith & Grenon, 2019) which is an
upper-level ontology that encodes philosophical concepts to align (and unite) the knowledge bases
from biomedical ontologies.
An ontology, according to Gruber, is a “description (like a formal speci cation of a program) of the
concepts and relationships that can formally exist for an agent or a community of agents (Gruber,
1995).” Simply, an ontology consists of entities and relationships between the entities that de ne
and model a knowledge space for a speci c domain. Notationally, ontologies can be described in the
following manner (Girardi, 2010):

O = {C, H, I, R, P, A}

(2.1)

Where O, in Equation 2.1 represents the ontology as a tuple. C is set of classes that abstracts the
entities in the ontology, and I indicates set of instances in the ontology that instantiates the classes.
Both C and I are generally entities of the ontology. H symbolizes the “type of ” relationships or
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hierarchical connections between classes (C), and R represents the non-hierarchical relationships
between the classes (C) or instances (I) - e.g. protects(MMR_Vaccine, measles). P represents properties
of the entities or their speci c data types that they encapsulate, i.e. has_DOB(Patient, DateTime),
and A is a set of axioms that describe rules in the ontology, i.e. Mother ≡ Parent ⊓ Female.
A knowledge triple is a “building block” of an ontology that is comprised of two entities and at least
one relationship between them - a subject-predicate-object statement. Figure 2.2 displays an example
knowledge triple, showing the various dimensions of an ontology - class (TBox) and instance level
(ABox). The class level from Figure 2.2 displays one knowledge triple manufactured_by(Vaccine, Company)
(Vaccine

manufactured by a company). On the instance level, Gardasil-9 is an instantiation of

Vaccine, and Merck is also an instantiation of Company. The relationship de ned on the class level,
manufactured by, is also alluded between Gardasil-9 and Merck.

Figure 2.2: Example of ontology abstraction.

Not shown in the gure are assertions for relational knowledge, RBox. RBox are a nite set of object
property assertions. These assertions provide additional meaning to the predication. For example,
we can further de ne the manufactured by in Figure 2.2 by also de ning another relationship, manufactur .
We can de ne manufactured by and manufactured as an inverse property assertion. This would
imply that not only a Vaccine is manufactured by a Company, but also asserts that a Company manufactur
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a Vaccine. Thereby, the instance from Figure 2.2, could reason that Merck manufactures Gardasil-9.
With our limited example, we can further express this relationship and the domain surrounding this
triple with other RBox de nitions:
• SubObjectPropertyOf - parent child relationship between classes and instances
• EquivalentObjectProperti - de nes equivalent classes and instances
• DisjointObjectProperti - de nes non-equavialency between classes and instances
• InverseObjectProperti - a relationship between classes and instances is an inverse of another
relationship between classes and istances
• ObjectPropertyDomain - that a class or instance is domain of relationship
• ObjectPropertyRange - that a class or instance is a range of relationship
• FunctionalObjectProperty - a relationship that establishes that a class or instance (domain) has
only one distinct class or instance (range)
• InverseFunctionalObjectProperty - inverse of FunctionalObjectProperty where a class or
instance (range) has one distinct class or instance (domain)
• ReﬂexiveObjectProperty - de nes a class or instance has a relationship to itself
• IrreﬂexiveObjectProperty - de nes that a class or instance cannot have a relationship to itself
• SymmetricObjectProperty - a relationship between classes or instances is reciprocal
• AsymmetricObjectProperty - a relationship between class or instances in not reciprocal
• TransitiveObjectProperty - a relationship is between classes or instances that have indirect
relationship with other related classes or instances.
Lastly, throughout this document, we use the word knowledge base and ontology interchangeable .
Formally, knowledge base is de ned as only the TBox and ABox.
Being a tool to model complex information, speci cally a domain like health care, yield some value
for ontologies, along with querying complex information. Other bene ts in using ontology to
describe domain knowledge include (Yu, 2011):
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• “Provid[ing] a way to reuse domain knowledge
• ...[M]akes domain assumptions explicit
• ...[P]rovides encoding of knowledge that machines can understand
• ...[A]utomat[e] large-scale machine processing...”
In general, knowledge in an ontology is represented as a triple in which information is presented
as subject → predicate → object. Essentially, the subject → predicate → object are concepts
that are “smallest, unambiguous unit of thought ... [that are] uniquely identi able” (Groth et al.,
2010). Each triple can seamlessly link to another triple to form an ontological knowledge base. For
the knowledge to be readable by a machine, we use a computer-based syntax to encode it. Once
encoded, this artifact can be shared and distributed for various purposes. Moreover, using OWL
(Web Ontology Language) or RDF (Resource Description Framework), speci c types of web ontology
language syntax for ontologies, we can de ne more complex axioms and assertions to fully describe
concepts which could provide machine reasoning capabilities.
The fundamental bene t of ontologies for the biomedical eld or any other eld is being able
to connect research in biology with applications in medicine. Simply, by having machines and
computational tools harness the encoded biomedical knowledge, it can reveal knowledge and information
unrealized before, support the development of new sof ware tools (Rubin et al., 2007), and model
complex health information (Cimino, 1998).
One main bene t of an ontology is allowing for search and querying of aggregate heterogeneous
data. Using a single identi cation where a concept might have several labels, heterogeneous information
can be queried and retrieved if the information is associated with one of the labels. This is of particular
use with image data where ontologies can link image data (e.g. MRIs) with non-image data (Martone
et al., 2004), or of use with research data to map and link di ferent data sources so they can be
queried at once (Shah et al., 2006).
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Another bene t is in information integration. Because ontologies can link and map di ferent data
sources, by nature, the information is integrated (Rubin et al., 2007). This bene t is of importance
in the medical domain where there is a need to make data interoperable and shareable (Yu, 2006).
Ontologies can also facilitate data exchange between systems. Ontologies are formalized representations
of a domain space and are consistent formats that allow for distribution and sharing (Rubin et al.,
2007). For clinical decision support systems or systems that utilize ontological knowledgebases, this
would be a useful feature in sharing data between various systems (Yu, 2006).

2.2.1

Ontology Evaluation

The evaluation of ontologies is not settled (Alani & Brewster, 2006; Obrst et al., 2007; Amith
et al., 2018a). Ontology evaluation “is the problem of assessing a given ontology from the point
of view of a particular criterion of application, typically in order to determine which of several
ontologies would best suit a particular purpose” (Brank et al., 2005). For the last decade several ideas
emerged addressing ontology evaluation (Brank et al., 2005), but none have appeared to be adopted
universally by ontologists (Obrst et al., 2007; Almeida, 2009). Commonly, subject matter expert
reviewers are sought to evaluate an ontology and provide feedback for changes. However, this e fort
is a time and resource intensive approach, especially if the reviewers need to acclimate themselves on
the topic of ontology and ontology-related tools, like Protégé (Musen et al., 2015). A brief review
of 200 randomly selected biomedical ontologies hosted on the National Center of Biomedical
Ontologies’ (NCBO) BioPortal reveal that only 15 out of 200 have a formal assessment described
in a corresponding design paper, and the remaining do not have any explicit documented evaluation
(Amith et al., 2018a). With ontologies helping to further research in the biomedical domain, this
highlights a strong need for evaluation for biomedical ontologies.
One of the future direction noted by Brank et al. (2005), is the need for automated tools to perform
ontology evaluation. From research culled from the ACM and IEEE databases, six papers discussed
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automated or semi-automated tools to preform ontology evaluation. All of the tools mentioned in
the six papers were of experimental nature and not available for public use. Table 2.1 is from (Amith
et al., 2019a) that brie y discusses some of the experimental tools for ontology evaluation.

Paper
Ontology Evaluation and Ranking
using OntoQA (Tartir & Arpinar,
2007)
A Web-Based Ontology Evaluation
System (Jianliang & Xiaowei, 2008)
A Survey on Ontology Evaluation
Tools (Aruna et al., 2011)

Quality Model and Metrics of
Ontology for Semantic Descriptions
of Web Services (Zhu et al., 2017)
An Ontology Selection and Ranking
System Based on the Analytic
Hierarchy Process (Groza et al.,
2014)
Ranking ontologies in the Ontology
Building Competition BOC 2014
(Jimborean & Groza, 2014)

Method
OntoQA metrics (Tartir et al., 2005)

Burton-Jones based; focused on the
“subjective” metrics
Survey paper that discussed OntoAnalyser
(OntoEdit plugin), OntoGenerator
(OntoEdit plugin), WebODE plugin
for OntoClean, Ontology Evaluation Tool,
and S OntoEval
Paper is corrected version (Liu et al., 2016)
that extends the ontology evaluation
framework they introduced earlier
Applies analytic hierarchy process to
evaluate ontology through Java-based
application tools. Calculates language
expressivity, domain coverage, size,
consistency, and cohesion
Ranking-based metric system implemented
as a web-based tool. Calculates structural,
semantic, and term quality

Table 2.1: Papers surveyed for ontology evaluation software tools.

2.2.1.1 Applying Semiotics Theory for Ontology Evaluation
Ontologies are sometimes alluded as symbolic representations of a domain space where the terms
signify the entities contained within the domain space. Likewise, semiotics is a study of meaning
behind signs and symbols or representations, divided by three aspects - pragmatic, syntactic, and
semantic. Ontologies are generally though of as semiotic products (Burton-Jones et al., 2005; Dividino
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et al., 2008; Gangemi et al., 2006; Stamper et al., 2000) Rationale for utilizing semiotic theory have
been explained in several practical endeavors. For example, Tolk et al. (2012) discussed the possibility
of utilizing semiotic theory for modeling and simulation and Price & Shanks (2016) discussed the
utility of semiotics for information systems and evaluating data models and information quality .
Burton-Jones, et al. introduced an ontology evaluation framework based on the theories of semiotics
that utilized various metrics formulated within the three branches of semiotics, along with an additional
branch called “social” (Burton-Jones et al., 2005). Each evaluation criteria, based on the branches,
asks if the ontology is useful (pragmatic), can it be read (syntactic), can it be understood (semantic),
and can it be trusted (social). Each of these branches are decomposed to additional aspects that
derive their values from data acquired from the ontology and external sources - subject matter
feedback, number of links to the ontology, etc. The weighted sum (b1 , b2 , b3 , b4 ) for the four criteria
results in the overall quality score (Equation 2.6).

P = bp1 · PO + bp2 · PU + bp3 · PR

(2.2)

Equation 2.2 illustrates the calculation for the pragmatic quality (P) where PO is the comprehensive
quality value, PU is the accuracy value, and PR is the relevance value. The normalized sum of the
three values provides pragmatic quality score. Comprehensiveness alludes to size of the ontology to
cover a domain. The larger the ontology the more complete the ontology represents its domain.
Accuracy is a rating for the truthfulness of the ontology, which is gathered from subject matter
expert review, and relevance relates to compliance of user requirements.

S = bs1 · SL + bs2 · SR

(2.3)

The syntactic quality represented in Equation 2.3 takes the weighted sum of lawfulness (SL) and
richness (SR). The lawfulness quality indicates compliance to the ontology language, and richness
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value designates the amount of ontology features utilized.

E = be1 · EI + be2 · EC + be3 · EA

(2.4)

Equation 2.4 represents the semantic quality equation, where EI is interpretability, EC is consistency,
and EA is clarity. The clarity value rates how ambiguous the terms in the ontology are, and consistency
indicates consistent meaning of the terms. Interpretability measures term meanings.

O = bo1 · OT + bo2 · OH

(2.5)

The social quality score in Equation 2.5 is composed of the weighted sum of authority as OT and
history as OH. Authority represents the number of ontologies that link back to the ontology, and
history is the number of times the ontology has been accessed by the community.

Q = b1 · S + b2 · E + b3 · P + b4 · O

(2.6)

The overall quality score (Equation 2.6) is the weighted sum of pragmatic (P), syntactic (S), semantic
(E), and social(O), which is a value between 0 (lowest) to 1 (highest). (Burton-Jones et al., 2005)
contains details to derive the various values for each of the quality aspects to generate the overall
quality score.

2.2.2

Ontology-based Question-Answering

Question answering (QA) is “the task of nding answers to natural language questions, meaning
that question answering systems do not retrieve documents (like information retrieval systems),
but instead provide short, relevant answers in an interactive setting” (Sonntag, 2010). Essentially,
the aims of QA is to help users use natural language to nd precise information and help end-
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users query knowledge sources without having to code computer-level queries, using a natural
language interface (Kaufmann & Bernstein, 2007). Some of earliest implementation of question
answering were natural language interfaces for databases (NLIDB) (Androutsopoulos et al., 1995;
Green Jr et al., 1961; Wood et al., 1978), and later, as data evolved into scheme-free corpora and
natural language processing methods matured, question answering methods moved towards querying
free-text sources and semi-structured sources (like health records) (Voorhees & Tice, 2000).
A completely di ferent take on question answering is QA for ontologies. For the last decade, several
QA for ontologies tools were proposed - AquaLog (Lopez et al., 2005), PANTO (Wang et al., 2007),
NLPReduce (Kaufmann et al., 2007), Freya (Damljanovic et al., 2011), Querix (Kaufmann et al.,
2006) - with relative success. These systems aimed to assist casual users and domain experts who
have inexperience with writing query computer commands to easily query a knowledge information
source, like a knowledge base triple store. While they each introduced their various approaches,
they all exhibit some similar features. This included a gazetteer subsystem that build a list of terms
utilized in the ontology, along with some procedures to perform term similarity between terms from
the query and the gazetteer. Additionally, another similar feature among the QA systems is a process
to extract knowledge triples from the natural language query, facilitated by a natural language parser
or a combination of a few natural language methods.
There are bene ts for an ontology-driven method for question answering over other question
answering methods (Lopez et al., 2011). Compared to QA for databases, ontology-driven QA has
the bene t of being loosely coupled from the natural language interfaces (NLI), meaning that there
is minimal con guration work for the NLI to accommodate new knowledge sources or databases.
Another bene t is semantics which allows for handling queries that have unfamiliar terms or terms
that may have ambiguities, allowing for better precision in the responses for the questions. QA for
free-text sources are burdened with taxonomic classi cations for answer types, rule-based mechanisms
to recognize types of entities, and use of information extraction to discern semantic relationships.
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Whereas, in the ontology-based QA, these speci c burdens are non-existent, and the ontology
itself will have semantic relationships embedded. Other bene ts also include (a) generating natural
language answers from the triples, instead of reliance on snippets of texts that have to be ranked and
chosen by a sub-system, (b) better handling unfamiliar answer types with the utilization of semantic
relationships, and (c) the bene t of retrieving extended responses from other linked ontologies
and/or inferred responses from reasoning capabilities of the ontology. Altogether, ontology-driven
question answering has unique characteristics to improve on question answering research and a
possibly provide better implementation.

2.3 Natural Language Processing
Earlier, the potential synergy between ontologies and natural language processing was noted. Natural
language processing (NLP) is is de ned as “computational techniques for analyzing and representing
naturally occurring languages at one or more levels of linguistic analysis for the purpose of achieving
human-like language processing for a range of tasks or applications” (Liddy, 2001). The fundamental
goal of NLP is to disambiguate and utilize natural language free text data for machine computational
tasks. Within the context of this study, NLP research is supplementary to goals of this research. The
body of research in NLP is expansive, ranging from question answering (discussed earlier within
the domain of ontologies) to named entity recognition, sentiment analysis, etc. This section focuses
on a few essential, yet unique, subtopics – one is the recent sub eld of open information extraction,
natural language generation, and primarily, dialogue systems. For the latter, we will focus on the
spoken modality of dialogue systems, but we acknowledge other modalities like text-based (e.g.
chatbots).
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2.3.1 Open Information Extraction
One aforementioned sub eld relates to information extraction, which involves extracting predicates
or triples automatically from unstructured sources for a variety of purposes such as ontology learning,
text mining and question answering. Open information extraction (OIE) is one variation and
is de ned as “extraction paradigm that facilitates domain – independent discovery of relations
extracted from text and readily scales to the diversity and size of the Web corpus. The sole input
to an OIE system is a corpus, and its output is a set of extracted relations. An OIE system makes a
single pass over its corpus guaranteeing scalability with the size of the corpus.” (Banko et al., 2007).
It is generally domain independent, designed to handle a variety of unstructured sources –speci cally
content from the web that is heterogeneous in nature, and unsupervised (no training data required).
Some open information extraction methods utilize dependency parsing that yields adequate precision
and recall, while others utilize chunking, shallow parsing, and parts of speech tagging methods that
yield high precision and low recall (Del Corro & Gemulla, 2013). Some examples of OIE methods
introduced include TextRunner (Banko et al., 2007), NELL (Carlson et al., 2010b,a), ReVerb (Fader
et al., 2011), OLLIE (Schmitz et al., 2012), CSD IE (Bast & Haussmann, 2013), ClausIE (Del Corro &
Gemulla, 2013), Stanford OpenIE (Angeli et al., 2015), Minie (Gashteovski et al., 2017), and Graphene
(Cetto et al., 2018).

2.3.2 Natural Language Generation
Natural language generation (NLG) aims to derive natural language text from data, and it is thought
of as one of two main topics within the eld of natural language processing (i.e. the other being
natural language understanding (NLU)) (Reiter & Dale, 2000). NLG is de ned as the “sub eld
of arti cial intelligence and computational linguistics that focuses on computer systems that can
produce understandable texts in English or other human languages” (Reiter & Dale, 2000). While
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NLU focuses on derivation of structured data from free text, NLG focuses on producing free text
from structured data. For the latter, the utility of NLG is to produce documents, ontology evaluation,
and the summarization of data. Within the biomedical domain, when given large volumes of complex
data, such as neonatal ICU data, NLG may be more bene cial than visualization of data (Portet
et al., 2009). A variety of tasks or subtopics exist within the domain of natural language generation
(e.g., structuring documents, content selection, lexicalization, co-reference expression generation,
aggregation of sentences, and surface realization) (Perera & Nand, 2017). The main NLG task that
our work focuses on is surface realization, speci cally grammar-based realization. Surface realization
is concerned with “mapping the text speci cation to the surface form of the sentences” (Perera
& Nand, 2017) for human consumption. Grammar-based realization generally utilizes linguistic
structures and heuristics to form sentences. The current state of the art in grammar-based realization
is SimpleNLG (Gatt & Reiter, 2009) which o fers an API interface to programmatically change
the morphological and syntactical features for a generated sentence. Optionally, SimpleNLG can
import the NIH Specialist Lexicon (Kazama et al., 2002) for biomedical related use-cases. We will
refer to SimpleNLG in later chapters.

2.3.3 Dialogue Systems
At some point of the life of a normally developed individual, they will learn how to carry conversation
beyond the obligatory “hello”. Determining whether to “give the oor” to another individual,
guring out what to say next, and how one should reply to someone’s speech are some of the basics
of natural discourse. In speech, one can potentially communicate more information than in written
form (D’Mello et al., 2010). Because speech is a natural act among humans, the ease to express
thoughts in speech is relatively easier than written (Chafe, 1982; Tannen, 1982). In addition, speaking
provides opportunity to convey more content in very little time (Damianos et al., 2003; Harris &
Biermann, 2002; Litman et al., 2006). Machines, unlike humans, are not social entities, yet NLP
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research is advancing the possibility of more interactive systems that can help users query systems.
Yet managing dialogue using a computer-based system poses some challenges. Jurafsky & Martin
(2009) states that dialogue is a form of discourse, which is a group of sentences that are connected by
meaning and with entities that are clearly presented and described. Similarly, Bickmore & Giorgino
(2006) also expound on the de nition of discourse as “extended use of language to convey desires,
beliefs, and intention” .
Within the scope of this proposal, a discussion of dialogue will be grounded in interactive learning
between the educator agent and the learner. Dialogue can garner bene ts by demanding the learner’s
attention, assessing the learner’s gaps in knowledge and rectifying the gaps, and identifying miscommunication
and incorrect information (VanLehn et al., 2007). Socratic teaching style, which in most forms
involves interactive dialogue between student and teacher, is said to develop the student’s language
skills (Core et al., 2003). Because speaking is a natural act, responses from learners require less e fort
than written format (De La Paz & Graham, 1997). One-on-one interactive learning also is said to
provide better learning outcomes than formal classroom environments (Cohen et al., 1982), while
not exercising pedagogical strategies (D’Mello et al., 2010).
Regardless of whether it is computer-based or human-facing, interactive learning has demonstrated
some educational gains with individuals (Evens & Michael, 2006; Graesser & Olde, 2003; Lane
& VanLehn, 2005; Person et al., 2001; Swanson, 1992; Wood et al., 1978). According to VanLehn
et al. (2007), non-interactive learning is a state of just “pure reading or video watching without any
problem solving or question answering”. Several studies, controlling for the same content in both
the non-interactive learning group and the interactive learning group, revealed that larger learning
gains are attained in the interactive learning intervention than the non-interactive group (Evens &
Michael, 2006; Graesser & Olde, 2003; Lane & VanLehn, 2005; Person et al., 2001; Swanson, 1992;
Wood et al., 1978; Craig et al., 2004).
To provide an interactive learning experience would require human resources which may be costly
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(Allen et al., 2006). Dialogue systems can automate and mimic the face to face interactive experience
for users, speci cally for educational use cases. A dialogue system, based on the Journal of Dialogue
Systems de nition, is
“a computational device or agent that (a) engages in interaction with other human
and/or computer participant(s); (b) uses human language in some form such as
speech, text, or sign; and (c) typically engages in such interaction across multiple turns
or sentences” (Konstantinova & Orasan, 2012).
Learning from an agent can be enjoyable and users may be more interested in learning from a computer
agent (Johnson et al., 2000). Also of value, dialogue systems o fer hands-free interaction, and the
usage of expressive natural language (Allen et al., 2006). Dialogue systems allow very novice users to
interact with a complex system or function using natural language (Allen et al., 2006). Despite users
knowing they were interacting with a computer, they “felt” they were talking to a real “person”,
according to interviews with users (Migneault et al., 2006).

Figure 2.3: Simple implementation of dialogue management using nite state automaton (Jurafsky & Martin, 2009).
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The literature describes at least 3 or 4 types of implementation of dialogue management - nite state,
frame-based, and plan-based/inferential (Jurafsky & Martin, 2009; Ginzburg & Fernández, 2010;
Bickmore & Giorgino, 2006). The nite state approach is the simplest approach where the nodes
of a nite state automaton represent questions that the system would ask the user and multiple
possible options and outcomes. Figure 2.3 taken from Jurafsky & Martin (2009) describes a simple
architecture of the nite state based dialogue system. Unfortunately, nite state machine-base dialog
management requires manually coding and thus is time consuming if modi cations are needed
(Kabanza et al., 2006; Rahati, 2012; Zhou et al., 1999). Another disadvantage is handling a large
number options or states in the dialogue and the designer has to anticipate every possible option
in the dialogue discourse between the user and the system (Rahati, 2012). Frame-based dialogue
management essentially captures missing information in order to execute a function. With a framebased system, speci c tasks require certain information captured from the user. Once, through
discourse with the user, the system “ lls” in the missing information, the system will execute a
particular command. Plan-based/Inferential approach of dialogue management follows the same
method as frame, but the salient di ference is the use of inferences and assumptions. An advantage
of using plan-based dialogue management is that it allows implementing discourse strategies and
the use of templates to handle transitions as opposed to enumerating all options that nite state
machines requires.
Dialogue systems need to account for the speaker’s turn, classi cation of speech (speech acts), the
subtleties of dialogue, grounding, and clear natural language speech. Figure 2.4 describes a basic
architecture for a dialogue system courtesy of Jurafsky & Martin (2009). Natural language understanding
requires the system to parse and analyze the natural language speech by the human participant, and
natural language generation produces utterances in human understandable free text. Automatic
speech recognition and text-to-speech synthesis are components that either translate utterances to
an equivalent string of text (speech recognition) and text-to-speech synthesis takes natural language
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free text and produces utterances from that free text. The dialogue manager and task manager are
the components that coordinate the exchange between the system and user.

Figure 2.4: Basic architecture of a dialogue system (Jurafsky & Martin, 2009)

Another factor to consider, speci c to health-related dialogue system, is to de ne a health objective
and sub-objectives that lead to a health-related goal (Migneault et al., 2006). This could be a theoretical
health intervention, like the health belief model (see 2.1.4).
Ontologies also o fer some possibilities to extend the eld of research for dialogue-based systems.
One area is coordinating the sequence of discourse between the parties, where the ontology can
index speci c behavior in which the system can engage in (Johnson et al., 2000). Some of the other
bene ts inherent in ontologies, such as extensibility of knowledge space (Johnson et al., 2000) and
providing reasoning and intelligence (Allnatt et al., 2001), can also contribute to dialogue management.
In Section 2.4, we highlight the role of ontologies in agent-based systems.

2.3.4

Ontology-based Dialogue Systems for Health

In the health care domain, health dialogue systems have some prospective use cases to explore, which
not only impact natural language processing research, but also medical and consumer informatics
research (Bickmore & Giorgino, 2006). With a consumer’s desire for face to face interaction and its
overall e fect on patient health (Naylor et al., 2004), health dialogue systems can support providers
in areas where they are needed, speci cally the lack of time providers have to interact with patients
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(Davido f, 1997), the lack of uniformity in communication style with patients, and providing detailed
health information to patients.
Dialogue systems for health care imbues several bene ts. In particular, health dialogue systems
have the bene t of positively a fecting the patient’s health-related behavior and assisting in the
observation of the health status of the patient. When o fered as an alternative to paper-based documentation
for patients, automated verbal communication can provide sophisticated goal oriented information
delivery for patients (Bickmore & Giorgino, 2006). Health dialogue systems with the power of
speech recognition can mimic the face-to-face interaction between provider and patient and automate
that experience (Migneault et al., 2006). Speci cally, the verbal mode of the health dialogue system
can o fer opportunities to enhance interactivity between patient and provider, such as using machine
intelligence for decision making and coordination of content delivery, utilizing interpersonal cues
to imitate human conversation and improve communication e forts with non-experts. It can also
personalize the experience with the user (Migneault et al., 2006). Health dialogue systems can be
cost e fective if it is portable and generic, meaning if the system is not coupled with any speci c
domain (Allen et al., 2006). These systems also have the potential to reach a wider audience to
deliver health information (Velicer et al., 1999). Communities that do not speak the native language
of the provider can also be positively impacted by health dialogue systems that have multilingual
support (Narayanan et al., 2004). In the eld of serious gaming for health, games for health can
also be enriched with dialogue (Luperfoy, 2004). While it may not replace the experience between
patient and provider, it can help assist both parties - in helping the patient connect with other
individuals and promoting self-management of care.
Since the 1990s, health dialogue systems, whether telephone-based or computer-based, have emerged
in published medical research and demonstrated usage in a variety of health-based applications.
Some examples of health dialogue systems utilization in managed care applications include nutrition
(Farzanfar et al., 2004; Delichatsios et al., 2001; Glanz et al., 2003) , cigarette use (Ramelson et al.,
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2003), hypertension (Friedman et al., 1996) , and asthma management (Adams et al., 2003). Also,
health dialogue systems have been demonstrated in health behavioral interventions such as encouraging
patients to engage in physical activity (Jarvis et al., 1997; Pinto et al., 2002; King et al., 2003), adhere
to medication routines (Friedman et al., 1996; Young et al., 2001; Farzanfar et al., 2004), and encourage
routine mammography screenings (Migneaul et al., 2005).
From a review of existing research for ontology-based dialogue systems on PubMed (Amith et al.,
viewb), only four papers involved the use of ontologies in some capacity. In one paper by Beveridge
& Fox (2006), their dialogue system for breast cancer screening utilized an ontology as a domain
knowledge base, while the dialogue ow is coordinated through an XML-driven system. Similarly,
in another paper by Tielman et al. (2017), an ontology served as a knowledge base to link data collected
from users su fering post-traumatic stress disorder through a virtual agent to build 3D worlds
of their memory. The remaining papers, by Bickmore et al. (2013, 2011), utilized ontologies for
conversational agents for diet interventions. Their work was somewhat limited as the ontology
for speech tasks and the behavioral change theory ontology were not interoperable, and there was
tightly coupling within their domain that prevented it from being portable.
From the body of literature discussed, it has been noted that provider-driven counseling on vaccines
is an important task to support vaccine uptake. Research has indicated that these interactions do
not take place for various reasons, even though consumers and other researchers nd it e fective.
Dialogue systems have been experimented with since the 1990s and could o fer a solution to automate
the experience of conversation between machine and human. While it may not replace patientprovider communication, dialogue systems may o oad the communication task and possibly help
initiate a future discussion about the vaccine (or other health related topics) between the patient and
provider in a subsequent meeting – a positive health literacy outcome.
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2.4

Agents and Agent Architecture

This subsection is light primer to sof ware agents and their architecture towards describing and
implementing them. Most of what is discussed here are relevant topics detailed by Wooldridge
(2009). The term agents is an abstract de nition of sof ware system. According to Wooldridge &
Jennings (1995), an agent “is a computer system that is situated in some environment, and that is
capable of autonomous action in this environment in order to meet its delegated objectives”(Wooldridge
& Jennings, 1995). Compared to other sof ware systems, agents are, to a degree, aware of their surroundings
incorporating sensory apparatus to retrieve feedback from environment where they inhabit. Based
on the feedback the agent preform some action, and without any intervention from the builder or
user, exhibits some autonomy.
Modern operating systems have sof ware daemons which are basic examples of autonomous agents
that operate in the background of every computer. More complex examples of agents are ones that
exhibit some measure intelligence. To be considered as an intelligent agent, the system must have the
following features (Wooldridge & Jennings, 1995):
• Reactive - respond to the environment in a timely manner
• Proactive - initiative-driven, takes actions to ful ll objectives
• Social Ability - interacting with agents and humans to satisfy design objectives. This
could involve negotiation and cooperation with autonomous agents with individual goals.
It is important to note that some sof ware systems may be mistaken for being intelligent agents, like
expert systems or even clinical decision support. Such systems are not agents due to being disembodied
and are dependent on a user as an intermediary with the environment. For example, a social media
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analytical tool powered by machine learning would not be considered an intelligent agent. Overall,
agents act with relative autonomy and are not disembodied.
A variety of architectures have been proposed by researchers to design autonomous agents. Three
basic agent architectures are reasoning agents, reactive agents, and hybrid agents which incorporates
reasoning and reactive-based aspects.

Reasoning Agents

Reasoning-based agents are bifurcated as either deductive reasoning or

practical reasoning agents. Deductive reasoning agents are theorem proving agents where it uses
a database of domain predicates(the beliefs of the agent), and harnesses logical theory (the rules
for the agent). They rely on representing the environment symbolically as logical formulae, e.g.,
at_location(desk). Overall they aim to solve :
• Transduction problem - how to translate the world around agent into symbolic representation
• Reasoning and representation problem - applying (reasoning and manipulate) the
symbolic representation for the agent
Deductive agents bene t from the clear, simple and transparent logical semantics. However, the
drawback is the challenge of translating the attributes of the environment into symbolic representations.
Practical reasoning agents utilize reasoning to preform an action by considering options and information
than just theorem proving. In general, practical reasoning is driven to accomplish a goal through
actions. These agents are involved in knowing the state of a fairs of the environment (deliberation),
then deciding the actions to achieve the state (means-end, i.e. planning). Deliberation aspect of
practical reasoning agents models the options available and then lter for the appropriate options to
ful ll the agent’s intention. During deliberation, the agent factors in the beliefs, intentions, desires,
and the current beliefs of the environment. Once options are provided, the system uses a planning
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algorithm to choose the best option/action. One noted example is the Procedural Reasoning System
which uses some pre-de ned actions (plans) that de ne preconditions and goals of each plan.
Reactive Agents:

Rodney Brooks, Ph.D., the progenitor of subsumption architecture for

reactive agents, outlines his position for reactive agents (Brooks, 1991a,b):
• Intelligence is an emergent attribute
• Representation is not required to display intelligence in agents
• Reasoning is not required to display intelligence in agents
Reactive agents do not adhere to any use of symbolic reasoning approaches, but subscribes to the
notion that intelligence emerges from the environment. In other words, intelligence is not embedded
within the machine, like in a statistical model, but an expression of behavior with the environment.
Reactive agents su fer from engineering challenges (i.e. di cult to build), and the lack of representational
model limits their scope to the local environment. Also, scalability is an issue as it is limited to 10
layers.
One of the most popular reactive agents architecture is Brooks’ own contribution —- the subsumption
architecture (Brooks, 1986). This architecture is a nite state machine arranged in a hierarchy. The
architecture has sensors that triggers an action (layer). Each layer of the architecture encapsulates the
lower layers. Essentially, a behavior or action (layer) includes, or subsumes, the behavior or action
of the layer(s) that are beneath it. Because of the simple approach it can also be implemented on the
hardware level if needed. Other reactive agent architectures include Pengi (Agre & Chapman, 1987),
situated automata (Kaelbling & Rosenschein, 1990), and agent network structure (Maes, 1991).
Hybrid Agents

Hybrid agents are the current architecture approach as of recent. Hybrid

agents merges ideas from reasoning and reactive agents but implements them in layers. As layers, it is
easier to see the intelligence represented, i.e. layers for reactive, proactive and social ability functions.
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These layers are arranged in either vertically or horizontally, the former reduces complexity than the
later. One example of hybrid agents is the 3T architecture that presents a layer for “reactive skills”
(reactive agents) and deliberation (practical reasoning) and structured in vertical layers. InteRRap
is another example of a vertical layered architecture (Müller, 1996). However, hybrid agents lack the
semantic coherency that reasoning agents would o fer.

2.4.1

Ontologies for Agent Architecture

Wooldridge (2009) also mentions the internal data structures of the agent. The data structure’s role
in the system is to provide the agent with decision making capabilities to perform autonomously in
the environment. Speci c roles for the structures may include representing the domain knowledge
for the agent, providing information of the surrounding environment of the agent, and cataloging
the previous actions of the agent (e.g. for the agent to learn).
According to Hadzic et al. (2009), these data structures could be manifested as a group of ontologies.
Furthermore, they state inherit bene ts such as producing shared communication models between
agents and systems, information retrieval, organization of the agent’s task, and analytical and reasoning
of the knowledge (Hadzic et al., 2009).
In the upcoming chapters, we will detail the modeling and development of ontologies that provide
the autonomous intelligence for our proposed sof ware architecture of an ontology-driven conversational
agent for HPV vaccine. The ontologies for the system will represent domain information for HPV
vaccine knowledge (patient-level), and interaction information for the agent’s environmental and
historical actions. This architecture will also include the sof ware to execute these models using NLP
methods to be discussed in separate chapters. Later on, we will demonstrate the practicality of the
tool through preliminary simulation studies – which will also inform the design of our agent.
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2.5

Summary

This chapter explores the background literature for HPV vaccine and ontologies, along with related
topics such as natural language processing. HPV vaccination rates are low among the population
and sometimes lower among speci c demographics like males, and young adults. Ontologies, representational
artifacts that contain semantically encoded knowledge, can model complex information and share
that knowledge base with other systems. Machines that employ ontologies can be imbued with
reasoning power and provide a repository that can be queried. With this, ontologies can be extended
in the area of dialogue management, an area that has seen minimal realization but has potential in
aligning with health theory models. In Chapter 3, we will discuss our work to develop a domain
knowledge layer that include (1) a vaccine ontology model from patient-level documents, (2) an
ontology that represents vaccine misinformation and (3) some tools to assist in engineering ontologies.
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Human behavior ﬂows from three main sourc – desire,
emotion, and knowledge.
Plato

3
Health consumer vaccine ontologies

This chapter covers the core knowledge bases that form an information repository for the HPV
vaccine conversational agent. Chapter 2 overviewed some of the legacy architectures for autonomous
agents where many had a subsystem or layer within their design relating to a domain knowledge
base. Within the proposed design of our conversational agent, the knowledge base is a set of ontologies
that encode patient-level information about the HPV vaccine. In contrast to “professional ontologies”,
our consumer-level ontologies may have information that are of concern for the health consumer
ranging from basic vaccine information (age appropriateness for the vaccine, dosing requirements,
etc.) to myths surrounding vaccines and the source of where those myths come from. Overall,
consumer knowledge are on the level of patient-directed brochures or yers that do not delve into
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the in-depth science about vaccines or use the nomenclature that experts wield. From our own
study where we analyzed vaccine-related corpora, the knowledge structures (i.e. mental models) for
vaccines di fer between experts and health consumers (Amith et al., 2017a, viewa). The development
of two vaccine knowledge bases that we introduce in this chapter pertains to (a) general HPV vaccine
knowledge that is covered at the time of their visit with their provider, and (b) modeling and cataloging
vaccine misinformation. In a later chapter, we analyze the quality of these knowledge bases using the
tools and methods that we discuss in this chapter.

3.1 Ontology Evaluation Tools and Methods
Much of our work, and the foundation of this research, involved the use of ontologies to serve
on various aspects of the architecture of the conversational agent for HPV vaccine. Aside from
application ontologies that are measured by their ability to preform a task, domain reference ontologies
need to be evaluated (veri ed and validated) (Gómez-Pérez, 2004; Vrandecic, 2009). Whether
(semi-)automating the development of ontologies using ontology learning methods or manually
curating them, the encoded information (intrinsic and extrinsic dimensions) has to be examined to
ensure proper future utility of the ontology. Overall, ontology evaluation is an important facet of
knowledge engineering as it supports their development and maintenance (Amith et al., 2018a).
Chapter 2 discussed a known semiotic metric suite by Burton-Jones and colleagues that evaluates
an ontology on various perspectives based on semiotic theory - a study of meaning behind signs
and symbols. The usefulness of this metric suite is that it is not speci ed to a certain domain, it
provides a “holistic” evaluation of the ontology that covers the intrinsic and extrinsic aspects, and it
is generally easy to compute the scoring (Burton-Jones et al., 2005). A later discussion in this chapter
indicates some evidence of its usefulness to evaluate an ontology through the use of OntoKeeper
(Amith et al., 2018b, 2019a), our automated tool that is based on the semiotic metric evaluation.
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Before discussing the domain knowledge base in this chapter, we summarize our venture into ontology
evaluation that includes developing natural language generation sof ware, creating a method for
evaluating ontologies using the semiotic metric suite by Burton-Jones and associates, and the development
of a comprehensive web-based tool that automates the process of evaluating an ontology.

3.1.1 Natural language generation with Hootation
In Chapter 2, we introduced natural language generation as one of two major sub- elds in natural
language processing. As opposed to natural language understanding, natural language generation
(NLG) produces free text from data. This has the bene t of making complex data simpli ed for
consumption and also has the bene t of being useful for ontology evaluation (Amith et al., 2017b).
For example, if given the Turtle syntax, the complex information embedded in the syntax would
be transformed into a human-readable sentence (Listing 3.1). This sentence would be accessible
for non-technical domain users who would usually have di culty utilizing Protégé (Musen et al.,
2015) or web ontology languages to examine the veracity of the ontology (Rector et al., 2004; Funk
et al., 2007). One of the challenge for ontology evaluation was how do we loop domain experts with
very little experience in using ontology authoring tools or knowledge of the semantic languages to
evaluate the ontologies.
# http://informatics.mayo.edu/TEO.owl#TEO_0000048
TEO:TEO_0000048 rdf:type owl:Class ;
rdfs:subClassOf TEO:TEO_0000084 ;
rdfs:label "Saturday" ;
Listing 3.1: Sample syntax coding from Time Event Ontology in Turtle syntax

We developed Hootation, a sof ware library API that could translate the machine level encoding
to free text which could potentially make it easier for domain experts to examine the veracity of an
ontology (Amith et al., 2017b). Hootation was developed in Java and derived some of the implementation
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from existing semantic web tools developed by the Agile Knowledge Engineering and Semantic
Web (AKSW) Research Group (Bühmann et al., 2015). Hootation utilizes both OWL API (v4)
(Horridge & Bechhofer, 2011) and SimpleNLG (Gatt & Reiter, 2009) to process an OWL- le ontology
into natural language statements. We also extended support for additional axioms types beyond the
initial 12 to 18 (Hootation now supports 25 axiom types).
We wanted to determine if the natural language statements from Hootation could accurately produce
free text information that subject matter experts could understand. This would enable us to use
the technology for the validation of ontologies and also allow us to integrate the technology into a
framework like the semiotic metric suite for ontology evaluation.
We enlisted the assistance of evaluators who had familiarity with one of the following ontologies:
• People Ontology (Schwarz & Kurfess, 2011) is an ontology representing family relationships
and of en used as a teaching example for students to learn of the various axioms in OWL.
This small ontology has 13 classes, 8 properties, and 9 instance level data elements.
• Time Event Ontology (School of Biomedical Informatics Ontology Research Group,
The University of Texas Health Science Center of Houston, 2019) is an ontology derived
from the Clinical Narrative Temporal Relation Ontology (CNTRO) (Tao et al., 2010) and
it involves the representation of temporal entities and their semantic relationships between
those entities. Time Event Ontology (TEO) has 156 classes, 51 properties, and 8 instances, and
it aligns to an upper-level ontology - the Basic Formal Ontology (BFO) (Smith & Grenon,
2019).
• Informed Consent Ontology (ICO) (Lin et al., 2014) is an ontology representing
informed consent documents and processes and related concepts concerning US Common
Law and medical ethics. Similar to TEO, ICO utilizes the Basic Formal Ontology (BFO)
and was built behind the principles supported by the Open Biomedical Ontology (OBO)
Foundry (Smith et al., 2007). ICO has 375 classes and 86 properties.
The Hootation library imported the above-mentioned ontologies and exported natural language

53

statements for each of the axioms contained in the ontology, along with the axiom type and the
logical axiom notation (See Table 3.1). Each evaluator was provided with the outputted data for
ontologies that they were familiar with and provided a rating to gauge the clarity of the natural
language statement (1-3, 1=clear, 3=not clear), delity to the encoded logical axiom (binary, 1=yes,
0=no), and delity to the domain that it expresses (1-3, 1=agreement, 3=disagreement). Table 3.2
aggregates the results for clarity, natural language delity to the axiom and the axiom delity to the
domain.
Table 3.1: Sample output showing axiom data from ICO.

Axiom Type
SubClassOf

Logical Axiom
ICO_0000062 ⊑
ICO_0000073

Natural Language Equivalent
every human subject unable
to give informed consent is a
human subject

Table 3.2: Evaluators results from examining natural language output. *(μ, σ) ** % of “yes”.

Ontology

Clarity*

People
Time Event
Informed Consent

1.19 (0.42)
1.32 (0.63)
1.28 (0.58)
1.26

NL Fidelity to
Axiom**
90%
92%
95%
92%

Axiom Fidelity to
Domain*
1.01 (0.14)
1.13 (0.38)
1.36 (0.64)
1.17

From our assessment of Hootation, evaluators reported that the generated statements had high level
clarity, and we noted that with a legacy ontology like the Informed Consent Ontology, that some
of the encoded axioms (n=∼ 41) did not accurately represent the underlying domain knowledge.
Overall, we concluded that Hootation has a strong usefulness in the engineering of ontological
knowledge bases as it provided an easy review of the encoded knowledge (Amith et al., 2017b). In
the next section relating to OntoKeeper, our automated tool for ontology evaluation, we incorporated
the Hootation API library to generate the natural language statements for domain experts to produce
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the accuracy score.

3.1.2 Benchmarking ontologies with semiotic metric suite
The semiotic metric suite provides an overall score based on an aggregate of the weighted sub-scores
(semantic, social, pragmatic, and syntactic). Interpreting scores for some of the aspects can reveal
certain strengths and weakness of the ontology. For example, a low richness score would indicate the
ontology’s low of usage of ontology axiom features or a high comprehensiveness score would indicate
high domain coverage. However, determining whether an ontology is a marked improvement
(and thus a contribution) over a similar ontology, or how it compares with other ontologies of the
same type could provide further interpretation of the scores. Burton-Jones et al. (2005) mentions
comparing an ontology with a library of other ontologies to further gain insight of the overall
quality of the ontology. We experimented with the idea of using a set of drug related ontologies and
a sample set of National Center of Biomedical Ontologies (NCBO) BioPortal ontologies to generate
scoring data that could serve as a benchmark to use the semiotic metric suite to evaluate biomedical
ontologies, as well as our own ontologies.
The NCBO BioPortal website is a federally-funded repository for a wide-range biomedical ontologies
with approximately with over 769 ontologies hosted on their portal . In September 2015, we sampled
a set of biomedical ontologies that had the most visits, according to NCBO BioPortal data (Amith
et al., 2018a). This sample included 66 ontologies that were the most popular of that month (Appendix
A), and we individually went through each ontology and created a merged ontology le that included
their imported ontologies. Using prototype sof ware that we developed that was a precursor to
OntoKeeper (Amith & Tao, 2015), we calculated their semiotic ontology evaluation scoring. Table
3.3 has the composite scores of mean, min, max and standard deviation of the 64 ontologies (2 were
removed due to processing errors).
In a published study, we further explored benchmarking libraries of ontologies by tailoring the
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Table 3.3: NCBO Sample Aggregate Scores

Quality
Syntactic
Lawfulness
Richness
Semantic
Interpretability
Consistency
Clarity
Pragmatic
Comprehensiveness
Social
History
Overall Score

Mean
.64
.92
.36
.88
.88
.84
.96
.02
.02
.02
.02
.39

Std. Deviation Min
.14
.18
.16
.27
.18
.07
.15
.09
.14
.01
.40
-.17
.13
.14
.07
0
.07
0
.02
0
.02
0
.05
.21

Max
.85
1
.69
.99
1
1
1
.52
.52
.13
.13
.48

weights of the score to emphasize the strengths and de-emphasize the weakness of the ontology
to attain a scoring that is representative of the ontologies (Amith & Tao, 2017). In that study we
utilized a set of NCBO drug ontologies and produced an aggregate of semiotic scoring and produced
a weighted formula that is speci c for drug-based ontologies. This further demonstrates the value
and exibility of this metric suite to evaluate an ontology. Our work in ontology evaluation was
advanced through the development of OntoKeeper which we utilized to evaluate the ontologies for
the conversational agent, but also provide an on-demand evaluation of biomedical ontologies for
other works (Manion, 2017; Lin et al., 2018).

3.1.3 OntoKeeper
The previous works in ontology evaluation have culminated in the development of a web-based tool
that automates the calculation of Burton-Jones et al. (2005) semiotic scoring metric for ontologies,
called OntoKeeper (Amith et al., 2018b, 2019a) (See Figures 3.1, 3.2, 3.3). Chapter 2 noted the lack
of automated tools to evaluate ontologies, and that future direction in this area of research would
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entail developing the technology to perform this task (Brank et al., 2005). OntoKeeper grew out of a
proof of concept prototype called SEMS (Semiotic Evaluation Management System) (Amith & Tao,
2015) and incorporated some of the lessons learned in previous research endeavors (Amith & Tao,
2017; Amith et al., 2017b; Manion, 2017).

Figure 3.1: Login screen for OntoKeeper.

OntoKeeper is built on the Vaadin Java web framework (7.7) and incorporates various sof ware
libraries to handle the parsing of data from ontologies and processing of the labels - OWL API
(v5), MIT Java WordNet Interface (Finlayson, 2014), Apache Commons libraries, and Hootation.
OntoKeeper also uses a PostgreSQL database server (v9.5.8) to store application data. The web
application was primarily developed by myself and deployed for testing on an Eclipse Jetty web
server hosted on an Ubuntu-based server (v16.04.3 LTS) with 4GB RAM with dual core processors.
We enlisted ve experienced ontologists with a background in engineering and publishing ontology
artifacts. Each tested the tool using an ontology of their choice and then they all completed a System
Usability Survey (SUS) (Brooke, 2013; Brooke et al., 1996), a simple, reliable usability survey that
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Figure 3.2: One of four panels (Semantic score) to review the sub-scores for the semiotic metric suite.

Figure 3.3: Panel for the aggregated score

produces a score ranging from 0 to 100 (highest). The average scoring (μ =93.5; minimum = 87.5,
maximum = 100) from all of the participants equated to “A+” according to a percentile ranking
(Sauro & Lewis, 2016).
Overall usability and the exibility of the metric suite implemented through OntoKeeper provided
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us with a tool to evaluate ontologies for this research (See Chapter 5). It also provides an automated
tool needed for the biomedical ontology community to assess the quality of biomedical knowledge
bases in the future.
In the next few sections, we discuss a couple of ontologies that provide the domain knowledge for
the conversational agent for HPV vaccine - one relating to patient-level knowledge for the HPV
vaccines and the other relating to representing vaccine misinformation.

3.2 Domain Knowledge Base for Vaccines
The subsequent sections cover the design and creation of two vaccine-related knowledge bases
serialized as ontology artifact. The rst ontology we discuss is the Vaccine Information Statement
Ontology (VISO) and its derivative the Vaccine Information Statement Ontology for HPV Vaccine
(VISO HPV). The detailed e fort in developing these ontologies have been documented in our
previous studies (Amith et al., 2015; Wang et al., 2016). Another ontology that is reviewed in the
following section is the Vaccine Misinformation Ontology (VAXMO). Details about the development
of VAXMO is also documented in our previous publication (Amith & Tao, 2018). The following
sections summarize the inception and development of VISO, VISO HPV (a contribution by Dennis
Wang), and VAXMO.
The Vaccine Information Statement documents are federally mandated yers given to patients at the
time vaccination to inform them of the risks and bene ts of a certain vaccine. They are “a document,
produced by CDC, that informs vaccine recipients - or their parents or legal representatives - about
the bene ts and risks of a vaccine they are receiving” (Centers for Disease Control and Prevention,
2014c). Aside from informing the risks and bene ts, it is also a minimal informed consent document
to diminish any possible liability on the part of the health care provider. Through the National
Childhood Vaccine Injury Act, these yers must be provided to the individual getting the vaccine or
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the parent/guardian of the individual (Centers for Disease Control and Prevention, 2014c).
The Vaccine Information statements themselves range from 1 to 2 pages (Centers for Disease Control
and Prevention, 2019), and are written at 10th grade reading level (Atkinson et al., 2012). Currently
there are 25 VIS documents available on the CDC website as PDF or rich text format, and they are
provided in multiple languages including Spanish and Vietnamese. Also, we observed some general
meta-level organization to these documents. Each VIS has a section for targeted population for
the vaccine, probable reactions to the vaccine, dosing information and recommendation, and basic
preventable disease information that the vaccine impacts.
In context of this project, the goal of constructing the ontology of patient-level vaccine knowledge is
to enable the conversational agent to provide foundational knowledge for questions about the HPV
vaccine and possibly any other vaccine. By formalizing this level of knowledge we can represent
the complexity of vaccine information that can be queried by machines and also provide a scalable
information infrastructure to link to other knowledge bases. In a later chapter, we demonstrate the
use of this ontology for the question-answering component. For conciseness, we discuss the TBox
structure of VISO, but a detailed treatment of our work can be found in our previous literature
(Amith et al., 2015).

3.2.1 Vaccine Information Statement Ontology
We introduce the Vaccine Information Statement Ontology (VISO) that models knowledge contained
in patient documentation for vaccines. The design of this ontology is based on analysis of six Vaccine
Information Statement documents. These six VIS documents were:
• Diphtheria, tetanus, and acellular pertussis vaccine (DTaP) (Centers for Disease Control and
Prevention, 2016b)
• Rotavirus vaccine (Centers for Disease Control and Prevention, 2016g)
• Hepatitis B vaccine (Centers for Disease Control and Prevention, 2016d)
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• Haemophil
2016c)

inﬂuenzae type B vaccine (Hib) (Centers for Disease Control and Prevention,

• Pneumococcal conjugate vaccine (PCV13) (Centers for Disease Control and Prevention,
2016f)
• Measles, mumps, and rubella (MMR) (Centers for Disease Control and Prevention, 2016e)

Figure 3.4: Process of creating models from each VIS document to create a singular common knowledge structure

model.

The above-mentioned VIS documents were for the rst six vaccines that any human should receive
upon birth. The basic development task included extracting the concepts and entities, and constructing
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the TBox level structure of the ontology. This would provide us with a framework to populate the
ontology with instance data that machine can use to query or utilize for any task to be called upon.
With each VIS document, we created a separate model from our analysis of the concepts, entities,
and relationships identi ed. With each of these separate models, we aggregated the common highlevel classes and relationships to create our TBox level ontology. The results of our analysis is shown
in Appendix B in Table B.1 for the classes, and Table B.2 for the object property relationships.
Table B.1 highlights the various class-level concepts contained in the Vaccine Information Statement
Ontology, with 22 basic TBox-level concepts. We identi ed various subclasses to facilitate the categorization
and descriptions from the VIS documents (e.g. VaccineAllergen and VaccineComponentAllergen
for Allergen concept). Also we identi ed universal concepts that relate to the concepts from the
VIS, like the Organ concept, which had several subclasses (e.g. Heart, Liver, Lung), and Substance
(e.g. Gaseous, Liquid, Solid). We observed consistent use of scaling information, for example Mild,
Moderate, and Severe (or Serious), to describe Reaction types and other concepts that utilized fuzzy
labels. Further description of each of the concepts are detailed in the table.

Figure 3.5: Dosage Pattern from VISO.

From Table B.2, 33 property-based relationships hold between the concepts. We attempted to normalize
relationship labels that were semantically similar within the domain of vaccine information, like
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Figure 3.6: Reaction Pattern from VISO.

Figure 3.7: Target Pattern from VISO.

protects and prevents.
Aside from normalizing semantic labels for concepts and relationships, we attempted to structure
consistent patterns that expressed the same knowledge. We noted three design patterns, one of
them being for the vaccine dosing knowledge (Dosage Pattern, Figure 3.5). Another pattern for
basic disease information was represented of how the targeted disease spreads, where it comes from,
the cause, and what it can eventually lead to (Target Pattern, Figure 3.7). The third pattern was the
Reaction pattern (Figure 3.6) that involves structuring knowledge about possible reactions, where it
would be located, and the chances of attaining the reaction.
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Figure B.1 in Appendix B shows simpli ed view of the TBox-level with the subclasses for readability
purposes. Overall the TBox structure of VISO serves as the basic skeleton for instance-level data
extracted from textual sources. From our analysis, we encoded the concepts and relationships in
Protégé. This version of VISO is available at the SBMI Ontology Research Group website * . The
published version of VISO contained 132 classes, 33 object properties and 2 data properties.

3.2.1.1

Vaccine Information Statement Ontology for HPV Vaccine

The Vaccine Information Statement Ontology for HPV Vaccine (VISO HPV) is an extension of
the Vaccine Information Statement Ontology (VISO). It uses the same TBox-level structure which
has been upgraded since its inception. This version not only utilizes the same high-level structure,
but it includes instance level data speci c to the HPV vaccine from the latest Vaccine Information
Statement document for the HPV vaccine and other sources. Detail of this work has already been
published (Wang et al., 2016).
VISO HPV has 38 instance-level data elements culled the VIS documents and O t and Mosers’s
Vaccines and Your Child handbook (O t & Moser, 2011). In addition, we have added a new annotation
property called “natural language” which serves as a natural language translation of the predicatelevel information. For example, the instance data of cervical cancer → death rate → 4000 women
had the natural language annotation of “the death rate for cervical cancer

4000 per year”. There

was approximately 182 uses of the annotation in VISO HPV. Figure 3.8 displays a screenshot of
VISO HPV in the Protégé editor.

* https://sbmi.uth.edu/ontology/project/viso.htm
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Figure 3.8: Screenshot VISO-HPV in Protégé.

3.2.2 Vaccine Misinformation Ontology
First historical evidence of the root of vaccine misinformation may have emerged in the 19th century
where the United Kingdom passed into law the Vaccination Act of 1953. As a result of the passage
of this Act, a group (called the Anti-Compulsory Vaccination League) formed to retaliate and
released publications that harbored anti-vaccination sentiments and beliefs. Years later, af er vaccines
have proven to be an e fective measure against diseases, Andrew Wake elds’ seminal but redacted
paper alluding to the link between the MMR vaccine and autism had a major in uence on vaccine
discourse in the modern time (Opel et al., 2011; Burgess et al., 2006). Dr Wake eld’s pro le was also
enhanced as he is still a major advocate for the anti-vaccine debate (Siegel, 2017).
Aside from public gures (Montanaro, 2017; White, 2015; Sears, 2011; InfoWars, 2017; Gorenstein,
2015; Green eld, 2010; Kata, 2012), the Web has been a major tool for anti-vaccine advocates. In
some early research by Kata (2010) and Bean (2011), early search hits when using certain vaccine-
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related terms had anti-vaccination websites appear. In addition, social media has also been an in uence
on vaccination attitudes (Dunn et al., 2015; Dubé et al., 2016). Current news reports indicate pressure
on tech companies to taper the misinformation content on their platforms but it is uncertain if it
there will be an impact. Some surveys had some troubling gures, where 11% deemed vaccines as
unnecessary and 20-25% believe in a link between autism and MMR Vaccine (Freed et al., 2010).
To this day, measles outbreaks in various parts of the world, including North America, are not an
uncommon news event (Lambert, 2019). One of the drivers for this project is to develop a knowledge

Figure 3.9: Class-level structure of the Vaccine Misinformation Ontology (VAXMO)

base of vaccine misinformation to equip the conversational agent with knowledge about pervading
falsehoods about the HPV vaccine. Aside from that, the ontology can help machines understand
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the meaning behind the content and also catalogue a history of vaccine misinformation, speci cally
about the HPV vaccine. This ontology could help expand the domain scope of VISO and VISOHPV.
VAXMO (Vaccine Misinformation Ontology) describes the domain of misinformation related
to vaccines (See Figure 3.9). As a substructure, VAXMO relies on the Misinformation Ontology
(MO) by Zhou and Zhang (Zhou & Zhang, 2004, 2007), an ontology of general misinformation
rooted on Information Theory concepts. The original misinformation ontology is not available
as a coded artifact, so we recreated the model based on Zhou and Zhang’s published studies that
illustrate the main concepts. Throughout the remainder of this section, we highlight those original
concepts including the VAXMO concepts. VAXMO also relies on nanopublication (Kuhn et al.,
2015), a micropublishing RDF model, for cataloging false assertions, of which we discuss in the later
sections.

Figure 3.10: Class structure of VAXMO showing the Misinformation concept and it associated classes, like Antivaccination Information. red is the VAXMO extension to the Misinformation Ontology, and purple corresponds to
the original Misinformation Ontology. Listing 3.2 shows of the Turtle syntax representation
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3.2.3 Anti-vaccination Information concepts
Starting with the central concept of VAXMO, the Anti-vaccination Information concept, which
is a subclass of the original Misinformation ontology (Figure 3.10). Since the Anti-vaccination
Information concept is a subclass, it inherits all of the class de nitions of Misinformation concept.
The Anti-vaccination Information concept has several concepts like Conspiracy Theories, False
Hoods, Alternative Medicine, etc.
# http://uth.tmc.edu/sbmi/vmo#Misinformation
<http://uth.tmc.edu/sbmi/vmo#Misinformation> rdf:type owl:Class ;
rdfs:subClassOf [ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/vmo#hasMotivation> ;
owl:someValuesFrom <http://uth.tmc.edu/sbmi/vmo#Motivation>
] ,
[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/vmo#hasReceiver> ;
owl:someValuesFrom <http://uth.tmc.edu/sbmi/vmo#Receiver>
] ,
[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/vmo#hasSender> ;
owl:someValuesFrom <http://uth.tmc.edu/sbmi/vmo#Sender>
] ,
[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/vmo#isAbout> ;
owl:someValuesFrom <http://uth.tmc.edu/sbmi/vmo#Subject>
] ,
[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/vmo#isIndicated> ;
owl:someValuesFrom <http://uth.tmc.edu/sbmi/vmo#Indication>
] ,
[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/vmo#linkedToFalseAssertedNanopublication> ;
owl:someValuesFrom <http://uth.tmc.edu/sbmi/vmo#False_Asserted_Nanopublication>
] ,
[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/vmo#hasEndTime> ;
owl:someValuesFrom xsd:dateTime
] ,
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[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/vmo#hasStartTime> ;
owl:someValuesFrom xsd:dateTime
] ,
[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/vmo#hasConfidence> ;
owl:qualifiedCardinality "1"^^xsd:nonNegativeInteger ;
owl:onDataRange xsd:double
] ;
dc:description "Central concept of the Misinformation Ontology by Zhou and Zhang" .

# http://uth.tmc.edu/sbmi/vmo#Anti-vaccination_Information
<http://uth.tmc.edu/sbmi/vmo#Anti-vaccination_Information> rdf:type owl:Class ;
rdfs:subClassOf <http://uth.tmc.edu/sbmi/vmo#Misinformation> ,
[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/vmo#isAbout> ;
owl:allValuesFrom <http://uth.tmc.edu/sbmi/vmo#Controversial_Vaccine>
] ,
[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/vmo#isIndicated> ;
owl:allValuesFrom <http://uth.tmc.edu/sbmi/ontology/vaxmo#Anti-vaccine_Evidence>
] ;
dc:description "Vaccine misinformation categories based on Kata's 2010 paper." .
Listing 3.2: Turtle syntax of Misinformation and Anti-vaccine Information from VAXMO

3.2.4

Controversial Vaccine concepts

Figure 3.11 spotlights our modi cation to an appropriate concept label (green colored concept) of
Subject, which was originally Object from the Misinformation Ontology. Subject is a concept that
denotes what the misinformation is pertaining to, with a link ( About) between the Misinformation
and Subject. As we noted earlier, Anti-vaccination information is a subclassed concept. Because
of subclass inheritance, it has an analogous relationship with the Subject concept. In this case,
Anti-vaccination information has association with Vaccine through the About link to designate
what vaccine the Anti-vaccination misinformation is concerning. The Vaccine concept has various
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subtypes for various vaccine types, like HPV Vaccine, MMR Vacine, etc.

Figure 3.11: Class structure of VAXMO showing the Subject concept and its associated classes, like

Contraversial_Vaccine. Listing 3.3 shows of the Turtle syntax representation.

#

http://uth.tmc.edu/sbmi/mo#Subject
<http://uth.tmc.edu/sbmi/mo#Subject> rdf:type owl:Class ;
rdfs:comment "Corresponds to Zhou and Zhang's object, \"object
indicates what misinformation is false about\" (Zhou and Zhang,
2007)" ,
"relates to what the misinformation is about" .

#

http://uth.tmc.edu/sbmi/vaxmo#Controversial_Vaccine
:Controversial_Vaccine rdf:type owl:Class ;
rdfs:subClassOf <http://uth.tmc.edu/sbmi/mo#Subject> ;
dc:description "Limited focus on controversial vaccines that have
caused contention among certain segments of the population." .

Listing 3.3: Turtle syntax of Misinformation and Anti-vaccine Information from VAXMO

3.2.5

Information Theory concepts

Mentioned before, the Misinformation Ontology relies on concepts from the Information Theory
process (Zhou & Zhang, 2007), like the inclusion of concepts such as Sender and Receiver. Figure
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3.12 highlights some of the concepts from included the Misinformation Ontology. The Sender and
Receiver classes were recreated and subclassed as Participants. Participants can also be a Sof ware
Agent, for example online bots and Human Being. The Human Being class is further extended
with an Individual Pro le concept that would de ne the concept culture, age, gender, etc. These
concepts could be further elaborated with links to other ontologies that can de ne population
information. The Familiarity concept (concept from Misinformation Ontology) for the Human
Being concept describes how acquainted the individual(s) are with the misinformation.

Figure 3.12: Class structure of VAXMO showing concepts related to Information Theory process, which were derived

from the original Misinformation Ontology. Listing 3.4 shows the Turtle syntax representation.

#

http://uth.tmc.edu/sbmi/mo#Participants
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<http://uth.tmc.edu/sbmi/mo#Participants> rdf:type owl:Class ;
rdfs:subClassOf [ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/mo#hasSize> ;
owl:someValuesFrom xsd:int
] ;
dc:description "agents involved in the communication of misinformation"
;
rdfs:comment "originally MO involved just sender and reciever classes.
According to Zhou and Zhang, \"Misinformation involves both the
sender and the receiver, who are involved in producing and receiving
misinformation, respectively. The sender of one misinformation
instance may be the receiver of another one.\"" .
# http://uth.tmc.edu/sbmi/mo#Software_Agent
<http://uth.tmc.edu/sbmi/mo#Software_Agent> rdf:type owl:Class ;
rdfs:subClassOf <http://uth.tmc.edu/sbmi/mo#Participants> ;
dc:description "A machine-based actor/participant who may be a sender or
receiver of misinformation, e.g. chatbot, robot, etc." .
# http://uth.tmc.edu/sbmi/mo#Human_Being
<http://uth.tmc.edu/sbmi/mo#Human_Being> rdf:type owl:Class ;
rdfs:subClassOf <http://uth.tmc.edu/sbmi/mo#Participants> ,
[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/vmo#hasFamiliarity> ;
owl:qualifiedCardinality "1"^^xsd:nonNegativeInteger ;
owl:onClass <http://uth.tmc.edu/sbmi/mo#Familiarity>
] ,
[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/vmo#hasIndividualProfile> ;
owl:qualifiedCardinality "1"^^xsd:nonNegativeInteger ;
owl:onClass <http://uth.tmc.edu/sbmi/mo#Individual_Profile>
] ;
owl:disjointWith <http://uth.tmc.edu/sbmi/mo#Software_Agent> ;
dc:description "homo sapien participant" .
# http://uth.tmc.edu/sbmi/mo#Receiver
<http://uth.tmc.edu/sbmi/mo#Receiver> rdf:type owl:Class ;
rdfs:subClassOf <http://uth.tmc.edu/sbmi/mo#Participants> ;
owl:disjointWith <http://uth.tmc.edu/sbmi/mo#Sender> ;
dc:description "a participant who is on the receiving end of
misinformation communication." .
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# http://uth.tmc.edu/sbmi/mo#Sender
<http://uth.tmc.edu/sbmi/mo#Sender> rdf:type owl:Class ;
rdfs:subClassOf <http://uth.tmc.edu/sbmi/mo#Participants> ;
dc:description "a participant who is communicating misinformation" .
# http://uth.tmc.edu/sbmi/mo#Familiarity
<http://uth.tmc.edu/sbmi/mo#Familiarity> rdf:type owl:Class ;
dc:description "\"The familiarity between a sender and a receiver of
misinformation may influence the ’senders choice on what type of
misinformation to produce and how to transmit it.\" (Zhou and Zhang,
2007)" .
# http://uth.tmc.edu/sbmi/mo#Individual_Profile
<http://uth.tmc.edu/sbmi/mo#Individual_Profile> rdf:type owl:Class ;
rdfs:subClassOf [ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/vmo#hasCulture> ;
owl:someValuesFrom :Culture
] ,
[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/vmo#hasGender> ;
owl:qualifiedCardinality "1"^^xsd:nonNegativeInteger ;
owl:onClass :Gender
] ;
dc:description "\"Prior deception research has suggested that some
demographic features
such as gender (Cody and Hair, 1983), age (Keating and Heltman, 1994),
and cultural profile (Zhou and Lutterbie, 2005) of human information
senders or receivers have impact on deception.\" (Zhou and Zhang,
2007)" ;
rdfs:comment "aka \"Persona\" in marketing" .
Listing 3.4: Turtle syntax of Participants and Familiarity concepts from VAXMO

Communication Channel (Figure 3.13) is also another legacy concept from the Misinformation
Ontology. Information or misinformation is transmitted through channels. The Communication
Channel describes how the information is exchanged and disseminated with concepts like Synchronicity,
Modality, and Distribution Method. It is also entails the degree of accessibility through the Recordability
concept
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Figure 3.13: Class structure of VAXMO showing Communication Channel, a concept from the original Misinformation

Ontology. Listing 3.5 shows of the Turtle syntax representation.

# http://uth.tmc.edu/sbmi/mo#Communication_Channel
<http://uth.tmc.edu/sbmi/mo#Communication_Channel> rdf:type owl:Class ;
rdfs:subClassOf [ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/mo#hasRecordability> ;
owl:someValuesFrom <http://uth.tmc.edu/sbmi/mo#Recordability>
] ,
[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/mo#isInFormOf> ;
owl:someValuesFrom <http://uth.tmc.edu/sbmi/mo#Modality>
] ,
[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/mo#hasSyncroncity> ;
owl:qualifiedCardinality "1"^^xsd:nonNegativeInteger ;
owl:onClass <http://uth.tmc.edu/sbmi/mo#Synchronicity>
] ,
[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/vmo#hasDistributionMethod> ;
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owl:qualifiedCardinality "1"^^xsd:nonNegativeInteger ;
owl:onClass <http://uth.tmc.edu/sbmi/mo#Distribution_Method>
] ;
dc:description "\"The communication channel comes in a variety of forms
such as face-to-face communication, phone, e-mail, and public speech
. Choosing communication channels is an integral part of the entire
course of misinformation transmission.\" Zhou and Zhang, 2007" .
# http://uth.tmc.edu/sbmi/mo#Synchronicity
<http://uth.tmc.edu/sbmi/mo#Synchronicity> rdf:type owl:Class ;
dc:description "\"representing whether the sender and receiver are
exchanging information simultaneously\" (Zhou and Zhang, 2007)" .

# http://uth.tmc.edu/sbmi/mo#Modality
<http://uth.tmc.edu/sbmi/mo#Modality> rdf:type owl:Class ;
dc:description "\"representing how misinformation is encoded (e.g., in
text, audio, video, image, or any of their combinations);\" (Zhou
and Zhang, 2007)" ;
rdfs:comment "form in which misinformation is expressed" .
# http://uth.tmc.edu/sbmi/mo#Distribution_Method
<http://uth.tmc.edu/sbmi/mo#Distribution_Method> rdf:type owl:Class ;
dc:description "\"representing whether the sender and the receiver are
physically located at the same place or are distributed while
sending/receiving misinformation\" (Zhou and Zhang, 2007)" .
# http://uth.tmc.edu/sbmi/mo#Recordability
<http://uth.tmc.edu/sbmi/mo#Recordability> rdf:type owl:Class ;
dc:description "\"representing whether or not misinformation is archived
for later reference.\" (Zhou and Zhang, 2007)" .
Listing 3.5: Turtle syntax of Communication Channel, Syncronicty, Modality, Distribtuion Method, and Recordability

concepts from VAXMO

3.2.6 Cues to motivation and indication concepts
VAXMO also represents motivations and cues of misinformation. The Indication concept is used
to classify what type of evidence supports misinformation and the Motivation concept that classi es
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the reason behind the misinformation content.

Figure 3.14: Class structure of VAXMO showing the Motivation concept and also the Indication class. Listing 3.6

shows of the Turtle syntax representation.

Indication concept is subclassed by various anti-vaccine subclasses. The Anti-vaccine evidence has
various subclasses (36 classes) that are based on research by Kata’s content analysis of various sources.
#

http://uth.tmc.edu/sbmi/mo#Motivation
<http://uth.tmc.edu/sbmi/mo#Motivation> rdf:type owl:Class ;
dc:description "The production and dissemination of misinformation are
commonly driven by motivations of creating conditions for positive
attributions of worth (Rue, 1994)" (Zhou and Zhang, 2007)" .

# http://uth.tmc.edu/sbmi/mo#Indication
<http://uth.tmc.edu/sbmi/mo#Indication> rdf:type owl:Class ;
dc:description "\"indicators of misinformation\" (Zhou and Zhang, 2007)"
;
rdfs:comment "Zhou and Zhang have stated that this concept would need
further development in the future. \"The definition of a class can
be enriched with additional ontological information. We would like
to leave such extensions for future research.\" (Zhou and Zhang,
2007)" ,
"aka \"cues\" of misinformation" ,
"replace with Provenance ontology" ,
"supporting information for the Content (misinformation)" .
# http://uth.tmc.edu/sbmi/mo#NonImmediacy
<http://uth.tmc.edu/sbmi/mo#NonImmediacy> rdf:type owl:Class ;
rdfs:subClassOf <http://uth.tmc.edu/sbmi/mo#Indication> .
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# http://uth.tmc.edu/sbmi/mo#NonImmediacy
<http://uth.tmc.edu/sbmi/mo#NonImmediacy> rdf:type owl:Class ;
rdfs:subClassOf <http://uth.tmc.edu/sbmi/mo#Indication> .
# http://uth.tmc.edu/sbmi/mo#Response_Latency
<http://uth.tmc.edu/sbmi/mo#Response_Latency> rdf:type owl:Class ;
rdfs:subClassOf <http://uth.tmc.edu/sbmi/mo#Indication> .
# http://uth.tmc.edu/sbmi/mo#Self-Reference
<http://uth.tmc.edu/sbmi/mo#Self-Reference> rdf:type owl:Class ;
rdfs:subClassOf <http://uth.tmc.edu/sbmi/mo#Indication> .

# http://uth.tmc.edu/sbmi/ontology/vaxmo#Anti-vaccine_Evidence
<http://uth.tmc.edu/sbmi/ontology/vaxmo#Anti-vaccine_Evidence> rdf:type
owl:Class ;
rdfs:subClassOf <http://uth.tmc.edu/sbmi/mo#Indication> ;
rdfs:comment "derived from Kata, 2010." .
# http://uth.tmc.edu/sbmi/ontology/vaxmo#No_Evidence
<http://uth.tmc.edu/sbmi/ontology/vaxmo#No_Evidence> rdf:type owl:Class ;
rdfs:subClassOf <http://uth.tmc.edu/sbmi/mo#Indication> ,
[ rdf:type owl:Restriction ;
owl:onProperty <http://uth.tmc.edu/sbmi/ontology/vaxmo#hasNumberOfCues
> ;
owl:qualifiedCardinality "0"^^xsd:nonNegativeInteger ;
owl:onDataRange xsd:int
] .
Listing 3.6: Turtle syntax of Motivation and Indication from VAXMO

3.2.7 Vaccine Theories concepts
Before further discussing this aspect of VAXMO, we need to introduce an RDF model for assertions,
called Nanopublications. Nanopublications are micropublishing format to annotate scienti c
assertions, like mosquitos spread malaria to borrow an example from a certain study (Kuhn et al.,
2015). Nanopubications are essentially an RDF graph model for one proposition or triple that state
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a scienti c nding. This graph model also annotates authoring information, like the name of the
researcher who discovered this nding, when it was discovered, etc. (Groth et al., 2013) There is also
a unique identi er associated with assertion for querying or machine reasoning (Groth et al., 2010).
Code Listing 3.7 shows an adapted example by Groth and associates (Groth et al., 2013).
@prefix
@prefix
@prefix
@prefix
@prefix

: <http://example.org/pub1#> .
ex: <http://example.org/> .
np: <http://www.nanopub.org/nschema#> .
prov: <http://www.w3.org/ns/prov#> .
xsd: <http://www.w3.org/2001/XMLSchema#> .

# HEADER SECTION
:head {
ex:pub1 a np:Nanopublication .
ex:pub1 np:hasAssertion :assertion .
ex:pub1 np:hasProvenance :provenance .
ex:pub1 np:hasPublicationInfo :pubInfo .
}
# ASSERTION SECTION
:assertion {
ex:trastuzumab ex:is-indicated-for ex:breast-cancer .
}
# PROVENANCE SECTION
:provenance {
:assertion prov:generatedAtTime "2012-02-03T14:38:00Z"^^xsd:dateTime .
:assertion prov:wasDerivedFrom :experiment .
:assertion prov:wasAttributedTo :experimentScientist .
}
# PUBLICATION SECTION
:pubInfo {
ex:pub1 prov:wasAttributedTo ex:paul .
ex:pub1 prov:generatedAtTime "2012-10-26T12:45:00Z"^^xsd:dateTime .
}
Listing 3.7: Sample nanopublication encoding adapted from Groth et al. (2013)

The nanopublication above is coded in RDF with four basic components that outline its structure
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- header, assertion, provenance, and authoring information. The header part declares annotation
labels of the nanopublication. The assertion of the nanopublication encodes the scienti c assertion.
In the example above, the assertion is “vaccines were developed for population control”. The assertion
stated is incorrect, but as we will explain later, the nanopublication’s model to annotate false assertions
serves a purpose for VAXMO. The provenance and authoring information annotates some origin
information for reference purposes of the assertion.
In Figure 3.15 and 3.16, we created a “Vaccine Theories” concept that inherits the nanopublication
structure and linked to Content to provide an association with Anti-Vaccination information.
Vaccine Theories is the concept in VAXMO that is used to annotate a proposition or triple like
“vaccine causes seizures”. In the example, vaccine → causes → seizures (Figure 3.16) is the false
assertion annotated as Anti-vaccination information. This false assertion abstracted by the nanopublication
model, provides information on the origin of the assertion by where and who it originates from
using the Provenance ontology. Overall, the gure is a graphical representation of the code listing
that shows the link to a concept that associates it with anti-vaccination.

Figure 3.15: Class structure of VAXMO showing False Asserted Nanopublication concept that is a subclass of

Publication. Unsubstantiated Vaccine Theory is a subclass of False Asserted Nanopublication that annotates triples
of vaccine misinformation.
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Figure 3.16: Further details of the nanopublication structure of the False Asserted Nanopublication class.

3.2.8

VAXMO’s Metrics

The total number of classes from The Vaccine Misinformation Ontology amounted to 116, with
6 data properties and 20 object properties. The latest version of VAXMO is hosted at the SBMI
Ontology Research Group website and was authored using Protégé using OWL2 syntax. In Chapter
5, we review the quality evaluation of VAXMO. In Chapter 6, we introduce some use cases that are
outside of the utilization by the conversational agent for HPV vaccine in Chapter 6.

80

3.3

Summary

The contents of this chapter examined our work in developing ontological knowledge bases for
health consumer-centric vaccine knowledge. The knowledge structures between consumers and
experts di fer in how they represent their notions regarding the vaccine, and this would be assumed
to be true for the HPV vaccine. This understanding led us to develop the Vaccine Information
Statement Ontology (VISO), and its extension Vaccine Information Statement Ontology for HPV
Vaccine (VISO HPV). Both of these ontologies derive their information from Vaccine Information
Statements, which are federally mandated informed consent documents to given to patients before
their vaccination (as required by National Childhood Vaccine Injury Act). Vaccine misinformation
is an important knowledge detail to cover with health consumers, and this led to the development
of the Vaccine Misinformation Ontology (VAXMO) that is built on the Misinformation Ontology
by Zhou and Zhang. Overall, these health consumer ontologies will support the domain knowledge
layer of our proposed conversational agent for the HPV vaccine. VISO, VISO HPV and VAXMO
are all available at the SBMI Ontology Research Group website † .
Chapter 2 also reviewed our work in the area of ontology evaluation which is an important facet of
knowledge engineering to validate the aforementioned ontologies. Some of the contributions in
this area include creating a benchmark standard based on a library of ontologies and an automated
web-based tool called OntoKeeper. This work will play important role in validating the quality of
the ontologies, which is covered in Chapter 5.
We would like to thank Dennis Wang for his work and contribution on VISO HPV.

†

https://sbmi.uth.edu/ontology/
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Pay no attention to that man behind the curtain! The
Great OZ h spoken!
The Wizard

4
Interaction-driven application ontologies

An aspect of this work involves understanding the user and designing the necessary tools based
on the users’ response. For our endeavor, we need to understand how the user would respond
to a conversational agent for HPV vaccine (since no such tool exists) and from that knowledge,
engineer the appropriate methods and technology. The lack of similar conversational agents led
us to implement a simulated version of the agent. This would permit us not only to understand
the needs of the users, but also gain an insight how to best develop the conversational agent by
collecting data to support the advancement of our work, which has led to developing the technology
for interaction. In this chapter, we introduce a simulation experiment involving a conversational
agent for HPV vaccine, and reveal how some of the data collected in uenced the design of the
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interaction technology for dialogue (Section 4.2). Also, we will describe the collaborative work with
a colleague in developing a unique visual interface that can be integrated with agents.

4.1

Wizard of OZ experiment

The Wizard of OZ experiment is said to take it inspiration from the famous novel and its movie
adaption of its same name. Other names for this experiment may have been “Pay No Attention
to the Man Behind the Curtain” (Fraser & Gilbert, 1991). The Wizard of OZ (WOZ) experiment
simulates the speech interaction between a prospective user of a natural language interface system manifested as sof ware application agent or robot. The modality of the interface may either be text
or speech emanating from the agent. The interaction of the natural language interface is driven by
a “wizard” or “operator” providing the dialogue of the agent (Figure 4.1). This would give the user
the appearance of an automated agent, thereby, yielding a genuine response of the user towards the
agent. The general purpose of this experiment is to forecast, understand, and collect data of the
interaction with users in order to build a completely automated version of the agent.
There are several bene ts for conducting WOZ experiments for automated natural language interface
agents (Cohen et al., 2004). One is the potential to do early testing, either for speci c sof ware
components that will be integrated into the automated agent or the dialogue uttered by the agent.
Speech recognition systems may lack the su cient language models to interpret the utterance of the
users which may cause recognition failures and impede the perception of the user towards the agent.
Since the simulated system is coordinated by a human user behind the scenes, there is the bene t of
vocabulary coverage. This may also be a disadvantage as some users may not believe that automated
agent would have a high vocabulary coverage and may dissuade the belief in the agent’s authenticity.
Another bene t is the relative ease in running and updating to the WOZ versus making updates to
an automated prototype.
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Figure 4.1: Wizard of OZ experimental protocol. “Support Icon” (CC Attribution 3.0) by Squid Ink (Squid Ink,

2019),“Brick wall Icon” (CC Attribution 4.0) by Anna Shlyapnikova (Shlyapnikova, 2019), “Gnome robots icon” (GNU
General Public License v3.0) by Papirus Development Team (Papirus Development Team, 2019), and “User female alt
Icon” (Public Domain license) by paomedia (paomedia, 2019)

Generally for the WOZ experiment to be e fective, Fraser and Gilbert outline a few perquisites
(Fraser & Gilbert, 1991).
1. The simulation must be possible - The experiment has to be feasible to mimic the automated
version.
2. The future system must be speciﬁable - Researchers needs to know how the system will interface
with the participant.
3. The simulation must be convincing - The experiment is realistic or believable as a machine to
the user.
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4.1.1

Tools and Methods

To understand the user experience of a conversational agent for HPV vaccine and attain guidance on
how to develop the conversational agent, we embarked on conducting a Wizard of OZ experiment
on users who may be decision makers for the HPV vaccine - either for themselves or their children.
At the time of my research, no dialogue system tool for HPV vaccine existed. The primary foci for
executing the Wizard of OZ technique was to discover how to converse with and counsel users on
the HPV vaccine, gain insight on the technology to be implemented in the interaction aspect of this
tool, and collect data. Later in Chapter 5, we will discuss some of the user experience data from HPV
vaccine decision makers – parents and young college adults.

Figure 4.2: Simulation software for the study’s Wizard of OZ experiment. Left application is the natural language

speech interface (“Wizard”) and at the right is the remote controller (“Oscar”) for “Wizard”

Simulation Software

The deployment for the conversational agent was envisioned to be

a tablet-based kiosk-like device in the waiting area of a clinic. I developed a basic iOS application
for an Apple iPad Pro that allowed for hands-free speech interaction with the device (“Wizard”).
The application was developed using Apple’s XCode and iOS SDK (v12) utilizing various sof ware
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libraries like SFSpeechRecognition (speech recognition) and AVFoundation (text to speech). For
convenience, the voice pro le used was the default voice for Apple’s Siri application.
Complementing the tablet was a Java-based desktop application (“Oscar”) that can be used on any
machine with a JVM (Java 8). This application was for designed for the operator to communicate to
the user to masquerade as the tablet. The sof ware noti es the operator when the user is ready to use
the tablet, and this will signal the operator to begin the conversation. A text box serves as the space
for the operator to type or copy and paste the messages to be uttered by the user. Optionally, several
buttons were available to send randomly canned responses like variations to prompt the user if they
have a question (e.g. “I am open to any questions you might have [name]. Have any questions?”,
“Would you like to ask a question [name]?”). Operators can create a set of variation of utterances
that express the same notion and the sof ware will randomly pick a variant. This saves time for the
operator to type or think about a response. The sof ware can collect dialogue exchanges between the
participant and the simulated agent and display it on the panel, and the operator can save the chat
log.

Dialogue Script

One of the goals of this research is to not only inform the user about the

HPV vaccine, but also to have some impact on their health beliefs towards the HPV vaccine. As a
standard baseline, we utilized the Carolina HPV Immunization Attitudes and Belief Scale (CHAIS),
which is a validated survey to measure the health beliefs of the HPV vaccine among parents (McRee
et al., 2010a; Gowda et al., 2012). Variations of CHAIS has been developed for young adults and has
been shown to have the same validation (Dempsey et al., 2014).
The CHAIS survey served as a touchstone for talking points about the HPV vaccine. Each notion
for the survey questions was expressed as dialogue that communicated that piece of information.
For example, the survey question, “How e fective do you you think the HPV vaccine is in preventing
cervical cancer?”. This particular question expressed the e fectiveness of the HPV vaccine to prevent
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Figure 4.3: A basic UML component diagram abstracting this project’s Wizard of OZ software.

cancer of the cervix. The dialogue for this notion became: “If your child is vaccinated with the HPV
vaccine it will protect against various HPV viruses which causes many precancerous and cancerous
lesions in males and females” and followed by an inquiry if they understood the information (e.g.
“Following me so far, [name]?”). The survey was also segmented into categories related to the health
belief model - Harms, Barriers, E fectiveness and Certainty. Harms had six questions/talking points,
Barriers had ve, and E fectiveness and Certainty had two and three respectively.
Af er the completion of the script in the form of simple state diagram, it was reviewed by public
health researchers * and a pediatrician (Julie Boom, MD). Complex information or information that
* Rebecca Cunningham, MPH of Texas Children’s Hospital, Lara S. Savas, PhD of UTHealth School of
Public Health, and Laura A. Shay, PhD of UT San Antonio’s School of Public Health
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Figure 4.4: General framework for discussing vaccine.

would invite a personal detailed discussion was minimized. For example, number of doses could
invite the user to ask which series of the HPV vaccine they should take - two-dose series or threedose series. Any discussion of the series would involve knowing when the health consumer had the
vaccine, what their age, etc. The dialogue ow also permitted opportunities for the user to ask a
question at any time. To closely represent how the agent would respond to participant questions,
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we used the knowledge triples from VISO HPV (discussed in Chapter 3). If the question was out of
scope of the knowledge base, the operator would respond with an apology and a recommendation
to ask their provider (e.g. “[name] That’s a good question. Sadly, I am not sure how to answer that
question. I would recommend writing down that question and asking your doctor when you next
see him or her. Shall I continue?”), along with a follow up if they have another question. Another
feature of the dialogue was the inclusion of a pursuit ow (contributed by Rebecca Lin). Provider
pursuit is a recommendation tactic detailed by Opel et al. (2013) where if a patient is disinterested in
the HPV vaccine to verbally nudge the patient towards having an interest in the vaccine. Research
have shown that pursuing vaccine hesitant parents encourage the parent to accept the vaccination
recommendation (Opel et al., 2012, 2013). Figure 4.4 shows the overall architecture of the dialogue.
We preformed WOZ experiment on two occasions, a preliminary trial with parents with at least one
child under 18 † and another test with young adults at Texas A & M University at College Station
‡.

Detailed discussion of the experiments is found in Chapter 5. The chat logs from the trials and

the dialogue script in uenced the design of an ontology in Section 4.2.1 Patient Health Information
Dialogue Ontology and the chat logs would later be used to test the automated dialogue system
(Chapter 5).

4.2

Ontology-driven dialogue engine

Using ontologies for dialogue management speci cally in the health-related domain o fers some
unique opportunities in healthcare research for conversational agents. According to Kennedy
et al. (2012) and demonstrated in research (Bickmore et al., 2011, 2013), there is potential to base
†

The University of Texas Health Science Center’s Committee for the Protection of Human Subjects
approved this study (HSC SBMI-17-0533)
‡
The University of Texas Health Science Center’s Committee for the Protection of Human Subjects
approved this study (HSC SBMI-19-0102), Texas A & M University Human Research Protection Program
(IRB2019-0118M)
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electronic-based interventions in established health behavioral models like the trans-theoretical
model (Prochaska & DiClemente, 2005), motivational interviewing (Miller & Rollnick, 1991), or the
health belief model (Janz & Becker, 1984; Becker, 1974). As we had mentioned in Chapter 2, there
is very little research in utilizing ontologies for dialogue systems for health yet there is unrealized
potential to exploit them from this area.
Coming o f the heels of some of the initial work completed in the Wizard of OZ experiment, we
developed an application ontology that can provide the facilities to manage dialogue ow and the
contextual dialogue information (e.g. whether a certain utterance has been evoked). This application
ontology could also be used in other similar domains that involve health information communication,
and also be shared and ported to various other systems – like embodied conversational agents or
web-based agents. As we have noted earlier, this ontology could be integrated with models of health
behavior. If an ontology is harnessed for health communication, there is the potential to represent
and structure the complexity of communicating health information and knowledge, and if that is
accomplished there is the potential to share that ontology to other systems and establish a formalization
and consistent standards in the domain of communicating health information to patients.
This section of the chapter will outline the design of PHIDO (Patient Health Information Dialogue
Ontology) and the development of the sof ware controller that is directed by PHIDO. The PHIDO
class hierarchy is represented by four basic classes - Utterance class, Speech Task class, Goal class
and Discussion class - to be discussed in the subsequent sections. A later section will introduce the
dialogue ow transition that relies on the PHIDO model.
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4.2.1

Patient Health Information Dialogue Ontology

4.2.1.1 Utterance Class
The Utterance class is the basic building block for PHIDO as it de nes information related to
evoking an utterance between the agent and the heath consumer user. The basic Utterance class
supports data types that enable the machine to facilitate utterances that are exchanged between it
and the human users. These data types include:
• h UtterancePriority, an integer type, to indicate the utterance’s rank. This property enables
the agent to organize and select utterances to be evoked.
• h UtteranceString, a string type, that is the actual verbiage to be spoken or printed by the
agent.
• h BeenSaid, a boolean type, to indicate whether a speci c instance of the utterance has been
spoken or printed by the agent.
• h UtteranceExampl , a string type, similar to the hasUtteranceString, but used by the agent
to discern utterances that are not evoked by the agent (i.e. Participant Utterance - see below)
• h Foc , a boolean type, to designate that the utterance is the current utterance. This property
is used for dialogue ow which we will discuss in the subsequent section.
PHIDO provides links with the Utterance class and between the Utterance class and the Speech
Task class (discussed in a later section). The object property of utteranceLink serves as a link to
connect instances of the Utterance class. This object property has several subtypes - follow and
preced . These two subtypes of object properties are the inverse of each other. If an utterance
instance a follows another utterance instance b, the machine reasoner (e.g. Pellet (Sirin et al., 2007),
HermiT (Glimm et al., 2014), etc.) would reveal b precedes a.
PHIDO has several subclasses of the Utterance class. The essential subclasses of the Utterance class
are the System Utterance and Participant Utterance. The System Utterance describes utterance

91

types that are elicited by the agent. This utterance, based on a review of chat logs and dialogue script,
has various subclasses of its own, as shown in Table 4.1. Similarily, Table 4.2, has a set of subclasses
of Participant Utterances, which are utterances that are expressed by the user to the agent. These
subclasses of the System and Participant Utterance are utilized in some of the Speech Tasks (Section
Speech Task).
In a minimal e fort to support upper level ontologies, like the Basic Formal Ontology (BFO) (Smith
& Grenon, 2019), that unites the hierarchical organization of biomedical ontologies, we incorporated
Searle’s speech classi cation (Searle, 1976). Currently, BFO has one class concept called “utterance”,
which could be subclassed by high-level classi cations for speech. Searle’s speech classi cation are
high-level categories that describe utterances. These classi cations include:
• “Assertive: committing the speaker to something’s being the case (suggesting, putting forward,
swearing, boasting, concluding)
• Directives: attempts by the speaker to get the addressee to do something (asking, ordering,
requesting, inviting, advising, begging)
• Commissives: committing the speaker to some future course of action (promising, planning,
vowing, betting, opposing)
• Expressives: expressing the psychological state of the speaker about a state of a fairs (thanking,
apologizing, welcoming, deploring)
• Declarations: bringing about a di ferent state of the world by the utterance (including many
of the performative examples above; we resign, you’re red)” (Searle, 1976)
While BFO serves as a template for biomedical and health ontologies with canonical information,
the PHIDO ontology is geared to be an application ontology for supporting sof ware tasks. Nonetheless,
work towards integrating utterance types would need to be investigated in later endeavors.
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Table 4.1: System Utterance classes

System Utterance
Acknowledgment
Agenda
Answer
No Answer
H Answer
Apology
Capitulate
Compassionate Utterance
Condolence
Happy For
Con rm Health Information
System Declaration
Disclaimer
Topic Transition
System Farewell
Concluding Farewell
System Greet
Inform
Inquire Personal
Interview Question
Option
Clariﬁcation Options
Question Options
Topic Options
Overview
Request
Request Repeat
Satisfaction Prompt
System Declaration
Disclaimer
Topic Transition
System Introduction
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Speech act type
Expressive
Commissive
Representative
Representative
Expressive
Expressive
Expressive
Expressive
Directive
Representative
Commissive
Expressive
Expressive
Representative
Directive
Directive
Directive
Directive
Directive
Commissive
Directive
Directive
Directive
Representative
Commissive
Representative

Table 4.2: Participant Utterance classes

Participant Utterance
Acceptance
Negative Utterance
Disconﬁrmation
Negative Personal Stat
Participant Farewell
Participant Introduction
Personal Status
Negative Personal Stat
Positive Personal Stat
Positive Utterance
Conﬁrmation
Positive Personal Stat
Prattle
Question
Divergent Question
Reciprocal Farewell
Reciprocal Greet
Request System
Request System Repeat
Unintelligible
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Speech act type
Expressive
Expressive
Representative
Expressive
Assertive
Expressive
Expressive
Representative
Expressive
NA
Directive
Expressive
Expressive
Directive
NA

4.2.1.2 Speech Task Class
PHIDO contains a class concept Task which has a subclass Speech Task. Essentially a group of
Utterances associated with a Speech Task de nes the meaning and purpose of the Speech Task.
Many instances of an Utterance class is linked to a Speech Task with belongsToASpeechTask, and
every Speech Task has many instances of the Utterance class (h Utterance). Similar to the Utterance
class, the Speech Task yields various subclasses - Pleasantry Task (Salutation and Valediction), Proposition
Task (Initiate Discussion, Transition to Topic, Interview Participant, Discuss Health Topic), and
Question and Answering Task. Figures 4.5 through 4.11 display all of the Speech Tasks that are
supported in PHIDO, with the class de nitions encoded. In all of the Speech Task classes there
are various System and Participant Utterances “chained” together to help the agent direct the ow of
the dialogue. For beverity sake, Table 4.3 summarizes each of the Speech Tasks.
Table 4.3: Outline list of the various Speech Tasks and their function/purpose.

Class
Salutation Task

Parent Class
Pleasantry Task

Valediction Task

Pleasantry Task

Initiate Discussion

Proposition Task

Transition to Topic

Proposition Task

Interview Participant

Proposition Task

Discuss Health Topic

Proposition Task

Question and Answering

Speech Task
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Function
Formal exchange of greetings with
the user at the start of discussion
Ends the discussion session with
the participant with exchanges of
good-byes
Formal introduction of the theme
of the counseling
Sequence to change topic of the
conversation
Probe for information about the
user; engage in “small talk” with
user
Communicate and con rm health
information to user
Sequence to engage and answer
the a question from the user

Figure 4.5: The Salutation class from PHIDO. Blue is the System Utterance and red is the Participant Utterance

Figure 4.6: The Valediction class from PHIDO. Blue is the System Utterance and red is the Participant Utterance.
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Figure 4.7: The Initiate Discussion class from PHIDO. Blue is the System Utterance and red is the Participant

Utterance.

Figure 4.8: This Transition to Topic class from PHIDO. Blue is the System Utterance and red is the Participant

Utterance.
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Figure 4.9: The Interview Participant class from PHIDO. Blue is the System Utterance and red is the Participant

Utterance.

Figure 4.10: The Discuss Health Topic class from PHIDO. Blue is the System Utterance and red is the Participant

Utterance.
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Figure 4.11: The Question Answering Task class from PHIDO. Blue is the System Utterance and red is the Participant

Utterance.
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4.2.1.3

Discussion and Communication Goals Classes

PHIDO has a couple of high level classes that organize and align the Utterance and Speech Task
classes. The Communication Goal class collates the various Speech Task class instances to form an
overall objective. These Communication Goals could potentially be aligned with health behavior
theories, like the health belief model discussed earlier in this chapter. Figure 4.12 shows the association
that is encoded in PHIDO where a Communication Goal has one-to-many Speech Task class(es).
Also the Communication Goal has several subclasses relating to the health belief model - Communicate
Bene ts, Communicate Uncertainity, Communicate E fectiveness, Communicate Harms. Overall,
this alignment assist in the organization and traceability of the communication with the health
belief model constructs. Lastly, every communication goal belongs to a general Discussion class.
Potentially, PHIDO can encode and serve as repository to various types of communication e forts
- health communication for diabetes management, genetic counseling, and cancer survivorship
counseling, etc.
Patient Health Information Dialogue Ontology was published in OWL2 using Protégé (Musen
et al., 2015) (Figure 4.13). PHIDO has 86 classes, 9 object properties and 5 data properties. PHIDO is
available at the SBMI Ontology Research Group page.
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Figure 4.12: UML class diagram of the relationship between the Communication Goal class with Speech Task class and

the Discussion class.

Figure 4.13: Screenshot of Protege with PHIDO.
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4.2.2

Conversational Ontology Operator Engine (COO)

The basis of PHIDO is to provide the agent with the structure of dialogue and understand some
attributes of utterances and other aspects of conversations. This goal advances the opportunity
to develop sof ware components that help agents to interact with users and communicate health
information. From this knowledge encoded in the ontology, we can compose an algorithm that
utilize PHIDO to guide the system to interact with health consumers.
Figure 4.14 displays the core sequence which involves a natural language interface, the sof ware
controller (i.e. sof ware wrapper), and PHIDO. This sequence provides the mechanism for the
agent to control and transition the dialogue ow and capture contextual dialogue information to
make necessary decisions during its interaction with the user. The sequence starts with an utterance
instance with its data property of h Foc set to true. From that point the sequence begins by
having the sof ware controller query for the next Utterance type and what the next Utterance’s
attributes. If the next instance utterance is a System Utterance, this would signal the controller
to send a text string for the natural language interface to evoke that string data, either by printing
it out for the user on the screen or speaking it through text-to-speech component. However, if
the next utterance instances is a Participant Utterance, the controller will receive data from the
natural language interface to interpret the speci c type of Participant Utterance based on attribute
information. Af erwards, the contextual dialogue information is updated - setting the current
h Foc attribute to false, setting the next utterance instance’s hasFocus attribute to true, and optionally
setting the previous utterance instance’s hasBeenSaid to true. The sequence then repeats again till
the end of the dialogue instances.
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Figure 4.14: A UML sequence diagram describing the transition mechanism for PHIDO’s dialogue ow

4.2.2.1 Software Engine for Dialogue Interaction
we have developed a sof ware controller that implements the above-mentioned transition sequence
called Conversational Ontology Operator (COO). COO was developed using Java 8 and harnesses
RDF4j (Eclipse Foundation, 2019) to query and modify the instance level data of the PHIDO
ontology. COO also uses the OWL API (Horridge & Bechhofer, 2011) (5.1.0) and HermiT reasoner
library (Glimm et al., 2014) (1.4.1) for supporting functions. In Chapter 5, we describe testing COO
using the chat logs from the Wizard of OZ experiments to assess the sof ware engine’s ability to
handle the dialogue ow.
The Conversational Ontology Operator is also supported by a question answering mechanism called
Frankenstein Ontology Question-Answering for User-Centric Systems (FOQUS). This sof ware
component was developed in Java 8 and used a combination of OWL API (5.1.0) (Horridge &
Bechhofer, 2011), Stanford Core NLP (3.92) (Manning et al., 2014), MorphaStemmer (Minnen et al.,
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2001; Schmitz & Thomson, 2013), HermiT reasoner library (1.4.1) (Glimm et al., 2014) and term and
string similarity libraries -Simmetrics-Core (Korstanje, 2019) for various string similarity measures
and extjwnl (Autayeu, 2016) for WordNet 3.1 synonymous matches. We also experimented with
vector-based similarity using Numberbatch (Speer & Lowry-Duda, 2017), a vector model based on
ConceptNet (Speer & Havasi, 2013). Chapter 5 describes testing FOQUS with questions parsed
from the chat logs from the Wizard of OZ experiments.
The design of question answering component takes it cues from previous ontology-based QA
approaches. We focused on some of the classic implementations (NLP Reduce (Kaufmann et al.,
2007) and FREyA (Damljanovic et al., 2011), for example) that aims to be domain independent,
meaning the system is not tightly coupled with domain speci c aspects. This would allow any type
of ontology to be queried using natural language questions. Our goal was to have a portable system
that is relatively light-weight, simple, and would not require any modi cation of the ontology or
the QA component. Overall, our QA system borrows ideas used in previous studies to create a
workable system, hence the “Frankenstein” name. The gure in Appendix D outlines the system
process.
FOQUS begins with importing an ontology knowledge base (Figure 4.15) where Object Property
Assertions, Data Property Assertions, and Class Assertion-based axioms are extracted. These axioms
are generally the core domain knowledge from which user questions will query. Object Property
Assertions are basic instance-level triples and Data Property Assertions are instance-level triples
attributing data to the entity-level instances. Class Assertions are domain Tbox axioms. The delineation
of these types of axioms would later serve in ranking and selection of answers to be discussed later.
In Figure 4.15, af er the speci c axioms are extracted, the domain (i.e. subject), property (i.e. predicate),
and range (i.e. object) are parsed and identi ed. This would later serve as tuples used for comparisons.
FOQUS analyzes the user’s question by extracting the noun phrases and verb phrases, and identifying
the question type (Figure 4.16). The extraction of noun phrases and verb phrases are preformed by
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Figure 4.15: Extraction process from ontology for FOQUS (Appendix D)

Stanford Core NLP. The question type identi cation is based on NLP Reduce’s classi cation which
is rooted in looking at a series of keywords. For example, if the question contains “how many” or
“the number of”, the question is classi ed as COUNT-based question. The classi cation has six
categories - UNKNOWN, ALL (list all results), COUNT (count the results and give back the total),
MAX (requesting maximum value), MIN (requesting the minimal value), and NUMERIC.
Figure 4.16 also describes FOQUS step in cleaning the terms from the noun and verb phrases. This
would include removing special characters like underscores, removing duplicate words, removing
common words (based on Oxford’s top 100 words), and normalizing the word to their root using
MorphaStemmer.
Af er extracting the axiom assertions from the ontology and the question data, FOQUS computes
the similarity scoring to determine what triple among axiom assertions are a probable answer for
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Figure 4.16: Question analysis for FOQUS (Appendix D)

the question. Figure 4.17 describes the method for scoring. We utilized two methods for similarity –
vector-based approach using Numberbatch as the vector model, and string-based similarity. For the
later, we used the MongeElkan method, which is the method that FREyA uses for their similarity
matching. By default, the Simmetrics library uses the Smith-Waterman-Gotoh for MongeElkan § ,
instead of Jaro-Winkler, as its root metric.
The process for determining similarity compares the predicate from triple with the verb phrase from
the question. Similarly, FOQUS uses entities (subject and object) from the triple and compares it
with the noun phrases from the question. In certain cases, the verb phrase was non-existent in the
question so any comparison with the predicate of a triple would be ignored. All triples are sourced
from the Object Assertions, Data Assertions, and the Class Assertions.
Some random, initial experiments with a sample of questions provided better scoring using WordNet
§

https://github.com/Simmetrics/simmetrics/blob/59dc148f402da6a8a82ad8604a64fa35d1f70460/simmetricscore/src/main/java/org/simmetrics/metrics/StringMetrics.java
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to enhance the resulting score. Using extJWNL, if two terms were deemed as synonymous within
WordNet (using graph depth of 3), the score is increased by 25%. If there are no synonyms, hypernyms,
and hyponyms relationships between the terms, the score (even if there was some similarity indicated
by the two methods), would be decreased to 0. Otherwise, the scores are lef as is. Lastly, the average
between predicate and entity scores are recorded for the axiom triple.

Figure 4.17: Similarity scoring between question data and ontology data for FOQUS (Appendix D)

The next step for FOQUS is ltering for the answer triple using the recorded scores (Figure 4.18).
Af er all of the Object Property, Data Property, and Class Assertion triples are scored against the
entities of the question, FOQUS captures the highest similarity score of the Object Property Assertion
triple. If that top similarity score is above 50%, the top 20% of the Object Property and Data Property
Assertions are captured. If this condition was not met, FOQUS defaults to ltering for the Object
Property and Data Property Assertions above 45%. FOQUS utilizes the question type to determine
additional ltering so if a question was identi ed as COUNT, MAX, or MIN, the system looks for
triples among the selected Object Property and Data Property that have numerical content. For
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example, if the triple contained “one” or “1” in its label, that triple would be selected.
If the question type were neither of the mentioned, FOQUS uses the top 20% scored of the Class
Assertion triples for further selection. Using the URI for the triple’s domain, property, and range,
FOQUS harnesses OWL API and the reasoner (HermiT) to query for their respective TBox assertion.
If that assertion was among the 20% of the Class Assertion triples, the Object or Data Assertion
triple was selected. For example, the Object Assertion triple, throat_cancer → affects → mal , is
instantiated from {Disease, Target} → {affects}→ {Mal , People of Gender, People} (if we were to
include the non-direct classes). If Disease → affects → People is among the top 20% from the Class
Assertion triples, then throat_cancer → affects → mal is selected.

Figure 4.18: Selection of answer triples based on ranks for FOQUS (Appendix D)
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Answer composition for triples

The last process involves composing a response from the

nal selected triples. The assumption is that the nal set of triples provided answers that are within
the range of what is asked by the user. However, the issue arises on how to best present the answer
that appear natural language-like and how to order the triples in a coherent manner. The following
is the method used to produce a response from a set of triples using a combination of the subject,
predicate, and object tuples and the similarity scoring.
De nition 4.2.1 (Object Assertion Triple) An instance triple t with subject s, predicate p, object o
that

an object assertion h a class assertion triple association T with subject S, predicate P, object O.
to := {s, p, o, }, T := {S, P, O}, to ≈ T where s ≈ S, p ≈ P, o ≈ O

De nition 4.2.2 (Compounding Triples) Given an object assertion triple toa with its associated class
assertion triple T, and another object assertion triple tob , if their associated class assertion tripl are
equal but their instance level subject sa , sb are dissimilar, we generate a natural language statement
nlg by compounding the tripl .
toa ≈ Ta , tob ≈ Tb where toa = {sa , pa , oa },
Ta = {Sa , Pa , Oa }, tob = {sb , pb , ob }, Tb = {Sb , Pb , Ob }.
If Ta = Tb and sa ̸= sb ,
then nlg = sa pa oa “and” sb pb ob

De nition 4.2.3 (Aggregate Triples) Given an object assertion triple toa with its associated class
assertion triple T, and another object assertion triple tob , if their associated class assertion tripl are
equal but their instance level subjects sa , sb are similar, we generate a natural language statement nlg

109

by a regating the objects.
toa ≈ Ta , tob ≈ Tb where toa = {sa , pa , oa },
Ta = {Sa , Pa , Oa }, tob = {sb , pb , ob }, Tb = {Sb , Pb , Ob }.
If Ta = Tb and sa = sb , pa = pb ,
then nlg = sa pa oa “and” ob

De nition 4.2.3.1 (Aggregate Triples) Given an object assertion triple toa with its associated class
assertion triple T, and another object assertion triple tob , if their associated class assertion tripl ’
Sa , Sb are equal and their instance level subjects sa , sb are similar, we generate a natural language
statement nlg by a regating the objects.
toa ≈ Ta , tob ≈ Tb where toa = {sa , pa , oa },
If Sa = Sb , Pa = Pb and sa = sb ,
then nlg = sa pa oa “and” ob

De nition 4.2.4 (Compound Triple for Data Property Assertions) An instance triple tda with
subject s, predicate p, object o that

an data assertion. If the subject sa and predicate pa are similar

with another data assertion triple tdb subject sb and predicate pb . We generate a natural language
statement nlg by compounding the tripl .

If sa = sb , pa = pb , then nlg = sa pa oa “and” sb pb ob

For the last part for the composition of the triples, we examine the highest among the nal selected
Object Property Assertion and the Data Property Assertion set of triples. Whichever is the highest
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determines which set will precede the other set of assertion triples.

4.3 Ontology-driven visual interface for agents
The origination behind the visual interface design presented in this section is the fact we are solely
relying on the voice and speech to communicate with the user. The data collected from users in the
trials with the Wizard of OZ experiment indicated the lack of humanized voice or lack of visuals.
In earlier chapters, we remarked on how speech is the natural way for us to interact with others,
but there are a variety of other modalities supporting speech, like the human face that can evoke
emotions. What we intend to do in this section is discuss our work in designing an innovative and
unique approach to give the conversational agent a face. With some visual interface to supplement
the speech we could augment the stoic-like utterances to improve the “humanization” of the conversational
agent.

Figure 4.19: Examples of virtual agents from (Bickmore et al., 2010) on the left and on the right is AutoTutor (licensed
under the CC BY-SA 3.0. https://commons.wikimedia.org/wiki/File:AutoTutor.png).

We break from tradition in the large body of research on virtual agents. Our reasoning is that there
is di culty in attempting to naturally mimic the human face, not to mention the time and resources
to work towards a natural human face would be consuming. We attempted to experiment with an
idea of using abstract visualization motifs that is acceptable for machines.
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Figure 4.20: Leonardo da Vinci: Diagram of a proposed ying machine (1789). Licensed under CC BY-SA 2.0.

https:// ic.kr/p/f35VPL

For years, innovators have looked to the natural world for inspiration. Da Vinici’s ying machine,
a conceptual precursor to the airplane, used wings to y that are similar to avian creatures. Yet,
modern ying vehicles do not have apping wings, either opting for static mechanical wings or
rotating blades for ight. Similar to an abstract painting in a museum that can evoke or communicate
a nonrepresentational idea or emotion, we experimented with the use of abstract composition
of geometric features - lines, colors, shapes, to form some visual motif to provide an emotional
dimension to possibly augment a conversational agent for health communication.
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Figure 4.21: Jackson Pollock from Museum of Modern Art NYC. By cormac70 licensed under CC BY-NC-ND

2.0.https:// ic.kr/p/pZSJ1

4.3.1

Visualized Emotion Ontology

Emotions can play an integral part for health consumers in their decision making, actions and
thoughts (McColl-Kennedy et al., 2017; Lerner et al., 2015). For example the emotional valence of
a health consumer could determine their involvement in the their personal care with their provider
(Gallan et al., 2013). From a provider point of view, the providers’ emotion can guide the emotion of
the health consumer, a phenomenon known as emotional contagion (Hat eld et al., 1993). Overall,
any interaction with a health consumer should factor in the emotion-related aspect. The work
related to visual interface for the conversational agent o fered an opportunity to utilize emotions
that can serve as a substitute for a human-like face. We propose an ontology-driven approach which
can help machines reason and understand the scope of human emotions so that conversational
agents can better interact with users, particularly when discussing health information like the HPV
vaccine. With the ontology, we can create dynamic visual interface for conversational agents while
discussing health-related topics. In this section of the chapter, we represent visual compositions
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of emotions as an application ontology and also create these visual compositions for each of the
emotions de ned in the ontology.
The rst step in this project was to de ne what is an emotion or what are the emotions of a human.
Many researchers in the past have proposed various models of human emotions (Ekman et al., 2013;
Plutchik, 2001; Russell & Mehrabian, 1977; Lövheim, 2012; Watson & Tellegen, 1985). We utilized
a model of emotions by Ortony, Clore and Collins (OCC) that describe 22 emotions (Ortony et al.,
1990; Clore & Ortony, 2013). This model was later revised in 2009 by Steunebrink and colleagues
where they added interest and disgust and modi ed the logical structure to represent an inheritancelike structure (Steunebrink et al., 2009). Our rationale for using the OCC Model was for the following
reasons:
• The revised OCC model utilizes semantics and logical structures that can be derived to be
encoded in OWL2. No other study have attempted to transform this model into an ontology
for distribution.
• The emotions from OCC model are de ned by a collection of situational and behavioral
attributes, which might be bene cial for machines to interpret assuming the machine can
observe these attributes in its environment.
Aside from the revised OCC model we added the emotion of surprise from Ekman’s model of
emotion since all of the other Ekman’s universal emotions are covered by the revised OCC. Figure
4.22 shows the nal model containing 25 emotions in total. Emotion types are bifurcated as either
positive or negative emotions, and then branch into three other areas - emotions that relate to
the consequence of an event, emotions that relate to the actions of an agent, and emotions that
involve the appraisal of an object. As an example, love is de ned as a positive emotion involving
linking some familiar aspect of an object, and fear is de ned as a negative emotion involving some
displeasure of a future consequence.
With each of the emotions, we preformed a literature review to nd speci c cues or visualizations
associated with the emotions. From the literature, we created some composite visualizations using
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Figure 4.22: Graphical structure of the revised OCC model that includes the emotion surprise from Ekman

shapes, lines, and colors for each emotion on the revised OCC model (See Figure 4.23)). For brevity,
details of the review of the literature is discussed by Lin et al. (2018). Table 4.4 shows a summarization
of the visualization for each of the emotion. We encoded this model using OWL2 into an distributable
ontology, which we called the Visualized Emotion Ontology or VEO. Table C.1 and C.2 (Appendix
C) shows the axiom de nitions of the positive and negative emotions of the model.

115

Figure 4.23: Graphical structure of revised OCC model (Figure 4.22) showing each emotion associated with a
composite visualization.
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Table 4.4: Visualization motifs for emotions.

Emotion
Admiration
Anger
Disappointment
Disgust
Distress
Fear
Fears-con rmed
Gloating
Grati cation
Gratitude
Happy-For
Hate
Hope
Interest
Joy
Love
Pity
Pride
Relief
Remorse
Reproach
Resentment
Satisfaction
Shame
Surprise

Shape Attribute
Pink circle
Red downward triangle
Red downward triangle
Green downward triangle
Blue downward triangle
Black downward triangle
Black downward triangle
Purple circle
Yellow circle
Yellow circle
Yellow circle
Black downward triangle
White circle
Orange circle
Yellow circle
Red circle
Brown downward triangle
Purple circle
Green circle
Blue downward triangle
Green downward triangle
Blue downward triangle
Green circle
Gray downward triangle
Yellow upward triangle

Line Attribute
Curved red lines, single
Curved black lines, double
Sharp blue lines, single
Sharp brown lines, double
Sharp purple lines, doubled
Sharp purple lines, doubled
Sharp purple lines, single
Curved black lines, single
Curved purple lines, single
Curved pink lines, single
Curved orange lines, single
Sharp red lines, single
Curved yellow lines, single
Curved yellow lines, single
Curved orange lines, doubled
Curved pink lines, single
Sharp blue lines, single
Curved yellow lines, single
Curved blue lines, single
Sharp gray lines, single
Sharp black lines, single
Sharp black lines, single
Curved yellow lines, single
Sharp blue lines, single
Sharp blue lines, double

We present in Figure 4.24 the basic class-level structure of the Emotion class in the Visualized Emotion
Ontology. Each emotion concept, as described in Figure 4.23, is divided into a negative or positive
emotion. The Emotion concept relates to a concept for the appraisal of an aspect (Aspect), as well
as a Action and Consequence. Each of these branches are further speci ed according to the revised
OCC model. Finally, each Emotion is linked to a Composite Visualization. The Composite Visualization,
linked to an Emotion, has several de nitions of a visualization which involves the types of Lines,
Shapes, and Colors (Figure 4.25).
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Figure 4.24: Graphical representation of the Emotion concept from VEO.

Figure 4.25: Graphical representation of the Visualization concept from VEO.

The Visualized Emotion Ontology was encoded in the OWL2 using Protégé. VEO has 126 classes, 11
data and object properties, and 25 instances (each emotion). We extended VEO from an existing
emotion reference ontology called Emotion Ontology (EMO) for the sake of uniformity even
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though EMO is a reference ontology and would not be an appropriate application model for interaction
and visualization. Also VEO is more appropriate than EMO since EMO has responses like guilt as
emotions and other behaviors that we deemed to be not emotions applicable to our needs (Lin et al.,
2018).

4.3.2

VEO Engine

Using the Visualized Emotion Ontology that we developed, a sof ware interface processes contextual
user data to interpret emotions and provide the agent a method to express emotion by querying
a linked visualization from this emotion ontology. With this sof ware engine that we call the VEOEngine, we can demonstrate the utility of VEO harnessed by conversational agents to express emotions
using composite visualizations as its “face”.
The VEO Engine was compiled as Java JAR executable le. It was developed using Java 8 using
OWL API, Apache Jena (Apache Sof ware Foundation, 2009), and HermiT reasoner libraries. It
uses the core of the Visualized Emotion Ontology thus links to the Basic Formal Ontology and
the Emotion Ontology are not included. As stressed earlier, the ontologies discussed so far are
application ontologies, and any linked knowledge base that does not o fer any application purposes
needed to be unlinked. This made it relatively easy to test and integrate the ontology with sof ware.
The VEO Engine provides two basic functionalities: deducing the emotion from variables provided
by the environment and retrieving a visualization to express an emotion. In Figure 4.26, the classic
knowledge hierarchy (or wisdom hierarchy to some (Rowley, 2007)), but rotated to show the pathway
to interpret the emotion of the user by the agent. Essentially, to reason about an emotion that
is being expressed by a user, the process would involve transforming the contextual data (noisy
information) and then classifying the data into structured information. The classi ed information
can be provided to a knowledge based system (of an agent) to determine the emotion of the user.
The VEO Engine facilitates the process of consuming the input data and reasoning what the emotion
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Figure 4.26: Mapping of the knowledge hierarchy as the process for machine interpretation of emotions.

is. The VEO Engine utilizes the reasoning power of the VEO and HermiT reasoner library to de ne
the emotion. The formula below is the format for the sof ware to de ne emotion.

[positive | negative] and [concept_property1 [. . . and concept_propertyn ]]

(4.1)

Using our previous published example, the emotional valence is positive and the classi ed contextual
data relates to liking something or someone that is familiar to them, the machine will reveal that the
emotion is love. Love according to its de nition in VEO is a [positive] emotion that concerns aspects
of some familiar aspect ([concept property := “concernsAspect some Familiar_Aspect′′ ]).
The other functionality involves expressing emotion. Earlier we discussed how the VEO links
every OCC-based emotion to a visualization. Figure 4.27 shows a screenshot of Protégé where an
instance of relief visualization has a link to a web-based image and local image of the corresponding
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Figure 4.27: Protégé screenshot of the relief visualization with a link to an image on the Web and a local image.

visualization. The system simply takes the name of the emotion that the agent wants to express and
executes the SPARQL query, shown below (Listing 4.1), that retrieves the linked visualization from
VEO.
PREFIX rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>
PREFIX owl: <http://www.w3.org/2002/07/owl#>
PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>
PREFIX xsd: <http://www.w3.org/2001/XMLSchema#>
PREFIX veo: <http://sbmi.uth.tmc.edu/ontology/VEO#>
SELECT ?link WHERE
{
?viz veo:has_local_image_file ?link .
?viz a ?c .
?c rdf:type owl:Restriction .
?c

owl:allValuesFrom [EMOTIONHOLDER]

}
Listing 4.1: SPARQL query for a visualization from VEO

In Chapter 5, we review the evaluation of the Visualized Emotion Ontology. Also we discuss the
evaluation for the utility of VEO by evaluating the visualization through crowdsourcing. We will
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also discuss the tests relating to the VEO Engine to further demonstrate its utility.

4.4

Summary

To recap, this chapter presents the components of the interaction aspect of the proposed conversational
agent for the HPV vaccine. The work initiated from knowledge gathered from the Wizard of OZ
experiments on prospective decision makers of the HPV vaccine conversation agent - parents with
children under 18 and young adults. This led to development of ontology-driven interaction tools
that would be integrated in the conversational agent. One of them is the Patient Health Information
Dialogue Ontology (PHIDO), an ontology that formalizes the delivery of health information using
dialogue discourse modeled in OWL2. The other was the Visualized Emotion Ontology (VEO) that
serves as an innovative knowledge base for interface visualizations for sof ware agent’s emotions.
Both of these ontologies are supported with their respective sof ware engines - Conversational
Ontology Operator and the VEO Engine. In Chapter 5, we present some results of the e forts of
this chapter.
Lastly, we want to acknowledge and thank Rebecca Lin for her signi cant contribution to the
Visualized Emotion Ontology that made much of the overall work possible.
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Software and cathedrals are much the same – ﬁrst we
build them, then we pray.
Samuel T. Redwine, Jr.

5
Architectural assessment and analysis of
components

In this chapter, we examine the works previously discussed in Chapter 3 and Chapter 4. To recap,
Chapter 3 introduces the development of domain ontologies for consumer health knowledge for
the HPV vaccine. These ontologies serve as the agent’s knowledge base layer from which the agent
will query to power the agent’s knowledge of the domain. These domain ontologies are VISO
and its HPV-vaccine derivative VISO HPV that encodes the body of knowledge found in patientdirected VIS documents. Complimenting the VISO HPV ontology is the VAXMO ontology which
anatomize misinformation of vaccines. The primary focus of this ontology is to expand the domain
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scope of VISO and VISO HPV. As mentioned in an early chapter , the extensiblity of ontologies are
an important bene t.
Chapter 4 discussed a couple of ontologies with a speci c application-based purpose. One of the
discussed ontologies was the Visualized Emotion Ontology which represented the OCC model of
emotions and linked each emotion entity to an abstract visualization. The purpose of that ontology
was to support a fective responses of an agent – interpreting emotions and expressing emotions.
To enable this we had developed the VEO Engine that harness the VEO knowledge base. Another
ontology mention in the same chapter was Patient Health Information Dialogue Ontology (PHIDO).
PHIDO, inspired by our experiment with the Wizard of OZ protocol, illuminated the aspects of
dialogue for patient interaction concerning HPV vaccine with a conversational agent. It describes
the various utterance types that are exchanged and provided a framework to codify sequence of
utterances for dialogue management. PHIDO was designed to be open to any health-related communication
tasks involving an automated agent. Similar to our work with VEO, we had developed a sof ware
wrapper called Conversational Ontology Operator (COO). COO is backed by the PHIDO ontology
which regulate the dialogue ow and maintains the contextual dialogue data, both of which are
primary functionalities of dialogue managers. To complement COO, we also discussed the development
of an automated QA subsystem, Frankenstein Ontology Question-Answering for User-Centric
System (FOQUS), to respond to user questions while the COO engine is active. FOQUS utilizes
an ontology as knowledge source and processes the user question to retrieve an answer from the
ontology.
Our work in Chapter 3 and 4 culminated to the next step of evaluating the various components
of the ontology-driven conversational agent, in order to prove the feasibility of ontology-based
framework for automated agents. We start by reviewing the quality of the ontologies from the
domain layer - VISO HPV and VAXMO. Af erwards, we test the various ontology-driven sof ware
components for the application layer. Lastly, we reveal our analysis of user experience data collected
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from the simulated trials of a HPV vaccine conversational agent, and present some evidence of
perception and attitudes a fected through exposure with the agent.

5.1

Evaluation of the domain ontology

We utilized a semiotic metric suite introduced by Burton-Jones and colleagues that measures an
ontology based on the branches of semiotic theory (semantic, syntactic, and pragmatic) (BurtonJones et al., 2005). Each of the scores in the metric range from 0 to 1, and the composite of the scores
provided an overall score – ((0.33 · syntactic) + (0.33 · pragmatic) + (0.33 · semantic)). OntoKeeper
is a web-based tool we have developed that calculates metrics rooted in semiotic theory - semantic,
pragmatic, and syntactic. OntoKeeper is powered by OWL API (Horridge & Bechhofer, 2011) and
other natural language processing libraries to parse and calculate the data from the ontology. These
metrics were introduced by Burton-Jones, et al. and have been used in some previous studies to
evaluate ontology artifacts (A fy et al., 2017; Jianliang & Xiaowei, 2008). The bene t of this metric
according to the authors, is that it is domain independent and applicable to measuring the quality
of ontologies of any domain, and concise and easy to interpert and to use for evaluators (BurtonJones et al., 2005). OntoKeeper automates the calculations of each of the metrics except for the
metrics that involve external participants (i.e. subject matter expert review). The user uploads their
ontology and the tools parses and extracts the meta-data needed to calculate the scores and presents
them in an easy to use interface. Each of these metrics qualitatively measures the lexical quality
of the concept labels (semantics), the domain coverage and domain applicability of the ontology
(pragmatic), the quality of syntax for machine-readability (syntactic), and the community usage
(social). For review of the semiotic evaluation scoring for ontologies see (Burton-Jones et al., 2005;
Amith & Tao, 2017) for a primer. As a benchmark, we used the National Center for Biomedical
Ontology (NCBO) BioPortal sample evaluation scores from our previous work (Amith & Tao,
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2017).

5.1.1

Vaccine Misinformation Ontology quality assessment

Table 5.1: Comparison of quality scoring derived from semiotic metric suite (Burton-Jones et al., 2005) for VAXMO

and the NCBO BioPortal sample from (Amith & Tao, 2017).
* scores and values from (Amith & Tao, 2017).
** Overall score does account for social quality scores reported in (Amith & Tao, 2017).

Quality Metric
VAXMO
Syntactic
0.69
Lawfulness
0.95
Richness
0.44
Semantic
0.94
Interpretability
0.91
Consistency
1.00
Clarity
0.95
Comprehensiveness
<0.00
Pragmatic
<0.00
Overall Score
0.54

NCBO Sample (σ)*
0.64 (0.14)
0.92 (0.16)
0.36 (0.18)
0.88 (0.15)
0.88 (0.14)
0.84 (0.40)
0.96 (0.13)
0.02 (0.07)
0.02 (0.07)
0.51 (0.07)**

z-score
0.36
0.19
0.44
0.40
0.21
0.40
-0.08
-0.29
-0.29
0.43

We produced some initial scoring to determine an early evaluation (Table 5.1) of VAXMO’s quality
using our in-house web application, OntoKeeper (Amith et al., 2018b, 2019a). The syntactic score,
which measures syntax-level assessment of the ontology (i.e. machine readability) based on any
breach of syntax (lawfulness metric) and utilization of ontology features (richness metric) was 0.69,
with lawfulness and richness at 0.95 and 0.44, respectively. The semantic score, a score that measures
the term label quality of the ontology was rated at 0.94. The semantic score is comprised of a consistency
score that quanti es inconsistent labeling of concepts and instances was 1.00, clarity that quanti es
ambiguity of the term labels was 0.95, and interpretability that measures the ontology’s term labels’
meaning was 0.91.
For the comprehensiveness score (a component of pragmatic score to assess the utility of the ontology),
we utilized the seed number of 1,277,993, which is the average number of classes, instances, and
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properties from a sample of NCBO Ontologies in a previous study (Amith & Tao, 2017). Ideally, we
would like to have identi ed appropriate ontologies that are comparable to VAXMO, but for initial
scoring we settled on the aforementioned seed number from the previous study. Comprehensiveness
score from the NCBO seed number provided a very low number value of less than 0.00. The overall
quality score based on equal weighting of syntactic (0.69), semantic (0.94), and pragmatic (comprehensiveness
at less than 0.00) was 0.54. A summary of the scores are presented in Table 5.1.
We calculated the z-score using the data from the NCBO BioPortal scores to attain an initial evaluation.
When comparing the syntactic score, z-score yielded 0.36 indicating above-average syntactic score
for VAXMO. The z-score for semantic was 0.40 also indicating above-average semantic score for
VAXMO, and the z-score for pragmatic was −0.29 revealing below-average rating for VAXMO. Also,
we calculated the z-score for the nal overall quality using the average NCBO overall score (0.51) that
does not account for the social metric. The z-score for the overall score of VAXMO was 0.43, which
is above average in its overall quality compared to the NCBO sample.
We examined the z-score to assess the quality of VAXMO. The syntactic score of VAXMO appear
to be of higher quality with the NCBO BioPortal sample (z=0.36). We interpreted this to mean
that the encoding of the ontology with respect to utilization of formal logic (richness) and minimal
syntactic violations (lawfulness) is better than other ontologies. The semantic score for VAXMO
was also better than the sample NCBO BioPortal ontologies (z=0.40) with respect to minimal
inconsistencies with the term labels (consistency), and with respect to meaningful term labels, i.e.
at least one word sense (interpretability). However, clarity was slightly weaker than average (z=–
0.08), where there may have been term labels that had ambiguous meaning, i.e. above average
word senses. The sample from NCBO had the bene t of larger ontologies and therefore were more
comprehensive in its domain coverage than VAXMO (z=–0.29) in regards to comprehensiveness.
Overall, with the exception of pragmatic (comprehensiveness), the Vaccine Misinformation Ontology
(VAXMO) is, in its current state, a relatively respectable quality ontology based on its comparison
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of syntactic, semantic, and overall quality scores with a sample of NCBO BioPortal ontologies. The
low pragmatic score indicates the need for greater expansion of the ontology, and we acknowledge
that VAXMO still needs some re nement and expansion. In addition, we also plan on attaining a
pragmatic score’s accuracy score (Burton-Jones et al., 2005) that would involve public health experts
to provide a review of VAXMO’s veracity which would also produce a more complete pragmatic
score.

5.1.2

VISO HPV quality assessment

Table 5.2: Comparison of quality scoring derived from semiotic metric suite (Burton-Jones et al., 2005) for VISO-HPV

and the NCBO BioPortal sample from (Amith & Tao, 2017).
* scores and values from (Amith & Tao, 2017).
** Overall score does account for social quality scores reported in (Amith & Tao, 2017).

Quality Metric
VISO HPV
Syntactic
0.69
Lawfulness
1.00
Richness
0.38
Semantic
0.94
Interpretability
0.94
Consistency
1.00
Clarity
0.92
Comprehensiveness
<0.00
Pragmatic
<0.00
Overall Score
0.54

NCBO Sample (σ)*
0.64 (0.14)
0.92 (0.16)
0.36 (0.18)
0.88 (0.15)
0.88 (0.14)
0.84 (0.40)
0.96 (0.13)
0.02 (0.07)
0.02 (0.07)
0.51 (0.07)**

z-score
0.36
0.50
0.11
0.40
0.43
0.40
-0.31
-0.29
-0.29
0.43

The ontology uses the previously developed VISO model (Amith et al., 2015) to de ne the conceptual
class level, but also includes some re nement to accommodate complex HPV vaccine knowledge.
The Vaccine Information Statement Ontology For Human Papillomavirus (VISO HPV) (Wang
et al., 2016) contains 160 triples, 141 classes (125 subclasses), 52 properties (36 object properties and 16
data properties), and 55 individuals. Using OntoKeeper, we automatically generated the syntactic,
pragmatic, and semantic scores and present the results on Table 5.2. The overall quality score based
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on the three quality aspects amounted to 0.54. The syntactic score is 0.69 and is comprised of lawfulness
and richness qualities, which are 1.00 and 0.38, respectively. Semantic aspect of the ontology rates at
0.94. The interpretability, consistency, and clarity qualities make up the semantic aspect, which rated,
0.94, 1.00, and 0.92, respectively. The pragmatic aspect score only included one factor, comprehensiveness,
so its score is 0.00. Similar to the VAXMO, the scores comparison with the NCBO sample was
similar – exceeding on all sub-scores except for clarity and comprehensiveness. The below average
comprehensiveness is best explained because VISO HPV is a relatively small ontology encompassing a
limited of information appropriate for consumers. Most likely, VISO HPV may have some ambiguous
labels – just as VAXMO has – which explains the below average clarity.

5.1.3

Visualized Emotion Ontology (VEO) quality assessment

The VEO was encoded in the Protégé ontology authoring tool (Musen et al., 2015) in OWL2 format.
The ontology contains a total of 126 classes, 11 object and data properties, and 25 instances. We
scored the quality of the VEO using OntoKeeper. We compared the VEO to a sample of ve cognitive
ontologies (Mental State Assessment, Emotion Ontology, Mental Functioning Ontology, the
Behavior Change Technique Taxonomy, and the Cognitive Atlas Ontology), which would provide
us with a baseline measurement. Results of our comparison are presented in Table 5.3.
For the VEO, the syntactic score, a score that measures the machine-readability of the ontology,
based on breaches of syntax (lawfulness metric) and utilization of ontology features (richness metric),
was rated at 0.76, with lawfulness and richness at 1.00 and 0.54, respectively. The semantic score, a
score that measures the label quality of the ontology based on the consistency of labeling of concepts
and instances (consistency metric), the ambiguity of term labels (clarity metric), and the meaning
of ontology term labels (interpretability metric), was rated at 0.97, with consistency, clarity, and
interpretability at 1.00, 0.99, and 0.97, respectively.
The pragmatic score, a score that assesses the utility of the ontology based on the comprehensiveness
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Table 5.3: Quality scores comparing the VEO with cognitive ontologies.

Quality Metrics
VEO
Syntactic
0.76
Lawfulness 1.00
Richness 0.54
Semantic
0.97
Consistency 1.00
Clarity 0.99
Interpretability 0.97
Pragmatic
0.82
Comprehensiveness 0.82
Overall Quality
0.85

Cognitive ontologies (z-score)
0.58 (1.12)
0.90 (0.45)
0.28 (1.68)
0.95 (0.61)
0.96 (0.43)
0.97 (0.51)
0.97 (0.00)
0.67 (0.39)
0.67 (0.39)
0.68 (0.98)

metric (i.e., domain coverage), was 0.82. The overall quality score based on equal weighting of
syntactic (0.76), semantic (0.97), and pragmatic (0.82) scores was 0.85.
We calculated the z-scor using the data to evaluate our metrics compared to that of the sample of
cognitive ontologies. The z-scor for the syntactic, semantic, and pragmatic metrics yielded 1.12, 0.61,
and 0.39, respectively, indicating above-average machine-readability, linguistic quality, and domain
coverage. Also, the z-score for the nal overall quality was 0.98, indicating higher overall quality for
the VEO than other cognitive ontologies.
Two of our collaborators (Rebecca Lin, Chen Liang) have cognitive science backgrounds. They
reviewed and conferred with each other on the ontology’s veracity, and we agreed that the ontology
re ected the information described in the revised OCC model.

5.1.3.1

Crowdsourced survey for VEO

In total, 1082 participants were surveyed through Amazon Mechanical Turk, and for each emotionimage pair, we determined the percentage of people that disagreed (1 or 2), were neutral (3), and
agreed (4 or 5) that the image represented the emotion (Table 5.4).
For the majority of the emotions (17 in total – p < 0.001 for 16 emotions, and p = 0.014 for
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Table 5.4: Survey results of visualization. Green highlights indicate statistically signi cant results.

Emotion Disagreed
Admiration
24.2 %
Anger
6.8 %
Disappointment
43.5%
Disgust
51.7%
Distress
40.3%
Fear
18.6%
Fears-Con rmed
21.9%
Gloating
46.8%
Grati cation
23.6%
Gratitude
19.4%
Happy-For
10.4%
Hate
10.3%
Hope
27.0%
Interest
26.6%
Joy
9.3%
Love
29.8%
Pity
46.4%
Pride
25.2%
Relief
20.2%
Remorse
42.8%
Reproach
48.0%
Resentment
57.9%
Satisfaction
21.7%
Shame
35.1%
Surprise
17.2%

Neutral
23.1 %
8.1 %
23.9%
17.6%
20.9%
16.4%
18.7%
27.1%
27.7%
27.5%
13.6%
11.8%
19.5%
27.8%
11.8%
18.4%
25.3%
24.5%
22.6%
25.5%
31.1%
22.5%
22.7%
24.0%
18.8%

Agreed
52.7 %
85.1 %
32.6%
30.7%
38.8%
65.0%
59.4%
26.1%
48.7%
53.1%
76.0%
77.9%
53.5%
45.6%
78.9%
51.8%
28.3%
50.3%
57.2%
31.7%
20.9%
19.6%
55.6%
40.9%
64.0%

P-value
< 0.001
< 0.001
1.000
1.000
0.711
< 0.001
< 0.001
1.000
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
1.000
< 0.001
< 0.001
1.000
1.000
1.000
< 0.001
0.014
< 0.001

emotion of shame), people tended to agree that our visualization matched the emotion more than
they disagreed, which validates our model; these emotions included admiration, anger, fear, fearscon rmed, grati cation, gratitude, happy-for, hate, hope, interest, joy, love, pride relief, satisfaction,
shame, and surprise. This conclusion is based on a rigorous hypothesis testing procedure. Speci cally,
we assumed that the choice of each participant was distributed as a multinomal distribution with
parameters p1 , p2 , p3 corresponding to the proportions of “Disagreed”, “Neutral”, and “Agreed”. We
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then performed one-sided hypothesis tests to test whether the proportion of people who agreed is
greater than the proportion of people who disagreed for each of the 25 emotions, i.e. H0 : p1 < p3
for each emotion. Bonferroni correction was applied to control the family-wise error rate at 5%.
P-values are reported in Table 5.4. Signi cant results of higher proportion of agreed than disagreed
(p-value < 0.001) were found for 16 out of 25 emotions including all of the emotions previously
stated except for shame (p-value = 0.014).
For the remaining eight emotions, more people disagreed than agreed with our visualization. However,
for ve of these emotions, including disappointment, disgust, gloating, pity, and remorse, more
people agreed with our emotion-image pairs than they did for the incorrect emotion-image pairs. In
these cases, the randomly-selected incorrect emotion-image pairs included disappointment-interest,
disgust-satisfaction, gloating-gratitude, pity-admiration, and remorse-grati cation. For distress,
reproach, and resentment, however, more people agreed with the incorrect emotion-image pairs
than they did with the correct ones; these incorrect pairs included distress-fear, reproach-resentment,
and resentment-disappointment, respectively.

5.1.4 Patient Health Information Dialogue Ontology (PHIDO) assessment
In a previous study, we generated scores for a BioPortal sample to serve as comparison benchmark to
assess drug ontologies (Amith & Tao, 2017). We used this benchmark comparison data to compare
with PHIDO’s metrics to compare its quality with other ontologies. To calculate PHIDO’s scores,
we imported the ontology to OntoKeeper, a prototype tool we developed that facilitates the aforementioned
semiotic metric suite (Amith & Tao, 2017) and present the results on Table 5.5.
PHIDO’s syntactic score, which measure the quality of syntax language of the ontology, was 0.69.
The sub-scores for syntactic, lawfulness and richness, were 1.00 and 0.38, respectively. Lawfulness
indicates any syntactic violations to OWL2 pro le. The high score of 1.00 reveals no syntactic violations.
Richness highlights the percentage amount of unique types of logical axiom ontology features. The
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Table 5.5: Comparison of quality scoring derived from semiotic metric suite (Burton-Jones et al., 2005) for PHIDO and

the NCBO BioPortal sample from (Amith & Tao, 2017).
* scores and values from (Amith & Tao, 2017).
** Overall score does account for social quality scores reported in (Amith & Tao, 2017).

Quality Metric
PHIDO
Syntactic
0.69
Lawfulness
1.00
Richness
0.38
Semantic
0.94
Interpretability
0.94
Consistency
1.00
Clarity
0.92
Comprehensiveness <0.00
Pragmatic <0.00
Overall Score
0.54

NCBO Sample (σ)* z-score
0.64 (0.14)
0.36
0.92 (0.16)
0.50
0.36 (0.18)
0.11
0.88 (0.15)
0.40
0.88 (0.14)
0.43
0.84 (0.40)
0.40
0.96 (0.13)
0.31
0.02 (0.07)
-0.29
0.02 (0.07)
-0.29
0.51 (0.07)**
0.43

score of 0.38 revealed that PHIDO only used about a third of these features. In comparison, with
the BioPortal sample, the z-score for the syntactic score was z=0.36 (z=0.5 for lawfulness and z=0.11
for richness) indicating a better syntactic-level quality.
The Semantic score measures an ontology’s quality of term labels. The semantic score for PHIDO
was 0.94. The semantic score comprises of interpretability, consistency, and clarity. Interpretability
measured at 0.94, consistency measured at 1.00, and clarity was 0.92. Z-score for semantic score rated
at z=0.40 (z=0.43 for interpretability, z=0.40 for consistency, and z=-0.31 for clarity). While the
overall semantic score was better, the sub-score for clarity was low compared to the National Center
for Biomedical Ontology (NCBO) sample’s clarity sub-score. This may indicate that the term labels
have some ambiguity (i.e. term labels that has above average number of word senses).
The pragmatic score assessed the ontology’s domain coverage and utilization. This score was limited
to its sub-score of comprehensiveness. The other sub-scores of pragmatic included relevance and
accuracy which required external assessment resources (domain experts). Essentially, comprehensiveness
measured the ontology’s domain coverage based on its size in comparison with the average size of a
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ontology library. The pragmatic score (comprehensiveness) when rounded to nearest two digits was
0.00. Z-score yielded z=-0.29 , below average in domain coverage than the average NCBO ontology,
which indicates that the ontology may need to be further expanded (e.g., more Speech Tasks to be
modeled).
The overall score for PHIDO is a mean value of the previously mentioned scores (Q = wq1 ∗ S +
wq2 ∗ E + wq3 ∗ P + wq4 ∗ O) to indicate general assessment of the ontology. PHIDO’s overall score
was 0.54 and when compared, the z-score value was z=0.43. The overall score indicated that PHIDO
was above average quality compared to most published ontologies, however, as noted, the domain
coverage and ambiguity of term labels were lacking.

5.2

Application of ontologies for dialogue system components

The application layer of the system is supported from a combination of domain and application
based ontologies. For dialogue, PHIDO was designed to manage the agent’s dialogue interaction
using the dialogue script tested in the Wizard of OZ experiments. In these experiments users asked
questions about the HPV vaccine. To support automated question answering, we utilized VISOHPV as the core knowledge base to query information to answer patient questions. Both the automated
dialogue management and question answering was facilitated by the dialogue engine that we call
COO (Conversational Ontology Operator), which also furnished a subsystem for question answering.
COO utilized both the PHIDO and VISO HPV to power the communication functionality of
the agent. VEO Engine facilitated the visual interface as a means to express motive interactions
with users. This engine was supported by the aforementioned VEO that encodes the model of
emotions de ned by the OCC model with links to abstract visualizations. The engine also utilized
the ontology’s reasoning capabilities to interpret emotions of the user based on situations. In the
following subsections, we discuss some experimental tests to assess the functionality of these systems
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which could be leveraged by a conversational agent.

5.2.1

PHIDO for managing the dialogue engine (COO)

Most of the dialogue interaction is primarily communicating the singular pieces of information
about the HPV and HPV vaccine. We chose to focus on the core dialogue exchange which is the
communication of health information to the user as our test example. Figure 5.1 has the gure that
outlines the structure of this core interaction. To assess PHIDO’s ability to direct the COO engine’s
interaction, we present the following:
Can PHIDO direct the agent’s engine (COO) to
1. Impart a piece of health information (HPV vaccine related) to the user?
2. Coordinate question answering?
3. Transition the conversation to discuss a health topic?
For the rst question, we tested several use cases. One of the use cases was to assess if the system can
handle the user con rming they have heard the health information. Another use case was to review
the system’s ability to mange if the user did not agree or did not understand the health information
communicated to them. Other use cases included requesting repeating the health information,
switching to question answering mode, and handling misunderstanding from the user. For the
second question, we tested the engine’s ability to provide the answer or no answer to the user’s
question and also present options for the user to ask another question. The question answering
for our test cases are all simulated, but in a later section we will discuss the automated question
answering that aims to be integrated as subsystem for COO. By default, all of the use cases end with
transition to the next health topic to ful ll the third objective.
For our test, we created several instances in PHIDO that represented dialogue utterances, which
instantiated the various Utterance classes for the Health Information Task (See Figure 4.10). Figure
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5.2 shows a screenshot of Protégé with the instances populating PHIDO. In total, we had 19 instances
of various Utterance classes. Each of these utterance instances were linked using a speci c object
property preced . For convenience, the instance labels were annotated according to the classes they
were derived from. This allowed us to easily assess and explain our test cases. The test cases involve
sample user interaction and were enacted in a text-based console.

Figure 5.1: Modi ed version diagram of the Discuss Health Task with the Transition Topic utterance.

In the following section, we utilize an annotated-version of Figure 5.1, accompanied by the console
print out to demonstrate the operation of the engine. Figure 5.1 is an adaption of Figure 4.10 with
the Utterance class Transition Topic to address the third competency question relating to transitioning
to the next health topic.
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Figure 5.2: Screenshot of Protégé with PHIDO’s instances for testing.

5.2.1.1 Results for the Conversational Ontology Operator

Figure 5.3: Dialogue interaction showing con rming health information.Red arrows indicate the path, and yellow box is

the Utterance utilized in the result. See Figure 5.1 for a complete view of the ow diagram.
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Figure 5.4: Dialogue interaction showing discon rming health information.Red arrows indicate the path, and yellow

box is the Utterance utilized in the result. See Figure 5.1 for a complete view of the ow diagram.

For the test case revolving around the user indicating that he/she understands the health information
communicated to them, Figure 5.3 shows text console demonstrating the test case. For this case, the
COO engine tells the user the HPV vaccine is available irrespective of their insurance status and then
follows up with the agent asking whether the user con rms this information. In this assessment
we responded with a “yes” and the engine identi es that it is a con rmation. The engine declares
the dialogue continues to the next health information. The contrast to the previous use case is
if the user misunderstands or has some contentious notion of the information provided. Figure
5.4 outlines the test case with the a simulated user saying “not really” in response to the health
information uttered. The engine identi es the utterance as Discon rmation and directs the agent
to inquire if they have a question. The response is negative (e.g. “nah”) which the agent understands
as prattle. The engine directs the agent to ask the user to move on to the next topic and that it is best
to ask their health care provider if there is an issue.
If the user wants the agent to repeat the engine can facilitate repeating the same health information
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Figure 5.5: Dialogue interaction showing requesting the repeat of health information. Red arrows indicate the path,

and yellow box is the Utterance utilized in the result. See Figure 5.1 for a complete view of the ow diagram.

Figure 5.6: Dialogue interaction facilitating misunderstood utterances from the user. Red arrows indicate the path,

and yellow box is the Utterance utilized in the result. See Figure 5.1 for a complete view of the ow diagram.

before (Figure 5.5). In the test case, the agent repeats the same information af er there is utterance
that is recognized as a request to repeat (Request_System_Repeat). The agent complies as instructed
by the COO engine, and the test follows the course of early use case (See Figure 5.3).
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Figure 5.7: Dialogue interaction showing the transition from health information exchange to question answering mode
(simulated). Red arrows indicate the path, and yellow box is the Utterance utilized in the result. See Figure 5.1 for a
complete view of the ow diagram.

COO, with direction from the PHIDO ontology, can handle situations where there may be a misunderstanding
between the user and machine. Figure 5.6 shows an example, albeit a humorous situation, that
highlights the engine’s ability to handle a use case where confusion may happen. Figure 5.6 has a
series of exchanges from the user that was identi ed as Unintelligible class to rectify any confusion
and then segueing to the next health topic to discuss.
Figure 5.7 illustrates the test case for one of the ways the engine can switch to question answering
mode (to be facilitated by FOQUS). In this case, not really is discerned as a Discon rmation utterance
and the COO engine directs the agent to ask if the agent’s user has a question. The question is
provided and successfully identi ed as a Question utterance type, which directs COO to switch
to question answering mode (simulated for test cases). The simulated question answering system
responds (the agent does not have an answer). The utterance “nope no question” detected as Discon rmation
utterance type signals the COO engine to continue. Figure 5.7 displays the details of the exchange
for this use case.
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Figure 5.8: An alternate dialogue interaction showing the transition from health information exchange to question

answering mode (simulated). Red arrows indicate the path, and yellow box is the Utterance utilized in the result. See
Figure 5.1 for a complete view of the ow diagram.

Another way in the dialogue interaction to direct the agent to question answering mode is demonstrated
in Figure 5.8. The use case is similar to the previous, with the di ference of the user asking a question
when the agent inquires if the user con rms the information communicated to them.
Figures 5.9 and 5.10 show a similar dialogue interaction for answering a question, one is where
the agent has a response to the question and the other is where the agent has no response to the
question. The question regarding whether insurance is covered by the HPV vaccine (i.e. “can you
tell me if insurance covers the hpv vaccine”) is recognized as a Question type utterance. This directs
the system to switch to question answering mode and the simulated question answering gives either
an answer or no answer. Af erwards, the COO engine directs the agent to continue with the next
health information content. Both Figures 5.9 and 5.10 contain details of the exchanges for the use
cases.
Within the question answering interaction, COO handles situations where the user may ask multiple
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Figure 5.9: Dialogue interaction showing a question answered. Red arrows indicate the path, and yellow box is the

Utterance utilized in the result. See Figure 5.1 for a complete view of the ow diagram.

questions. Figure 5.11 illustrates this use case starting from utterances that signals the COO engine
to switch to the question answering subsystem. The engine facilitates the interaction for the rst
question (“can you tell me if insurance plans cover vaccination”) and second question (“how does
hpv a fect males”), then segues to next health topic. Details of the sequence of the interaction are
shown in Figure 5.11.
In all of the above-mentioned use cases, by default, an instance of the next health information
(health_information_2) is added to demonstrate COO’s movement from one Speech Task to another.
In the examples provided the agent transition from the Discuss Health Task (for expressing that
HPV vaccine is available regardless of insurance status) to an utterance of Health Information
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Figure 5.10: Dialogue interaction showing a question with no answer. Red arrows indicate the path, and yellow box is

the Utterance utilized in the result. See Figure 5.1 for a complete view of the ow diagram.

class (for expressing there is a misbelief of long term e fects of the HPV vaccine) of another Discuss
Health Task.
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Figure 5.11: Dialogue interaction providing the user the option to ask another question. Red arrows indicate the path,

and yellow box is the Utterance utilized in the result. See Figure 5.1 for a complete view of the ow diagram.

5.2.2

Question answering (FOQUS) for VISO HPV

In Chapter 4, we outlined the subsystem that analyzes user questions and produces an answer
from an ontology. This subsystem was designed to support the PHIDO-driven COO engine that
manages the dialogue for HPV vaccine counseling. The question answering service is called FOQUS
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and utilizes the VISO HPV to provide a knowledge base of vaccine information for patients to
query.
To test FOQUS, we used questions asked during our simulated experiment with participants (Amith
et al., 2019b). In total, we collected 53 questions that range from age appropriateness for the vaccine,
gender-related questions, cost, etc. Some of the questions may have been mis-transcribed from
speech recognition, yet we kept them as is to imitate how the live system would process the question.
Because of the possibility of mis-recognition of the utterances, FOQUS relies on the salient terms of
the question (noun and verb phrases) to retrieve an answer. FOQUS provides two variants, one that
employs vector similarity and the other string similarity matching. Both of these were tested against
the 53 questions. Each of these questions was imported into the FOQUS system and FOQUS
outputted answers for each of the questions.
We enlisted the help of four evaluators and asked them to evaluate the question and answer pairs
based on two criteria: the acceptability of the answer for the questions (on a 5 point Likert scale)
and whether the answer matches the question (2=yes, 1=partial, 0=no). The rst criterion was
devised to help us understand if the presentation and composition of the question from triples.
The second criterion question helped us to determine if system can answer the question with some
degree of relevancy. We calculated Cohen Kappa’s inter-rater reliability Cohen (1960) for both of
these questions to determine the e fectiveness of FOQUS.

5.2.2.1 Results for FOQUS
We compiled the assessments for each of the questions from our evaluators. For the criterion regarding
the acceptability of the answer, we normalized the ratings for degree of acceptability (5 and 4) to
1, neutral (3) to 0, and degrees of unacceptability (2 and 1) to -1. For criterion addressing whether
the answer responded to the question correctly, both answered (2) and partially answered (1) were
recoded as 1 and unanswered (0) coded as 0. In addition, we also tallied the non-normalized agreement
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(conservative) to further assess the performance of the question answering system. Kappa’s interrater agreement was calculated on these recoded values among the four evaluators. In Table 5.6, we
present agreement results for FOQUS.
Table 5.7 presents the accuracy of FOQUS, along with the percentage of acceptability for natural
language composition of the answer. Similar to above, we calculated accuracy of the question responses
by coding the partially answered and completely answered as 1, and 0 coded for not answering the
question. We also present the accuracy for completely answered as 1, and coded partially answered
and not answered as 0. Presentation of the answer was coded as 1 for degrees of acceptability, and
neutral and the degrees of unacceptability to 0.
Table 5.6: Agreement ratings for the question answering component.

FOQUS con g

Acceptable answer

vector variant
string variant

0.55
0.64

Perceived
correctness
(conservative)
0.59
0.66

Perceived
correctness

Vector variant

String variant

0.72
0.54
0.50

0.70
0.50
0.49

0.80
0.82

Table 5.7: Accuracy of the question answering component.

Response answered the question
combined with partial
without partial (exact)
Acceptable presentation of answer

Based on the agreement for acceptability, the semantic vector variant for FOQUS rated at 0.55.
While the string-based variant rated at 0.64. For the agreement of whether the answer addressed
the question, the vector-based variant rated at 0.80, and the string-based con guration rated at 0.82.
The raw conservative agreement was 0.59 and 0.66 for vector and sting variants, respectively.
FOQUS’ vector-based variant appear to preform slightly better for answer accuracy on both exact
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(0.54 to 0.50) and calculations that include partially answered (0.72 to 0.70). When considering the
agreement from Table 5.6 where the string variant of FOQUS has slightly more agreement from
evaluators, the better accuracy may not be conclusive. The same can be said for the presentation of
the answer where the vector-based variant of FOQUS was slightly better (0.50 to 0.49).

5.2.3

VEO Engine

The objective of this study was to show that, for small devices, we could use an emotion ontology
to reason and query emotions. This study could further our work in developing conversational
agents that include emotions in interactions with humans. Also, this may further interest in using
ontologies and the semantic web to help machines express and interpret emotions with humans
users.
To support our objective, we performed the following:
1. Developed the proof-of-concept engine that harnessed VEO to allow for querying and
interpretation of emotions using an application programming interface (API)
2. Tested the VEO Engine’s functionality to query and perform reasoning for emotions
To test the sof ware library, we used a Raspberry Pi 3 Model 3 board with Raspian version 9. Speci c
to Raspberry Pi, the device was also connected to 7” touchscreen display with 800 x 400 pixel screen
resolution. The VEO Engine was deployed to the device, and we executed sample tests through the
command line to assess both the visualization query and the emotion reasoning of the library.
Aside from the input parameters we provided through the command line, the entire library was
executed locally on the Raspberry Pi device and performed its functions without any connection to
external sof ware services.
Through a command line input for a speci c emotion, the VEO Engine queried for the corresponding
image le and displayed a sample window showing that the visualization was linked to the emotion.
Figure 5.12 shows anger displayed from the VEO Engine on a Raspberry Pi device.
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Figure 5.12: Touchscreen device displaying results of a visualization query for the emotion anger.

Figure 5.13: VEO-Engine performed a reasoning task based on parameters for the emotion of hope.

We tested the VEO Engine’s reasoner by feeding a string of data describing an emotion. To test, the
input required:
reason [positive|negative] [concept_propertyn ]
For example, the input parameters of reason [positive] [concernsConsequence some Prospective_Consequence]
was revealed to be the emotion of hope. Figure 5.13 displays the result of a sample parameter input
for hope to demonstrate the reasoning capability of VEO Engine on a small device.
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5.3 Examining usability and impact on the users’ health beliefs
We assessed the usability of the conversational agent for HPV counseling (referred to as “Beverly”)
on individual users. One group involved parents with at least one child under 18 and another group
involving young adults who were under 25, an age group that the vaccine is still e fective for. These
two groups are potential users for whom the HPV vaccine counseling agent could target. In the
following sections, we describe some early assessment through a simulated agent to gain some
insight to develop an automated tool (some of the components discussed earlier were the result
of that insight) and also attain some evidence on the probable success of this system if it were to be
used in a clinical environment. Section 5.3.1 looks at an early pilot using Wizard of OZ protocol (see
Chapter 4) with parents with at least one child under 18. Section 5.3.2 looks at an early pilot with
the same protocol but with young adults at a major Texas campus. This speci c trial collected more
detailed data, like perceived beliefs of the HPV vaccine and data from validated usability surveys.

5.3.1

Early Usability Assessment of Conversational Agent

Our aim is to gather preliminary assessment knowledge of a vaccine-centric conversational agent
(CA) to help re ne our idea of utilizing an automated CA for HPV counseling at a clinical environment.
For our early assessment and data collection process, we employed the Wizard of OZ protocol that
simulates speech interfaces with a potential user who thinks they are interacting with an automated
machine or robot (Fraser & Gilbert, 1991). It allows us the evaluate the usability and acceptability of
the system rather than to measure the quality of an entire system.
We proposed the following questions:
• How would parents with a child under 18 assess the usability (ease of use, e ciency, and
expected capabilities) of a voice user interface for HPV vaccine counseling application?
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• Would the parents’ vaccine hesitancy have an impact on the usability of an HPV vaccine
conversational agent?
• What are the features and requirements that users desire in order to be feasible?
Our study was approved by UTHealth’s Internal Review Board and conducted from February to
July of 2018. Flyers were posted across the campus to advertise for participants. During that time
period, we recruited 18 participants, who were adults with at least one child under age of 18. This is
primarily because the HPV vaccine is an adolescent vaccine that is administered between the ages of
11 through 18, and the parent is the decision maker for the child. Each participant was escorted to a
private room by the data collector assistant and completed a pre-assessment survey that included
basic information about the subject and a Parent Attitudes about Childhood Vaccines (PACV)
survey (Opel et al., 2013) that measures vaccine hesitancy. Adjacent to the room, another researcher,
the operator, was seated with the desktop application and the dialogue script.
Af er completing the pre-assessment survey, the experiment started, and the participants went
through the simulated automated counseling system with the operator coordinating the interaction
through the guidance of the dialogue script. At the end of the simulated counseling session, we
administered a usability survey voice user interfaces provided by (Cohen et al., 2004) that had
three questions pertaining to the aforementioned usability variables, and we collected the free text
comments from the participants which were later segmented by positive and negative comments.
Out of the 18 participants, one refused further participation and one experienced technical di culty,
and overall, the nal count of participants was 16. Of these 16 participants, 6 spoke English as a nonprimary language. There was an equal number of healthcare professionals or researchers and nonhealthcare professionals or researchers. 9 of the participants had a graduate degree. Most people
have children below 10 years of age.
The PACV survey measured parent attitudes about childhood vaccines. Each answer had a value
and a raw score was obtained for all of the questions. That score was then converted to a score that
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measured vaccine hesitancy. A score of 0-50 represents not vaccine hesitant, 50-80 represents vaccine
hesitant, and 80-100 represents very vaccine hesitant. All 16 of the participants were considered not
vaccine hesitant, which prohibited us to measure the impact of vaccine hesitancy on the usability of
the voice interface. This lack of vaccine hesitancy is likely the result of recruiting at a health science
center, where individuals are presumably better informed on vaccines.
On a scale from 1-7, there was an average score of 5.4 (σ=1.59) for ease of use and an average of 4.5
(σ=1.46) for the expected capabilities. Most of the participants relatively disagreed with the statement
that the system was quick and e cient with an average score of 3.3 (σ=1.85) on a scale from 1-7* . On
average, participants relatively agreed that the system was easy to use and had the capabilities that
they expected. However, the perceived slowness was attributed to how fast the remote operator
responded to the user’s utterance, and in an automated setting would be less of an issue.
The Pearson’s correlation coe cient (r) was used to quantify the linear correlation between two
variables in order to investigate if the score of one variable a fected the other in a linear fashion.
Correlation coe cient is a continuous number ranging from -1 to 1, with -1 stands for perfectly
negative linear relation, and 1 stands for perfectly positive linear relation. For interpretation purpose,
we classify the absolute values of correlation coe cients of less than 0.30 as “small or no correlation”,
values of [0.30, 0.50] as “weak correlation”, values of [0.50, 0.70] as “moderate correlation”, and
values of [0.70, 1.00] as “strong correlation”. Also, we calculated the Fisher’s z transformation to
obtain a normal distribution for our correlation calculation.
As a result of this correlation analyses, we found the weak correlation between the ease of use and
the e ciency of the system with an estimate of 0.34 (95% CI [-0.18, 0.72], with two-sided p-value
of 0.197), the moderate correlation between the ease of use and the expected capabilities of the
system with an estimate of 0.63 (95% CI [0.08, 0.82], p-value=0.024), and the moderate correlation
* 7-strongly agree, 6-agree, 5=agree somewhat, 4=neither agree nor disagree, 3=disagree somewhat,

2=disagree, 1=strongly disagree
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between the e ciency and the expected capabilities with an estimate of 0.55 (95% CI [0.20, 0.86],
p-value=0.007), where the 95% CI were computed by proper use of Fisher’s z transformation (Fisher,
1915). In summary, these analyses suggested that the score given for the expected capabilities has a
moderate e fect on the scores given for the ease of use and e ciency.
The written comments from the participants can be separated into two broad categories, negative
and positive. The negative comments mainly concerned ve things: the response time, the repetitiveness,
the lack of visuals, the need to humanize the system, and the inability to answer all questions. The
biggest concerns were regarding the response time and the repetitiveness. Most people wrote that
the system needed to improve its response time and that it repeated the same points. People also
stated that adding graphics would help with the overall look, improve interaction, and make it less
uncomfortable. Some people also stated that they would prefer speaking to a person or a system that
sounded more human-like. The positive comments mainly regarded four things: the interactivity,
how informative it is, the accessibility, and the clarity of the system. Most people enjoyed the interactive
aspect of the system and how it understands them and encourages them to ask questions. Many
people also stated that the system provided useful information on the HPV vaccine and reinforced
the important points. Not only did the system o fer useful information, it also stated the information
clearly, had a clear voice, and was very straightforward and easy to operate.

5.3.2

Extended Usability Assessment of the Conversational Agent

Again, we utilized the Wizard of Oz (Fraser & Gilbert, 1991) where the dialogue exchange is handled
by a drone operator of the conversational agent (designated as “Beverly”). Potential participants
were young adults above the age of 18 to 26. The participant was o fered an explanation of the study
(design, procedures, and risks) and was given time to ask questions. Each participant was told that
their participation is voluntary, and they can withdraw from the study at any time without negative
consequence. If they agree to participate, the study personnel will obtain informed consent from
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them. The participant entered a designated observation area on TAMU campus with a conversational
agent device (simulated – Wizard of OZ). The participant was lef with the conversational agent
and the conversational agent initiated conversation with the user. For 15-30 minutes, the patient
and conversational agent engaged in discourse and discussion about the HPV vaccine. The drone
operator utilized a script designed by the study personnel to counsel on the HPV vaccine (Amith
et al., 2019b) (See Chapter 4). Af er the session of the simulated counseling information session, the
study sta f administered a few surveys for the participant to complete.
The surveys were provided in English and consisted of three instruments – System Usability Survey
(SUS) (Brooke et al., 1996; Brooke, 2013), The Speech User Interface Service Quality (SUISQ)
(Polkosky, 2008, 2005), and the Carolina HPV Vaccine Attitude and Belief Scale (CHIAS) (McRee
et al., 2010a). SUS is a validated industry standard to provide a “quick and dirty” scoring for usability,
providing a rating between 0-100 derived from 10 survey items (Appendix E). The SUS scoring can
be interpreted by associating a school grade (i.e. 80-89 = B, 70-79 = C, etc.) or associating with an
adjective rating (Sauro & Lewis, 2016; Bangor, 2009).
SUISQ is a 25 question survey developed speci cally for interactive voice response applications
based on four factors: User Goal Orientation (8 items), Customer Service Behaviors (8 items),
Speech Characteristics (5 items), and Verbosity (4 items). Each item is on a Likert scale between
1 to 7. The factor scores are the mean of their items and an overall score is the mean of the factor
scores (Verbosity mean has to be reversed – subtract from 8). User Goal Orientation describes
the “system’s e ciency, user trust, con dence in the system, and clarity of the speech interface”.
Customer Service Behaviors involve “friendliness and politeness of the system, its speaking pace, and
its use of familiar terms”. Speech Characteristics refer “naturalness and enthusiasm of the system
voice”, and Verbosity is the “talkativeness and repetitiveness of the system.” (Lewis & Hardzinski,
2015).
CHIAS is a 16 item survey relating to the four factors of the health belief model (Harms, E fectiveness,
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Barriers, Uncertainty) for the HPV vaccine. This survey has demonstrated stability of the factors to
describe HPV vaccination attitudes over time. With the exception of the E fectiveness factor, the
other three factors have been attributed to parent HPV vaccination intention and predicted HPV
vaccination utilization of parents (Brewer et al., 2011). The CHAIS is adaptable for young adults and
have shown to have similar validity to the parent version (Nicol et al., 2016; Dempsey et al., 2014).
Two recent studies utilized this variation of CHIAS on samples of a young population under 25.
Kamimura et al. (2018) utilized the Risk and Denial, and Bene t factors of the survey to measure
di ferences between young Vietnamese and United States college students. For Hanson et al. (2019),
they focused and measured on the E fectiveness, Uncertainty, and Harms factors of the HBM for
their survey study.
One aspect where we were interested in exploring was how this agent would fare with similar systems
that employed a voice interface. This would give us an idea of how receptive and how e fective
a conversational agent for HPV vaccine would be to future users. Furthermore, we also wanted
to know the impact of this type of sof ware would be on vaccination uptake. The health belief
model has some predictability towards cue to action, namely vaccination uptake (Janz & Becker,
1984). If there is some early evidence that a conversational agent may have on their beliefs it maybe
encouraging enough to further pursue this area in later studies. Therefore, we propose the following
questions:
• What is the overall usability of “Beverly” (i.e. simulated conversational agent) compared to
the usability of most interactive voice user interfaces?
• What is the association of the usability of “Beverly” with the users’ perceived beliefs of the
HPV vaccine?
• Does “Beverly” improve the users’ perceived beliefs of the HPV vaccine?
We conducted the experiment on individuals of young adults who attend Texas A&M UniversityCollege Station. The sample size was 25 who responded to a call for recruitment on the campus,
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coordinated by our collaborators from Texas A&M University. The inclusion criteria were open to
any individual. Overall, among the sample, 11 were females and 14 were males, and the average age
is 20. Ethnic breakdown was 19 white, 3 black, 2 Hispanic, and 1 Asian. 8 had the HPV vaccine, 8
did not have the HPV vaccine, and 9 don’t know. 1 user who experienced technical di culties was
removed from analysis (n = 24).
We collected their survey responses from the aforementioned instruments. Appendix E list the
various variables from the survey. For four questions of the HBM survey, we reversed the scale to
match the direction of the HBM variables - higher scores were indicative of less receptiveness to the
HPV vaccine. For the SUS survey, we neglected the question “I think I would like to use th system
frequently”. According to Lewis & Sauro (2017) analyses, removal of this question would not have
a major impact on the statistical validity of the SUS nal score. To compensate for the neglected
question, we adjusted the SUS calculation based on what is described by Lewis & Sauro (2017). This
was done because we do not foresee this agent being used everyday as a consumer tool. Essentially,
we envisioned the agent to be situated in a clinical environment while the patient is waiting for their
health care provider. Which means they will most likely encounter the system at least once. All of
the statistical analysis was completed through SPSS v25.
For the primary question for overall usability, we computed one sample t-test against an average
SUS score for voice interfaces, μ = 72 (n = 233) (Bangor, 2009). We preformed a one sample t-test
to compare the mean of the SUS score with the reported industry SUS mean for voice interfaces.
The analysis produced a t-statistic of 1.627, with a probability score of 0.059. Overall, there is 94%
con dence that the system has a score above the industry mean of 73. This would reveal that the
conversational agent had an on-par or a slightly above average SUS score with industry-based interactive
voice interface systems. We also looked at the di ferences between users by vaccination status (See
Figure 5.14).
The SUS overall score was higher among those that never had the vaccination (μ = 80) compared
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to those that did have the HPV vaccine (μ = 77) and those did not know if they had the HPV
vaccination (μ = 74).
We also looked at the attributes of individuals in relation to the SUS score to ascertain any association
with the SUS Score. A Fisher Exact Test (p = 0.54, 12.42) indicated a statistically marginally signi cant
relationship between vaccination status and SUS score. None of the other attributes such as school
classi cation, parents’ income, etc. indicated any signi cance with the SUS Score.
While the SUS survey has a history of being a valid measurement tool for quick usability scoring,
the SUISQ survey has yet to be as standardized as the SUS. We administered the SUISQ survey in
conjunction with SUS, as recommended by Lewis (2016). We looked at the correlation between SUS
and SUISQ to ascertain any signi cant relationship. For the most part, there appear to be positive
correlation between SUS Score and SUISQ score, moderately strong, and statically signi cant

Figure 5.14: SUS Scores among different vaccination statuses. Red line is the average of all the participants. Black line

is the baseline mean measure reported for interactive voice interface systems reported by Bangor (2009).
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(r=0.486, p=0.016). With the User Goal Orientation and Verbosity factors of SUISQ, there also
appear to be a strong, positive relationship with the SUS score (r=0.508,p=0.005). The same is said
for Verbosity with SUS Score (r=0.627,p=0.000). There is also moderately positive correlation with
Customer Service Behavior Score with the SUS score (r=0.438, p=0.014).
For the next group of analysis, we investigated any e fect of usability on the participants’ beliefs of
the HPV vaccine. Looking at those who reported to not had the HPV vaccine and did have the
HPV vaccine, we calculated the Spearman rank correlation. Among those that reported to not
had the HPV vaccine, there was a strong inverse relationship (i.e. lower CHAIS rating indicates a
greater propensity for the HPV vaccine) between SUISQ and the e fectiveness construct, which
was statistically signi cant (rs= -.711, p=0.037). There was also a strong inverse relationship between
Verbosity factor of SUISQ and the uncertainty construct for the CHAIS health belief model, which
was statistically signi cant (rs= -0.874, p=0.05). Among those that reported yes to the HPV vaccine,
there was a strong inverse relationship between SUISQ and the barrier construct, which was statistically
signi cant (rs= -0.639, p=0.044). Also a strong inverse relationship between SUISQ and the e fectiveness
construct, which was statistically signi cant (rs= -0.655, p=0.039). In addition there was a strong
inverse relationship between Verbosity factor of SUISQ and the e fectiveness construct, and statistically
signi cant (rs= -0.764, p=0.014).
Lastly, we examined if there is any possible improvement in the users’ perception of the HPV vaccine
compared to samples from published studies conducted by Kamimura et al. (2018) and Hanson
et al. (2019). We re-scaled our collected CHIAS HBM data to match the scales for Kamimura’s
and Hanson’s CHIAS data – ve point and 11 point scale respectively. Then we computed a onesample t-test with the means of the CHIAS factors with the CHIAS factors of the aforementioned
published studies. Table 5.8 summarizes the our results where the green signifying statistical signi cance,
yellow with marginal statistical signi cance and red with no statistical signi cance.
There appear to be better beliefs and perceptions with Risk and Denial (μ =1.41, p=0.00), Perceived
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Table 5.8: Comparing means of CHAIS constructs from the intervention and published studies. Lower values for CHIAS

indicate positive attitudes in favor of the HPV vaccine.

CHIAS HBM Construct
Perceived Barriers
Risk and Denial
Perceived Harms
Perceived E fectiveness
Perceived Uncertainty

Agent+CHIAS
1.94
1.41
1.92
3.82
2.13

CHIAS
p-value
2.33 (n=437)(Kamimura et al., 2018)
0.09
2.00 (n=437)(Kamimura et al., 2018)
0.00
3.5 (n=108)(Hanson et al., 2019)
0.00
4.3 (n=108)(Hanson et al., 2019)
0.26
4.8 (n=108)(Hanson et al., 2019)
0.00

Harms (μ =1.92, p=0.00) and Uncertainty (μ =2.13, p=0.00) among the individuals who experienced
“Beverly”. There was some improvement if accounting for the marginally statistical signi cance
with Perceived Barriers (μ =1.94, p=0.09). There was no evidence of improvement with Perceived
E fectiveness despite better rating (μ =3.82, p=0.26).
Overall, based on the initial analysis, we could conclude that the possibility of using a conversational
agent for the HPV vaccine could be as good the industry standard for usability of a voice user interface.
And that the usability could have some correlation on the health beliefs of its users as it relates to the
HPV vaccine. While these results are preliminary at best, and lack a larger sample size, there is some
promise that deploying a tool for a health care environment could be feasible. However, additional
research is needed to further validate our assumptions.

5.4

Summary

This chapter details the assessment of the various components for a proposed ontology-driven
architecture for HPV vaccine counseling. We reviewed the intrinsic and extrinsic quality of ontologies
for VISO HPV, VAXMO, PHIDO, and VEO using semiotic theory-based measures. The results
indicated satisfactory quality when compared to sets of ontologies that are were of the same domain
or from a sample benchmark of NCBO BioPortal ontologies. We also evaluated the system functionality
of ontology-driven sof ware components that used some of the aforementioned ontologies as their
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core component. The ontology-driven sof ware engines (VEO Engine, COO, and FOQUS) were
able to preform with functional tests to adhere to tasks for which they are designed for the agent.
Lastly, we also gathered user data on the perception of a conversational agent and possible e fect
on their beliefs of the HPV vaccine. The results show some in uence of the usability of the voice
interface with speci c health belief model constructs for the HPV vaccine (e.g. perceived e fectiveness
and uncertainty) among those that have reported to have had the HPV vaccine and those that
reported to never having the HPV vaccine. There is some evidence that a conversational agent can
improve the perception and beliefs of the HPV vaccine when we compare to existing studies that
measured health beliefs of the HPV vaccine among the young. Overall the domain, application, and
interaction view of the system architecture provided the possible realization of the development
and deployment of an automated conversational agent in a live environment. In the next and nal
chapter, I will discuss the implication of our work and limitations (i.e. our future direction).
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Perfection (in design)

achieved not when there

nothing more to add, but rather when there

nothing

more to take away
Antoine de Saint-Exupery

6
Conclusion

We presented an ontology-driven architecture for a speech-enabled conversational agent for the
HPV Vaccine. This architecture is modeled using a vertical layered structure, where each layer
is facilitated by an ontology artifact that provides the intelligence to interact with the user. Each
component was scienti cally evaluated. For example, ontologies were assessed using a metric suite
against other ontologies, and if they had any unique provision, we assessed the ontology with an
appropriate evaluation. Application sof ware components were tested for their primary functionality,
ranging from the ability to retrieve visualizations based on an emotion, interpret emotion, answer
HPV vaccine-related questions, and manage the dialogue. Aside from the system architecture, we
also presented some evidence to support the notion that high usability of an automated spoken
dialogue could impact the beliefs of the user’s perception of the HPV vaccine. The combination
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of the architecture and early results from usability tests provides some feasible support for the
development and deployment of an ontology-based spoken dialogue system for the HPV Vaccine.
In this last chapter, we discuss some of the results and limitations of this study, and o fer some
future steps and directions to expand this work.

6.1 Discussion

Figure 6.1: Layered architecture of the conversational agent for HPV vaccine.

For simplicity, we will refer to the gure from Chapter 1 that outlines the scope and system architecture
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of this study (Figure 6.1). We will start by discussing the user experience and user impact involving
the usability of the HPV vaccine conversational agent, and the e fect it had on their perception
of the HPV vaccine (User Experience, Section 6.1.1). Then we will segue in explaining the work
related to the ontology-driven interface layer (Interface Layer, Section 6.1.2), and the ontologies
related to the application layer (Application Layer, Section 6.1.3). Lastly, we will brie y review the
work in the domain layer (Domain Layer, Section 6.1.4). This chapter will end with some notes on
contributions and limitations that could inform the future direction of the research in this area.

6.1.1

User Experience

6.1.1.1 Early assessment with parents
While we received some encouraging positive comments, there were some useful suggestions that
could lead to an improved user experience. The responsiveness issue was an important aspect. Because
we were copying and pasting or typing responses to be transmitted wirelessly that may have had a
slight latency impact on perceived responsiveness. It also highlights that if the system were to be
automated and utilize arti cial intelligence components, the system would need to be relatively
quick in responding to the user’s utterance. Another issue was better usage of graphics or visualizations
to complement the dialogue. Lastly, the aim of the speech system is to alleviate some of the communication
challenges at a clinical environment. Some of the users expressed a desire to speak to a human.
Our belief is that the important discussion points, like personal contextual health information
as it pertains to vaccines should be handled by the provider to avoid confusion. Throughout the
dialogue, we emphasized that user should confer with the doctor for more nuanced and speci c
information, especially since we envision this conversational agent to be stationed as a kiosk or tablet
in the waiting room.
From our study of 16 participants, who were not vaccine hesitant, we determined that parents found
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that a vaccine conversational agent was relatively easy to use and had the expected capabilities. Most
participants found the agent to be slow and this is mainly due to responsiveness of the Wizard of
OZ (WOZ) remote operator. Nonetheless, the feedback highlighted the importance for automated
vaccine conversational agents to be responsive with utterances and with the suggestions from users,
therefore, we have collected future features and improvements to better develop an automated CA.

6.1.1.2 Extended Assessment with young adults
This second attempt at the Wizard of Oz experiment was performed on young adults who are also
potential targets for the HPV vaccine, considering the recent FDA approval for its e fectiveness
through age 45 (US Food and Drug Administration, 2018). Contrasting from the previous attempt,
we administered a more detailed usability survey — System Usability Scale (SUS) and Speech User
Interface Service Quality (SUISQ). SUS is a general usability measurement scale based on 10 Likert
scaled questions that has proven reliability. While SUISQ is a more robust usability survey for voice
user interfaces, it has yet to achieve the reliability of the SUS. Together they may provide further
validation support for SUISQ (Lewis, 2016). We also administered a health belief model survey
Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS) that was tailored for young
adults (Dempsey et al., 2014) to see of any correlation between the health belief constructs and
usability variables. We also compared the means for each of the constructs with previous published
studies that used this modi ed survey for a younger population (Kamimura et al., 2018; Hanson
et al., 2019).
The overall usability (i.e. satisfaction, e fectiveness, and e ciency), measured through the SUS
score, indicated that the conversational agent had average to slightly better than the mean of 72
among 223 interactive voice interface system, with an average SUS score of 77 (94% con dence).
To add, there was marginally statistical signi cance relationship with the SUS score and the HPV
vaccination status. There were slight variations of the SUS score among the di ferent users, with
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those that had the HPV vaccine (with 77) and those that do not know if they had the vaccine at 74.
The individuals that never had the HPV vaccine rated the system high at 80. The score from this
group is meaningful as this tool could be e fective for individual users who never had the HPV
vaccine and could perhaps inform and encourage them better than other paper-based methods.
With a small sample, we can conclude that there is evidence for those never had the HPV vaccine
that our conversational agent (while simulated) has strong usability with the tool. We need to
further analyze why those that don’t know they had the HPV vaccine scored lower at 74 and perhaps
look into ways to improve among this groups of individuals.
Lower values for the health belief ratings indicated a propensity for the HPV vaccine. Therefore,
we sought any statistical signi cance showing an inverse relationship between the CHIAS health
belief model (HBM) constructs and usability factors. No signi cant relationship exists between
SUS and CHIAS HBM constructs, but there are some statistical signi cant relationships between
the SUISQ factors and CHIAS HBM constructs. Among the individuals who never had the HPV
vaccine, the SUISQ Overall Score has a strong inverse relationship with perceived e fectiveness of
the HPV vaccine. This would indicate that the participants who never had the HPV vaccine and
the liked agent, are more likely to consider the HPV vaccine and believe in its e fectiveness. With
that same group, the Verbosity factor — measuring how repetitive and talkative the agent is — had
a signi cant inverse relationship with the perceived uncertainty. For background, a lower Verbosity
indicated low perception of repetitiveness and talkativeness. This score was reversed for analysis
where a higher Verbosity score indicated low perception of repetitiveness and talkativeness of the
agent. Perceived uncertainty represents how susceptible they feel on attaining a health issue. In this
case if they perceive they are susceptible to the HPV they are likely to engage behaviors to prevent
it. What we gather from our results for the relationship between Verbosity and Uncertainty is that
the information that was spoken by the system was not deemed insigni cant to the user and that the
content related to the virus had an e fect on their knowledge of HPV.
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Of interest, the individuals who reported yes to having the HPV vaccine also shared the same relationship
pairing — Verbosity ≈ Uncertainty, and Overall SUISQ ≈ E fectiveness. Also, SUISQ had a signi cant
relationship with Uncertainty and Barrier. The Barrier rating reveals any external challenges that
could impede attaining the HPV vaccine. Since individuals reported yes to having the HPV vaccine
it is clear they do hot have any barriers preventing them since they are vaccinated. The various
relationship with several variables are more likely due to them already having the HPV vaccine, since
SUISQ overall score was associated with three of the ve CHIAS constructs.
When we analyzed the Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS) user data
with CHIAS mean results from other published studies that used the same survey (Kamimura et al.,
2018; Hanson et al., 2019), there is a statistical di ference (i.e. improvement) with various means
of the constructs for the Health Belief Model. Aside from the perceived e fectiveness construct,
there was also a marginally statistical di ference with perceived barriers construct. In absence of a
true control group, there is some evidence of impact on health beliefs and perceptions of the HPV
vaccine as a result of the using a conversational agent for HPV vaccine.
The young demographic may have di ferent information needs compared to adults. For example,
emphasizing health sexual practices to prevent HPV transmission. Among those that reported not
knowing whether they had the HPV vaccine, no signi cant inverse relationship with any of the
variables existed. We need to investigate why this was the case. It might be possible that they have
low health literacy, but we cannot be certain unless we measure their health literacy skills. It may also
be due to their lack of interest in their personal health, in which case a tailored dialogue intervention
may be needed for this group.
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6.1.2

Interface layer

6.1.2.1 COO and FOQUS
The Conversational Ontology Operator (COO) was supported through the use of PHIDO. Using
PHIDO as the facilitator for the dialogue engine we were able to demonstrate the use of an ontology
to control the ow of the dialogue and maintain the dialogue context at the same time. Three use
cases were introduced – communicating one statement related to health information, facilitating the
interaction for question answering, and transitioning to the next topic. In all of the use case tests,
the engine was able to support the various dialogue interactions.
FOQUS provided question answering abilities to answer sample questions from the simulation
logs. It utilizes two variants (string matching and vector-based comparisons) to nd matches of
salient concepts of the question with the triples of the ontology. Irrespective of the con guration
for FOQUS, the question answering system did perform su ciently in answering the questions
from the chat logs collected from our Wizard of OZ experiment, with an accuracy ranging from
0.50 to 0.72 (depending on the variant or the inclusion of partially answered responses). With some
promising initial results and a system foundation to build upon, re nement is needed to further
improve FOQUS. We may explore natural language generation methods to better improve the
transformation of triples to clear and natural answers. However, one limitation of this study is
that we may need to factor in the impact of answers being uttered by a machine. For this, we need
to assess FOQUS in a live environment with users and test its portability with other consumer
ontology knowledge bases. Further discussion of the future directions and limitations of COO and
FOQUS is provided in 6.3.
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6.1.2.2

VEO Engine

While our results show promise for semantic driven technologies, there are still opportunities for
improvement. One would be to allow for synonymous emotion input in visualization queries, for
example, fondness in place of love. To permit this, we would need to expand the ontology to link
similar terms with each emotion and then modify the SPARQL queries. These improvements are
possible because ontologies are graph-like, and therefore they can be changed easier than, say, a
relational database (Allemang & Hendler, 2011).
To perform reasoning functions, the VEO Engine required structured data input, so for this technology
to be further applicable, it must map or translate the noisy contextual information from the human
user into structured data. Therefore, if we looked at unstructured, free text from a person’s utterances,
we would need to parse out the information and then map that information to the appropriate
parameters for emotional valences and concept properties to then input into the VEO Engine. In
this scenario, natural language processing might o fer a direction.
Our work exempli es how semantic-encoded emotions could be utilized by sof ware and small
devices to assist machines in understanding human emotions. Based on our previous VEO work
(Lin et al., 2018), we developed VEO Engine, a sof ware library that interfaces with the emotion
ontology. The VEO Engine was able to query for visualizations associated with an emotion, and
it was able to deduce an emotion based on sample input parameters. The combination of having
emotions semantically de ned and a sof ware wrapper to interface with the ontology makes semantic
web technologies a feasible option for a fective computing. In the future, we will look to incorporating
this work into conversational agents for health care applications. Speci cally, this could enhance
how machines react and respond to patients’ or health consumers’ utterances to improve their
outlook and well-being.
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6.1.3 Application layer
6.1.3.1

PHIDO

The representation of the patient-centric counseling was inspired from the dialogue script and the
Wizard of OZ implementation of the script with live participants, which included the interaction
logs from their participation. While the application ontology is rooted in real world activity, there
will likely be exceptional utterances that we may not anticipate by future user interactions. Currently,
our Wizard of OZ experiment is ongoing and future interaction logs may inspire modi cations for
the ontology.
We stressed that PHIDO is an application ontology, so it may not universally cover the domain of
dialogue interaction, nor are there immediate plans to align it with an upper ontology. Currently
our focus is on vaccine counseling, but we foresee the possibility that PHIDO could cover patientcentric communication of health information for a variety of topics while being grounded in some
behavioral theory. Also of similar importance, as indicated by the domain coverage, PHIDO would
need to model additional Speech Tasks since it only represented 6 types, which is not extensive.
Dialogue management is bifurcated into dialogue ow and dialogue context components (Jokinen
& McTear, 2009). Most of what we discussed for PHIDO facilitates dialogue ow with some minimal
contextual information (e.g. the Utterance class’s h BeenSaid). Ideally, we hope in the future that
PHIDO will encompass management for dialogue ow and contextual information for an ontologydriven approach.
We derived an application ontology for dialogue management called Patient Health Information
Dialogue Ontology (PHIDO) that is based on our on-going Wizard of OZ experiments conducted
at University of Texas Health Science Center at Houston. This application ontology is intended
to be used in a prospective dialogue engine for embedded and mobile devices that will automate
a counseling session for the HPV vaccine, a vaccine that has dramatically low coverage among the
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population. Our initial qualitative results based on the semiotic metric suite indicated that PHIDO
is of comparable quality to NCBO Bioportal ontologies. Our current activity is to develop the
sof ware engine that will harness PHIDO to be deployed in machines, and to link a lightweight
ontology-based question and answering system to the dialogue manager. We foresee that our work
will demonstrate and contribute to the usefulness of semantic web and ontology technology to
power patient-centric conversation for health information.

6.1.3.2

VEO

In the future, we could expand VEO by creating nuances within certain emotion types–for instance,
fear-like states can range from those that are mild (e.g., concern) to those that are intense (e.g.,
terror). These types of states could be included as subclasses in the ontology. We also intend to
expand the terminological space with some of the a fective terms found in WN AFFECT. Additionally,
we could add instances in the future that represent an individual user’s emotions.
Overall, the survey results validated the accuracy of our emotion visualizations. More people agreed
than disagreed that the image matched the emotion displayed for 17 emotions (with 16 out of these
17 emotions found to be statistically signi cant), and vice versa for eight emotions. However, only
for the three emotions of distress, reproach, and resentment did people prefer the incorrect emotionimage pair to the correct one. One reason the incorrect emotion-image pair was preferred for distress
could be due to its name—-distress and sadness have slightly di ferent connotations, and if we had
used the name “sadness”, perhaps the percentage of people that agreed with our visualization would
be higher. Af er all, even though people thought that the image for fear represented distress (in the
incorrect emotion-image pair), they still con rmed that the image for fear was accurate at a high rate
(65.0%).
Additionally, in future studies and from the ndings of the survey results, it would be helpful to
further investigate the eight emotions that did not support our visualizations by comparing them
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to di ferent incorrect emotion-image pairs. This could allow us to understand whether the speci c
randomly-chosen incorrect pair had any in uence on our results or if they still hold with di ferent
pairs used. If so, these results can inform us in regard to editing our visualizations so that they are
more representative of each emotion. Our research also does not consider the use of motion, which
could enhance the visualizations in the future.
In the future, this study could permit machines to utilize the VEO to interpret and understand
emotions, with the purpose of improving interaction with human users, such as patients. For
clari cation, recall that ontologies are artifacts of encoded knowledge to help machines understand
domain concepts and the relationships between them. Codifying a fective knowledge would help
intelligent agents, speci cally conversational agents, to understand the underlying emotions during
their interactions with humans. Looking at an emotion like love, which according to the OCC
model, contains positive emotional valence involving the appraisal of some aspect of an object, or
anger, which contains negative emotional valence relating to someone’s actions and the subsequent
outcomes of the actions. A sof ware agent can potentially capture contextual information and
emotional valence data, and through the use of descriptive logic queries, reason what the user is
feeling or expressing (see Figure 6.2). The use of ontologies to de ne emotions for machines and
then comprehend the emotions of users makes this possible. Further research could investigate
processing of the user’s emotions from utterances or other modalities of expression. This would also
include developing the sof ware that interfaces with the ontology and employing it in conversational
agents.
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Figure 6.2: Interpreting the user’s emotional information.

6.1.4

Domain layer

6.1.4.1 Vaccine Information Statement Ontology
Based on the analysis of the Burton-Jones scores, our initial HPV ontology demonstrating promise.
The syntactic score (0.76) demonstrates that the high machine readability of the ontology due to
correct use of syntax (lawfulness), and lack of total utilization of OWL features (richness). However,
for this speci c ontology and its use-case of only representing vaccine patient knowledge, some of
the features may not be necessary, but as we continually develop VISO for HPV, there may be
knowledge that may require other OWL features to better model the vaccine information. The
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semantic quality is also relatively high (0.93) resulting from low use of repetitive terms (consistency)
and low use of ambiguous terms (clarity). Overall, the scores are quite promising for initial work,
but evaluating the accuracy and expanding the use of OWL-based features are needed to fully evaluate
the quality.
Creating the ontology posed many challenges. Even though there is already an existing VISO representation
from which the HPV ontology is based, a few concept classes and subclasses had to be created
or modi ed in order to better represent some knowledge triples. For example, a subclass called
“Adjuvant” was conceptualized to describe speci c ingredients added to vaccines, like monophosphoryl
lipid A which is added to Cervarix, one of the licensed HPV vaccines. Another example, the super
class “DNA Virus” to describe Human Papillomavirus (HPV) was also created to elaborate on the
type of virus that the HPV vaccines target. Another di culty that we experienced was determining
whether to include some of the information found pertaining to HPV in the ontology such as side
e fects, contraindications, and mechanism of action. Ultimately, any information determined to be
bene cial and helpful to the patient was included. Additionally, some of the medical terms in the
VIS documents are subject to interpretation and could be ambiguous to patients, such as the terms
“mildly ill” versus “moderately ill”. Most patients will be unable to discern the di ference between
the degrees of illness; therefore, it can become misleading to patients.
As for the accuracy quality, we will need to obtain feedback from subject matter experts to improve
the overall quality. We are investigating the possibility of growing the knowledge base with any
information that is lacking; for example, inclusion of additional patient-level education about the
cancers caused by HPV, such as cervical and oropharyngeal cancer. While the initial knowledge base
included basic information regarding HPV-related cancers, additional information is needed to
improve the robustness of the knowledge base. Encoding extended information like these into the
knowledge base can help raise awareness for the need of HPV vaccination from a cancer-awareness
perspective. A neglected aspect, yet of great interest to us, is to go beyond encoding facts and information
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about HPV vaccine and consider incorporating multimedia content to enrich the knowledge base.
Ontological knowledge bases could indeed link the various concepts with complementary multimedia
content, like video and images, to deliver dynamic information through the patient-centered interactive
agents. In addition, there is also evidence that storytelling may have an impact to educate and raise
awareness of vaccination (Cunningham & Boom, 2013). Whether it would be speci c stories linked
to certain vaccine concepts or a method to semi-automatically generate a story, the implementation
of storytelling components in a machine-readable knowledge base is of interest and will be further
explored.

6.1.4.2 Vaccine Misinformation Ontology
The Vaccine Misinformation Ontology (VAXMO)’s purpose is to catalogue and analyze vaccine
misinformation that has been one of the drivers for low rates of vaccination rates worldwide. Ontologies
bene t from reusing other ontologies. We have utilized an existing model of misinformation, Misinformation
Ontology (MO), to address anti-vaccination information. In addition, we have utilized an innovative
approach using nanopublication (which is generally used for scienti c assertions) for linking common
false assertions or theories about vaccines (i.e. “vaccines causes autism”, “government created weaponized
Ebola vaccines”, etc.). Yet, this poses some di culty - lack of Protégé support and manually editing
the ontology artifact. This may inspire us to investigate the possibility of developing a Protégé
plugin that provides an interface to view and edit the nanopublication segment of VAXMO.
With some modi cations, we constructed the ontology based o f of the Misinformation Ontology
and extended some of its concepts from an existing survey literature. While MO is speci cally
designed to model false intention and not misfacts, as stated by the original authors, we further
extended the ontology to utilize nanopublication graph structure to store and represent false assertions
about vaccines. The current representation of VAXMO is encoded in OWL with only the class-level
eshed out and with some conceptual gaps.
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Noted earlier, there have been various studies that focused on content analysis of misinformation
and myths of vaccines in the public health domain. Some of the literature can help furnish additional
concepts to further expand VAXMO, which could help model and understand the features within
anti-vaccination information domain.
While VAXMO is of better quality than NCBO Bioportal ontologies, there is still some more work
needed to expand its conceptual domain space for anti-vaccine information. Also, we have described
a future use-case that aims to detect misinformation about vaccines, and we plan on reporting on
our ndings in a future study.
We assume that the impact of this work could lead to applicable uses of semantic web ontologies for
public health informatics and future informatics tools that can assist researchers to understand and
address health misinformation in the post-modern era.

6.2 Contribution
Health informatics is de ned as a “the interdisciplinary study of the design, development, adoption,
and application of IT-based innovations in healthcare services delivery, management, and planning”
(Procter, 2009). The ontology-based architecture described in this dissertation introduces a design
for conversational agents for HPV vaccine where each major component - knowledge domain layer,
the application layer and the interaction layer - all have a core ontology that facilitate the operations
of agent. This would open a whole new avenue for IT integration into the healthcare space and thus
expand the eld of health informatics.
Without either the PHIDO, VISO HPV, VAXMO, and VEO, the agent will not be able to direct
and track HPV counseling with the user, the question-answering system will not be able to provide
triples to answer and form a response, and the visual interface would not be able to provide the
utterances an emotive facade or a means to determine and reason the emotion of the user. Each of
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Figure 6.3: Hardware deployment for a conversational agent. Red highlights the hardware components.

the major components as described in early chapters have shown to preform their desired function.
Also, because the sof ware components are domain independent, this architecture was not designed
to tightly coupled with the vaccine domain. The domain is de ned in the ontologies itself and be
all it would require to port to a new domain is to replace the ontology with another. Overall this
architecture is a reusable framework for health-based conversational agents.
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Aside from the architecture, we were also able to substantiate the possibility of a fecting the user’s
health belief for the HPV vaccine using a simulated conversational agent (the end integrated product).
The initial assumption was that patient and provider counseling on vaccine information is able to
improve uptake dramatically, but with the burdens placed on providers this is not optimal across
every clinic. The results of the study are not only encouraging for vaccination uptake with conversational
agents, but it may open new venues to apply this same approach in other important spoken health
opportunities, like genetic counseling or PrEP education.
Another important output of our work was the development of a patient-level vaccine knowledge
base that can be utilized in consumer-facing sof ware tools. Both VISO HPV and VAXMO have
both been integrated in a components-related conversational agent or demonstrated in use cases
where it may be used for analytical purposes (Amith & Tao, 2018). We hope that our work could
open the possibility of more patient-centric knowledge bases that can be shared and reused and
power the intelligence behind sof ware agents.
Another outcome of our work is the formalization of the dialogue interaction for HPV vaccine
counseling. Previous researchers have outlined some high-level architecture and heuristics for discussing
vaccines for patients (Opel et al., 2013, 2012, 2015). The initial script provided a framework but also
a speci c dialogue and was based on constructs of the health belief model. This script was tested
in two experiments which showed to be relatively successful with users. The dialogue later served
as a template to create sca folds to within PHIDO, and within PHIDO we can link the utterances
to knowledge bases and categories related to the health belief model. In addition, PHIDO o fers
the opportunity to tailor the dialogue when we begin implementing rules using the Semantic Web
Rule Language (Horrocks et al., 2004; O’connor et al., 2005) or possibly the SPARQL Inferencing
Notation (SPIN) Knublauch et al. (2011). With the sca folding provided through PHIDO we can
also o fer the ontology as an ontological framework to allow other users to implement their dialogue
for health-based patient discussion. We have also demonstrated the use of ontologies for process-
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based use cases, outside of dialogue.

6.3 Future Direction and Limitations
While we have the blueprint and technology to develop and deploy (pilot test) a fully automated
prototype of a conversational agent for the HPV vaccine, there are many research and development
directions to pursue.
With regards to the user perception, we reported that some analyses were minimal or of no signi cance,
and this could be attributed to a small sample size. Studies of our scale that involve participants to
be physically in a live environment (i.e. as opposed to taking a survey online) require immense time
and resources that were limited in our e fort. Our results from the extended usability study focused
on young adult students. It remains to be seen if we would attain similar perception or impact if
experimented with parents, even though our early trial with parents showed some interest by that
demographic. A future experiment will need to include adults to show more evidence of usefulness
for the system. In a later passage, we talk about tailoring, but for di ferent audiences we need to
determine appropriate utterances for speci c users. For example, using slang words for young adults
– for humor or connection with the user. Our early simulation assessment, none of the users were
reported to be vaccine hesitant. It would be of interest to see how vaccine hesitant parents respond
to a conversational agent for HPV vaccine.

Domain Layer:

From the domain knowledge base, VISO could bene t from linked knowledge

sources to expand the scope of information available for the user. For example, the HPV vaccine is
a cancer preventive measure, and some of the questions posed by the users in the simulation were
cancer-related. VISO could bene t from another ontology pertaining to cancers caused by HPV
infection. We envision the possibility of cancer ontology for patient knowledge that have patientlevel information that are of concerns for everyday consumers. This would contrast with some of
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the professional level ontologies that are more “scienti c”.

Application Layer:

In our Wizard of OZ simulations, we experimented with two types of

audiences - young adults and parents with a child under 18. One of the opportunities that our
ontology for dialogue could provide is tailoring the dialogue for speci c audiences. This may require
an additional step in capturing contextual information from the user. The early draf s of the dialogue
script included small talk and inquiries about the user before it was edited to a bare minimum.
There are a few future steps to consider to make this tool more dynamic for individual users - develop
a user context ontology, expand the dialogue exchange to probe the user for information, and
populate the ontology with appropriate utterances speci c to user, and provide rules and reasoning
to coordinate tailored dialogue.
Our work with VEO and PHIDO introduces opportunities to associate emotions with utterances.
For each utterance class type, we could align it with the visualized emotion to supplement the speech
of the machine.

Interface Layer:

COO PHIDO discerns the various participant utterances based on simple

similarity. We assume that in the future depending on the interaction with the users, the utterances
may become more sophisticated if this work is expanded. This would mean that basic string similarity
to match the utterance of the user with the string text associated with an utterance may not be
su cient. Utilizing advanced approaches like machine learning to match utterance strings with a
Utterance class might be one option to consider.
In regards to question answering component, while the evaluators appear to be satis ed with most
of the responses to questions, we may need to show portability. An issue with ontology-based QA is
that tightly coupled systems that perform well with tested ontologies, but there is a requirement
to hack the system to make it usable for another ontology knowledge base (Damljanovic et al.,
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2011). We need to assess its portability by evaluating system with ontologies other than VISO HPV.
Another evaluation aspect was the presentation of the answers. About half of the responses were
acceptable to the evaluators, and thus, we may need to develop ways to generate a natural language
response from triples that sound “natural”. Also, some of the responses for the questions were
too verbose, and this may be due to the ranking and selection criteria and require us to develop an
alternative method for composing a response. While we have experimented and utilized natural
language generation as an ontology evaluation tool, we could utilize the Hootation API library or
components of it, like SimpleNLG to provide better automated natural language. For the most part,
the question answering component is a subordinate function of the overall dialogue interaction,
but we have to consider having the answer to a question spoken verbally versus reading it may elicit
di ferent outcomes for presentation and whether the answer is a proper response to the question.
Inter-rater agreement was performed for 3 undergraduate pre-med students and 1 graduated students
with a biology degree. The agreement of the results may be su cient to educated young adults,
like the sample in the extended simulation. It remains to be seen whether the agreement would
be similar with adults with children and health providers who work directly with patients. A future
direction would be to incorporate the feedback for these two groups to get a comprehensive evaluation
of the question answering system.
One area where we did not explore was open sourced, o ine speech recognition. We relied on
commercial o ferings to perform some o ine speech recognition on the iOS platform, but due to
the closed nature of the Apple iOS system there were limits on what we could do on their platform.
In several cases, from the dialogue that we collected there were apparent transcribing errors. Furthermore,
o ine speech recognition we believe could be of bene t in the health care domain where, if fully
utilized, can protect the utterances of the user where none of their information is sent to another
cloud server. Further research in this area could also have expanded impact beyond our conversational
agents.
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Finally, performance was a perceived issue during the simulations. Our assumption is that a fully
automated version may be faster than a touch typist or copy and paste operator. However, our next
goal is to deploy and test the sof ware engine with potential users and assess its performance for
possible use in a clinical environment.

With the work we have accomplished in the last few years, we have laid a solid foundation to explore
various informatics-related topics but more importantly this work has the potential to be portable to
other health care subdomains outside of the vaccine area.
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A
Sample Ontologies from National Center
for Biomedical Ontology Bioportal
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Table A.1: Popular ontologies from NCBO on September 2015.

Common Terminology Criteria for Adverse Events
(CTCAE)
EDAM bioinformatics operations, data types, formats,
identi ers and topics (EDAM)
Radiology Lexicon (RADLEX)
Experimental Factor Ontology (EFO)
Content Archive Resource Exchange Lexicon (CARELEX)
BioAssay Ontology (BAO)
Ontology for Biomedical Investigations (OBI)
Brain Region & Cell Type terminology (BRCT)
Cell Ontology (CL)
Robert Hoehndorf Version of MeSH (RH MESH)
Uber Anatomy Ontology (UBERON)
The Drug Ontology (DRON)
Orphanet Rare Disease Ontology (ORDO)
Symptom Ontology (SYMP)
NanoParticle Ontology (NPO)
Sof ware Ontology (SWO)
International Classi cation of Functioning, Disability and
Health (ICF)
Statistics Ontology (STATO)
Semanticscience Integrated Ontology (SIO)
Semantic Web for Earth and Environment Technology
Ontology (SWEET)
Multiple sclerosis ontology (MSO)
Neuroscience Information Framework (NIF) Standard
Ontology (NIFSTD)
Cell Line Ontology (CLO)
Radiation Oncology Ontology (ROO)
Information Artifact Ontology (IAO)
Kinetic Simulation Algorithm Ontology (KISAO)
Genomic Clinical Decision Support Ontology (GENECDS)
Metagenome and Microbes Environmental Ontology
(MEO)
Ortholog Ontology (ORTHO)
Autism Spectrum Disorder Phenotype Ontology
(ASDPTO)
Breast Cancer Grading Ontology (BCGO)
Infectious Disease Ontology (IDO)
Drug Interaction Knowledge Base Ontology (DIKB)
DICOM Controlled Terminology (DCM)
Galen Ontology (GALEN)
Vaccine Ontology (VO)
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Alzheimer’s disease ontology (ADO)

Basic Formal Ontology (BFO)
Biomedical Resource Ontology (BRO)
Ontology of Clinical Research (OCRE)
BioMedBridges Diabetes Ontology (DIAB)
Chemical Information Ontology (CHEMINF)
Ontology for General Medical Science (OGMS)
Clinical Trials Ontology (CTO)
Allen Brain Atlas (ABA) Adult Mouse Brain Ontology
(ABA AMB)
BioModels Ontology (BIOMODELS)
Microbial Culture Collection Vocabulary (MCCV)
Biomedical Informatics Research Network Project Lexicon
(BIRNLEX)
Cigarette Smoke Exposure Ontology (CSEO)
Translational Medicine Ontology (TMO)
Mathematical Modelling Ontology (MAMO)
Pathogenic Disease Ontology (PDO)
Bilingual Ontology of Alzheimer’s Disease and Related
Diseases (ONTOAD)
Anatomic Pathology Lexicon (PATHLEX)
The Drug-Drug Interactions Ontology (DINTO)
Plant Experimental Assay Ontology (PEAO)
Regional Healthcare System Interoperability and
Information Exchange Measurement Ontology (HEIO)
Time Event Ontology (TEO)
Dermatology Lexicon (DERMLEX)
WikiPathways (WIKIPATHWAYS)
Microarray and Gene Expression Data Ontology (MO)
VIVO Ontology for Researcher Discovery (VIVO)
Sage Bionetworks Synapse Ontology (SYN)
Suggested Ontology for Pharmacogenomics (SOPHARM)
Ontology for Biobanking (OBIB)
Cell Behavior Ontology (CBO)

B
Vaccine Information Statement Ontology
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Table B.1: Vaccine Information Statement Ontology Class Table

Meta-level Class
Vaccine
Target
People

Source

Channel

Cause
Location
Probability
Outcome
Duration

Substance
Combination
Method
NumberOfDoses
Dosage
Component
Age
Date
Occurrence
Action

Allergen
Reaction

Sign

Description
A class description to categorize vaccines
documented by the CDC’s VIS documentation
Provides class specification for virus, bacteria,
diseases, etc. that are prevented by Vaccine Disease
Categorizes various types of patients or groups of
individuals impacted by vaccines, diseases, reactions,
and other health conditions
Used to describe an origin of a vaccine’s target
(bacteria, disease). Can be reused in relations with
other classes.
Class of medium of travel for vaccine targets.

For a description of a condition as a result of a
vaccine target. E.g. infection, coughing spells.
Type to categorize location, specifically area of the
body, affected by a heath condition or reaction
Classification for types of probabilities enumerated
in VIS documents
Types of effects resulting from causation, reactions,
or chain of outcomes.
Used for various types of descriptions for qualitative
length of time for effects of health conditions or
signs of conditions.
Classification of kinds of substance for vaccines and
possibly other class groupings.
For various artifacts that interact with vaccines.
Groups and classifies inoculation methods for
vaccines.
Enumerates the maximum number of doses for
vaccine.
Designates the types of dose or the dose interval.
E.g. 1st Dose, 3rd Dose.
Categorizes types of elements of a vaccine.
Enumerates the type of quantitative classification of
age ? years, months, weeks, etc.
Enumerates the types of quantitative classification
of date ? days, months, weeks, etc.
Classification of types of events
Types of patient recourse in response to reactions
or actions required vaccine patients before
inoculation.
For classes of substances leading to an allergic
reaction.
Used to categorizes types of reactions that may
result from vaccination.
Class of indicators for vaccine reaction effects.
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Example Subclasses or Instances (in italics)
AlternateVaccine
Virus, SeriousDisease, Bacteria
PeopleWithCondition, Infants, PeopleWithIllness,
PeopleWithModerateIllness, PeopleOfAge,
Children, Adults
bacteria, Hepatitis B virus

PeopleChannel, ObjectChannel,
PeopleWithConditionChannel, DermalChannel,
HumanActivityChannel, FluidChannel
ear infection, long-term illness, coughing spells,
pneumonia
FacialLocation, ThroatLocation, ArmLocation
QualitativeProbability, QuantitativeProbability,
ProbabilityInCases
RareOutcome, AdultOutcome, ChildOutcome,
FatalOutcome
DurationInMinutes, DurationInWeeks

LiquidSubstance, GaseousSubstance, SolidSubstance
SafeCombination, DangerousCombination
InhaleMethod, InjectionMethod, OralMethod
OptionalNumberOfDoses
OptionalDose, DoseIntervals
ViralComponent, NoninfectiousViralComponent
AgeInMonths, AgeInYears
DateInYears, DateInMonths, DateInDays
VaccinatedOccurence, TimedOccurence
InactiveAction, ActiveAction, EmergencyAction

VaccineAllergen, VaccineComponentAllergen
MildReaction, TemporaryReaction,
SeriousReaction, ModerateReaction,
AdultReaction
fast heartbeat, crying, stomach pain, hives

Table B.2: Vaccine Information Statement Ontology’s object properties

Domain
Target, Cause, Reaction
Dosage
PeopleWithAllergicReaction, AllergicReaction
Dosage
PeopleBornFrom
Target
Vaccine
Vaccine
NumberOfDoses
Cause, Outcome, Reaction
Vaccine
Vaccine
Vaccine
Reaction
Vaccine
Vaccine
Vaccine
Vaccine
Target, Reaction, Sign, ObjectChannel
Target, Cause, Outcome, Reaction
Cause, Reaction
Vaccine
Reaction
Reaction, Sign
PeopleOfAge
Target
Vaccine
Vaccine
Target
People
Dosage
Cause
HumanActivityChannel
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properties
a fects
af er
allergic to
before
born from
causes
contains
discouraged for
for
happens
has alternate
has dosage
has number of
has signs
is a substance of
is safe for
is safe with
is taken
lasts
leads
located
may cause
need
occurs af er
of age
originates
prevents
protects
spreads through
take
taken at
to
with

Range
People, Location
Date
Allergen
Occurrence
Date
Cause
Component
People
People
Probability
Alternate Vaccine
Dosage
NumberOfDoses
Sign
Substance
People
Combination
Method
Duration
Outcome
Location
Reaction
Action
Date, Occurrence
Age
Source
Target
People
Channel
Action
Age
People
People
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Figure B.1: TBox level structure of VISO.

C
De nition of emotions from the Visualized
Emotion Ontology
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Table C.1: De nition of positive emotions.

De nition
positive is a valenced reaction (to
“something”)
pleased is being positive about a
consequence (of an event)
hope is being pleased about a
prospective consequence (of an
event)
joy is being pleased about an actual
consequence (of an event)
satisfaction is joy about the
con rmation of a prospective
desirable consequence
relief is joy about the discon rmation
of a prospective undesirable
consequence
happy-for is joy about a consequence
(of an event) presumed to be
desirable for someone else
gloating is joy about a consequence
(of an event) presumed to be
undesirable for someone else
surprise is joy or distress about the
discon rmation of a prospective
undesirable consequence
approving is being positive about an
action (of an agent)
pride is approving of one’s own
action
admiration is approving of someone
else’s action
grati cation is pride about an action
and joy about a related consequence
gratitude is admiration about an
action and joy about a related
consequence
liking is being positive about an
aspect (of an object)
love is liking a familiar aspect (of an
object)
interest is liking an unfamiliar aspect
(of an object)

OWL2 Axiom
Positive_Emotion ⊑ Emotion
Pleased ⊑ Positive_Emotion ⊓ (∃
concernsConsequence.Consequence)
Hope ⊑ Pleased ⊓(∃
concernsConsequence.Prospective_Consequence)
Joy ⊑ Pleased ⊓ (∃
concernsConsequence.Actual_Consequence)
Satisfaction ⊑ Joy ⊓ (∃
concernsConsequence.Con rmed_Desirable_Consequence)
Relief ⊑ Joy ⊓ (∃
concernsConsequence.Discon rmed_Undesirable_Consequence)
Happy_For ⊑ Joy ⊓ (∃
concernsConsequence.Consequence_Desirable_For_Other)
Gloating ⊑ Joy ⊓ (∃
concernsConsequence.Consequence_Undesirable_For_Other)
Surprise ⊑ Joy ⊓ (∃
concernsConsequence.Discon rmed_Consequence)
Surprise ⊑ Distress ⊓ (∃
concernsConsequence.Discon rmed_Consequence)
Approving ⊑ Positive_Emotion ⊓
(∃concernsActionsOf.Action)
Pride ⊑ Approving ⊓ (∃
concernsActionsOf.Action_Of_Self_Agent)
Admiration ⊑ Approving ⊓ (∃
concernsActionsOf.Action_Of_Other_Agent)
Grati cation ⊑ Pride Grati cation ⊑ Joy (n.b.)
Gratitude ⊑ Admiration Gratitude ⊑ Joy
Liking ⊑ Positive_Emotion ⊓ (∃ concernsAspect.Aspect)
Love ⊑ Liking ⊓ (∃ concernsAspect.Familiar_Aspect)
Interest ⊑ Liking ⊓ (∃ concernsAspect.Unfamiliar_Aspect)
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Table C.2: De nition of negative emotions

De nition
negative is a valenced reaction (to
“something”)
displeased is being negative about a
consequence (of an event)
fear is being displeased about a
prospective consequence (of an
event)
distress is being displeased about an
actual consequence (of an event)
fears-con rmed is distress about
the con rmation of a prospective
undesirable consequence
disappointment is distress about
the discon rmation of a prospective
desirable consequence
resentment is distress about a
consequence (of an event) presumed
to be desirable for someone else
pity is distress about a consequence
(of an event) presumed to be
undesirable for someone else
surprise is joy or distress about the
discon rmation of a prospective
undesirable consequence
disapproving is being negative about
an action (of an agent)
shame is disapproving of one’s own
action
reproach is disapproving of someone
else’s action
remorse is shame about an action and
distress about a related consequence
anger is reproach about an action and
distress about a related consequence
disliking is being negative about an
aspect (of an object)
hate is disliking a familiar aspect (of
an object)
disgust is disliking an unfamiliar
aspect (of an object)

OWL2 Axiom
Negative_Emotion ⊑ Emotion
Displeased ⊑ Negative_Emotion ⊓ (∃
concernsConsequence.Consequence)
Fear ⊑ Displeased ⊓ (∃
concernsConsequence.Prospective_Consequence)
Distress ⊑ Displeased ⊓ (∃
concernsConsequence.Actual_Consequence)
Fears_Con rmed ⊑ Distress ⊓ (∃
concernsConsequence.Con rmed_Undesirable_Consequence)
Disappointment ⊑ Distress ⊓ (∃
concernsConsequence.Discon rmed_Desirable_Consequence)
Resentment ⊑ Distress ⊓ (∃
concernsConsequence.Consequence_Desirable_For_Other)
Pity ⊑ Distress ⊓ (∃
concernsConsequence.Consequence_Undesirable_For_Other)
Surprise ⊑ Joy ⊓ (∃
concernsConsequence.Discon rmed_Consequence)
Surprise ⊑ Distress ⊓ (∃
concernsConsequence.Discon rmed_Consequence)
Disapproving ⊑ Negative_Emotion ⊓ (∃
concernsActionsOf.Action)
Shame ⊑ Disapproving ⊓ (∃
concernsActionsOf.Action_Of_Self_Agent)
Reproach ⊑ Disapproving ⊓ (∃
concernsActionsOf.Action_Of_Other_Agent)
Remorse ⊑ Shame Remorse ⊑ Distress
Anger ⊑ Reproach Anger ⊑ Distress
Disliking ⊑ Negative_Emotion ⊓ (∃
concernsAspect.Aspect)
Hate ⊑ Disliking ⊓ (∃ concernsAspect.Familiar_Aspect)
Disgust ⊑ Disliking ⊓ (∃
concernsAspect.Unfamiliar_Aspect)
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D
Frankenstein Ontology
Question-Answering for User-Centric
System
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Figure D.1: Process diagram of Frankenstein Ontology Question-Answering for User-Centric System

E
Usability Variables
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Table E.1: Participant demographic variables

Variable ID
DEMOGRAPHIC BLOCK
Participant
Participant’s self identi ed
gender
Participant’s HPV
vaccination status
Participant’s race/ethnicity

SPSS Code

Measurement/Value

participants
gender

Scale
Nominal {m, f}

hpv_vax_status

Participant’s age
Participant’s college
classi cation
Income

age
Class

Parent’s income

ParentIncome

Nominal
{1=yes,2=no,3=don’t know}
Nominal {white, black,
hispanic, asian}
Scale
Nominal {freshman,
sophomore, junior, senior}
Nominal {a= less than 5K
b=5001-10K;
c=10,001 – 20K;
d=20,001 – 30K;
e=30,001 – 40K;
f= 40,001- 50K;
g= 50K+
Nominal {1= less than
25,000; 2=25K – 34K;
3=35K-49K;
4=50K-74,999;
5=75K-99,999;
6=100K-149,999;
7= 150K+}

EXPERIENCE BLOCK
Technical di culties
experienced

Technical_di culties Nominal {0 = no, 1= yes}

ethnicity

Income

Table E.2: System Usability Survey variables

Variable ID
SYSTEM USABILITY SCALE
SUS computed score
SUS school grade
SUS adjective

SPSS Code

Measurement/Value

SUS_Score
SUS_Grade
SUS_Adjective

Scale
Ordinal {A, B, C, D, F}
Ordinal {Worst imaginable,
Awful, Poor, OK, Good,
Excellent, Best Imaginable}
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Table E.3: Speech User Interface Service Quality survey
Variable ID
USER GOAL ORIENTATION BLOCK
Beverly made me feel like I was in control
Beverly gave me a good feeling about being a
health consumer
I could nd what I needed without any
di culty
Beverly would help me to be productive
I could trust Beverly to work correctly
I would be likely to use Beverly again
I feel con dent using Beverly
The quality of Beverly made me want to
remain a health consumer
CUSTOMER SERVICE BEHAVIOR
BLOCK
Beverly used terms I am familiar with
Beverly used everyday words
Beverly was organized and logical
Beverly spoke at a pace that was easy to follow
Beverly seemed polite
Beverly seemed courteous
Beverly seemed friendly
Beverly seemed profession in its speaking style
SPEECH CHARACTERISTICS BLOCK
Beverly’s voice was pleasant
Beverly voice sounded like people I hear on
media devices
Beverly’s voice sounded like a regular person
Beverly’s voice sounded natural
Beverly’s voice sounded enthusiastic and full of
energy
VERBOSITY BLOCK
The messages were repetitive
Beverly gave me more details that I needed
Beverly was too talkative
I felt like I had to wait too long for Beverly to
stop talking so I could respond
SUISQ Scoring BLOCK
User Goal Orientation Score
Customer Service Behavior Score
Speech Characteristic Score
Verbosity Score
Verbosity Reversed (to calculate SUISQ)
SUISQ Overall Score

SPSS Code

Measurement/Value

UGO1
UGO3

Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}

UGO5

Ordinal {1=Strongly disagree – 7=Strongly Agree}

UGO10
UGO12
UGO13
UGO17
UGO19

Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}

CSB4
CSB6
CSB7
CSB9
CSB11
CSB21
CSB23
CSB25

Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}

SC14
SC16

Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}

SC18
SC20
SC24

Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}

V2
V8
V15
V22

Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}
Ordinal {1=Strongly disagree – 7=Strongly Agree}

User_Goal_Orientation
Customer_Service_Behavior
Speech_Characteristics
Verbosity
Verbosity_Reverse
Overall_SUISQ

Ordinal {0-7}
Ordinal {0-7}
Ordinal {0-7}
Ordinal {0-7}
Ordinal {0-7; 8- Verbosity_R}
Ordinal {0-7; mean of factors replacing Verbosity with
Verbosity_Reverse}
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Table E.4: CHIAS heatlh belief model (HBM)

Variable ID
Harms Factor BLOCK
The HPV vaccine might cause short term problems, like fever
or discomfort (Harms)
The HPV vaccine is being pushed to make money for drug
companies (Harms)
I think the HPV vaccine might cause health problems in the
future (Harms)
I think the HPV vaccine is unsafe (Harms)
The HPV vaccine is so new that I want to wait a while before
deciding if I should get it (Harms)
Barrier Factor BLOCK
It would be hard to nd a provider or clinic where I could
a ford the HPV vaccine (Barriers)
It would be hard to nd a provider or clinic that would be easy
to get to for getting vaccinated against HPV (Barriers)
It would be hard to nd a provider or clinic that has the HPV
vaccine available (Barriers)
I am concerned that the HPV vaccine costs more that I can
pay (Barriers)
It would be hard to nd a provider or clinic where I don’t have
to wait a long time to get an appointment to be vaccinated
(Barriers)
E fectiveness Factor BLOCK
How e fective do you think the HPV vaccine is in preventing
genital warts (E fectiveness)
How e fective do you think the HPV vaccine is in preventing
cervical cancer (E fectiveness)
Uncertainty Factor BLOCK
I have enough information about the HPV vaccine to decide
whether to get it (Uncertainty)
My friends are getting the HPV vaccine (Uncertainty)
Risk Denial (young adults) BLOCK
I think that getting the HPV vaccine makes it more likely for
someone to have sex (Risk Denial)
I think I am too young to get a vaccine for a sexually
transmitted infection like HPV (Risk Denial)
HPV vaccination is not really necessary because Pap smears
can be done to make sure cervical cancer doesn’t develop (Risk
Denial)
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SPSS
Code

Measurement/Value

H_1

Ordinal {1=Strongly disagree – 4=Strongly agree}

H_2

Ordinal {1=Strongly disagree – 4=Strongly agree}

H_3

Ordinal {1=Strongly disagree – 4=Strongly agree}

H_5
H_15

Ordinal {1=Strongly disagree – 4=Strongly agree}
Ordinal {1=Strongly disagree – 4=Strongly agree}

B_7

Ordinal {1=Strongly disagree – 4=Strongly agree}

B_8

Ordinal {1=Strongly disagree – 4=Strongly agree}

B_9

Ordinal {1=Strongly disagree – 4=Strongly agree}

B_10

Ordinal {1=Strongly disagree – 4=Strongly agree}

B_11

Ordinal {1=Strongly disagree – 4=Strongly agree}

E_12

Ordinal {1=Slightly e fective – 4=Extremely
e fective}
Ordinal {1=Slightly e fective – 4=Extremely
e fective}

E_13

U_14

Ordinal {1=Strongly disagree – 4=Strongly agree}

U_16

Ordinal {1=Strongly disagree – 4=Strongly agree}

RD_4 Ordinal {1=Strongly disagree – 4=Strongly agree}
RD_6 Ordinal {1=Strongly disagree – 4=Strongly agree}
RD_17 Ordinal {1=Strongly disagree – 4=Strongly agree}

References

Adams, W. G., Fuhlbrigge, A. L., Miller, C. W., Panek, C. G., Gi, Y., Loane, K. C., Madden, N. E.,
Plunkett, A. M., & Friedman, R. H. (2003). Tlc-asthma: an integrated information system
for patient-centered monitoring, case management, and point-of-care decision support.
In AMIA Annual Symposium Proceedings, volume 2003 (pp.1̃).: American Medical
Informatics Association.
A fy, Y. M., Badr, N. L., Moawad, I. F., & Tolba, M. F. (2017). Evaluation of cloud service
ontologies. In 2017 Eighth International Conference on Intelligent Computing and
Information Systems (ICICIS) (pp. 144–153).: IEEE.
Agre, P. E. & Chapman, D. (1987). Pengi: An implementation of a theory of activity. In AAAI,
volume 87 (pp. 286–272).
Ahken, S., Fleming, N., Dumont, T., & Black, A. (2015). Hpv awareness in higher-risk young
women: The need for a targeted hpv catch-up vaccination program. J Obstet Gynaecol Can,
37(2), 122–128.

196

Al-Naggar, R. A., Al-Jashamy, K., & Chen, R. (2010). Perceptions and opinions regarding human
papilloma virus vaccination among young women in malaysia. Asian Pac J Cancer Prev,
11(6), 1515–1521.
Alani, H. & Brewster, C. (2006). Metrics for ranking ontologies. In Evaluating Ontologi forthe
Web Workshop (EON2006).
Allemang, D. & Hendler, J. (2011). Semantic web for the working ontologist: effective modeling in
RDFS and OWL. Elsevier.
Allen, J., Ferguson, G., Blaylock, N., Byron, D., Chambers, N., Dzikovska, M., Galescu, L., &
Swif , M. (2006). Chester: towards a personal medication advisor. Journal of biomedical
informatics, 39(5), 500–513.
Allen, J. D., de Jesus, M., Mars, D., Tom, L., Cloutier, L., & Shelton, R. C. (2011). Decisionmaking about the hpv vaccine among ethnically diverse parents: implications for health
communications. Journal of oncolo , 2012.
Allen, J. D., Mohllajee, A. P., Shelton, R. C., Othus, M. K., Fontenot, H. B., & Hanna, R. (2009).
Stage of adoption of the human papillomavirus vaccine among college women. Preventive
medicine, 48(5), 420–425.
Allnatt, R., Engelhardt, J., Gao, J., & Mariano, A. (2001). An evaluation of the functionality and
acceptability of the voice prescription label. Journal of Visual Impairment & Blindness
(JVIB), 95(11).

197

Almeida, M. B. (2009). A proposal to evaluate ontology content. Applied Ontolo , 4(3), 245–265.
Amith, M., Cohen, T., Cunningham, R., Savas, L. S., Smith, N., Cuccaro, P., Gabay, E., Boom, J.,
Schvaneveldt, R., & Tao, C. (In Reviewa). Mining hpv vaccine knowledge structures of
young adults from reddit using distributional semantics and path nder networks. Cancer
Control Journal.
Amith, M., Cunningham, R., Savas, L. S., Boom, J., Schvaneveldt, R., Tao, C., & Cohen, T.
(2017a). Using Path nder networks to discover alignment between expert and consumer
conceptual knowledge from online vaccine content. Journal of Biomedical Informatics, 74,
33–45.
Amith, M., Gong, Y., Cunningham, R., Boom, J., & Tao, C. (2015). Developing VISO: Vaccine
Information Statement Ontology for patient education. Journal of Biomedical Semantics,
6(1), 23.
Amith, M., He, Z., Bian, J., Lossio-Ventura, J. A., & Tao, C. (2018a). Assessing the practice
of biomedical ontology evaluation: Gaps and opportunities. Journal of Biomedical
Informatics, 80, 1–13.
Amith, M., Manion, F., Liang, C., Harris, M., Wang, D., He, Y., & Tao, C. (2018b). Ontokeeper:
Semiotic-driven ontology evaluation tool for biomedical ontologists. In 2018 IEEE
International Conference on Bioinformatics and Biomedicine (BIBM) (pp. 1614–1617).

198

Amith, M., Manion, F., Liang, C., Harris, M., Wang, D., He, Y., & Tao, C. (2019a). Architecture
and usability of ontokeeper, an ontology evaluation tool. BMC Medical Informatics and
Decision Making, 225, 432–436.
Amith, M., Manion, F. J., Harris, M. R., Zhang, Y., Xu, H., & Tao, C. (2017b). Expressing
Biomedical Ontologies in Natural Language for Expert Evaluation. Studi in Health
Technolo

and Informatics, (pp. 838–842).

Amith, M., Roberts, K., & Tao, C. (In Reviewb). Conceiving an application ontology to model
patient human papillomavirus vaccine counseling for dialogue management. BMC
Bioinformatics.
Amith, M. & Tao, C. (2015). A web application towards semiotic-based evaluation of biomedical
ontologies. In Proceedings of International Workshop on Biomedical Data Mining,
Modeling, and Semantic Integration: A Promising Approach to Solving Unmet Medical
Needs (BDM2I 2015).
Amith, M. & Tao, C. (2017). Modulated evaluation metrics for drug-based ontologies. Journal of
Biomedical Semantics, 8(1), 17.
Amith, M. & Tao, C. (2018). Representing vaccine misinformation using ontologies. Journal of
biomedical semantics, 9(1), 22.

199

Amith, M., Zhu, A., Cunningham, R., Lin, R., Savas, L., Shay, L., Chen, Y., Gong, Y., Boom, J.,
Roberts, K., & Tao, C. (2019b). Early Usability Assessment of a Conversational Agent for
HPV Vaccination. Studi in Health Technolo

and Informatics, (pp. 17–23).

Androutsopoulos, I., Ritchie, G. D., & Thanisch, P. (1995). Natural language interfaces to
databases–an introduction. Natural language engineering, 1(01), 29–81.
Angeli, G., Premkumar, M. J. J., & Manning, C. D. (2015). Leveraging linguistic structure for
open domain information extraction. In Proceedings of the 53rd Annual Meeting of the
Association for Computational Linguistics and the 7th International Joint Conference on
Natural Language Processing (Volume 1: Long Papers), volume 1 (pp. 344–354).
Anhang Price, R., Tiro, J. A., Saraiya, M., Meissner, H., & Breen, N. (2011). Use of human
papillomavirus vaccines among young adult women in the united states: an analysis of
the 2008 national health interview survey. Cancer, 117(24), 5560–5568.
Apache Sof ware Foundation (2009). Apache jena. https://jena.apache.org/.
Aruna, T., Saranya, K., & Bhandari, C. (2011). A survey on ontology evaluation tools. In Process
Automation, Control and Computing (PACC), 2011 International Conference on (pp. 1–5).:
IEEE.
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P.,
Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000). Gene ontology: tool for the
uni cation of biology. Nature genetics, 25(1), 25–29.

200

Askelson, N. M., Campo, S., Lowe, J. B., Smith, S., Dennis, L. K., & Andsager, J. (2010). Using
the theory of planned behavior to predict mothers’ intentions to vaccinate their daughters
against hpv. The Journal of School Nursing, 26(3), 194–202.
Atkinson, W., Wolfe, C., & Hamborsky, J. (2012). Centers for Disease Control and Prevention.
Epidemiolo

and Prevention of Vaccine-Preventable Diseas . Washington DC: Public

Health Foundation, 12th edition.
Autayeu, A. (2016). extJWNL. http://extjwnl.sourceforge.net/.
Bair, R. M., Mays, R. M., Sturm, L. A., & Zimet, G. D. (2008). Acceptability of the human
papillomavirus vaccine among latina mothers. Journal of pediatric and adolescent
necolo , 21(6), 329–334.
Bakogianni, G. D., Nikolakopoulos, K. M., & Nikolakopoulou, N. M. (2010). Hpv vaccine
acceptance among female greek students. International journal of adolescent medicine
and health, 22(2), 271–274.
Bangor, A. (2009). Determining What Individual SUS Scores Mean: Adding an Adjective Rating
Scale. Journal of Usability Studi , 4(3), 10.
Banko, M., Cafarella, M. J., Soderland, S., Broadhead, M., & Etzioni, O. (2007). Open
information extraction for the web. In IJCAI, volume 7 (pp. 2670–2676).
Bartholomew, L. K., Parcel, G. S., Kok, G., Gottlieb, N. H., et al. (2011). Planning health promotion
programs: an intervention mapping approach. John Wiley & Sons.

201

Bast, H. & Haussmann, E. (2013). Open information extraction via contextual sentence
decomposition. In 2013 IEEE Seventh International Conference on Semantic Computing
(pp. 154–159).: IEEE.
Bastani, R., Glenn, B. A., Tsui, J., Chang, L. C., Marchand, E. J., Taylor, V. M., & Singhal, R.
(2011). Understanding suboptimal human papillomavirus vaccine uptake among ethnic
minority girls. Cancer Epidemiolo

Biomarkers & Prevention, 20(7), 1463–1472.

Bean, S. J. (2011). Emerging and continuing trends in vaccine opposition website content. Vaccine,
29(10), 1874–1880.
Becker, M. H. (1974). The health belief model and personal health behavior. Health education
monographs, 2, 324–473.
Bernard, D. M., Cooper Robbins, S. C., McCa fery, K. J., Scott, C. M., & Skinner, S. R. (2011). The
domino e fect: adolescent girls’ response to human papillomavirus vaccination. Med J
Aust, 194(6), 297–300.
Berners-Lee, T., Hendler, J., Lassila, O., et al. (2001). The semantic web. Scientiﬁc american, 284(5),
28–37.
Betsch, C., Renkewitz, F., Betsch, T., & Ulshöfer, C. (2010). The in uence of vaccine-critical
websites on perceiving vaccination risks. Journal of Health Psycholo , 15(3), 446–455.
Beveridge, M. & Fox, J. (2006). Automatic generation of spoken dialogue from medical plans and
ontologies. Journal of biomedical informatics, 39(5), 482–499.

202

Bickmore, T. & Giorgino, T. (2006). Health dialog systems for patients and consumers. Journal of
biomedical informatics, 39(5), 556–571.
Bickmore, T. W., Pfeifer, L. M., Byron, D., Forsythe, S., Henault, L. E., Jack, B. W., Silliman,
R., & Paasche-Orlow, M. K. (2010). Usability of conversational agents by patients
with inadequate health literacy: evidence from two clinical trials. Journal of health
communication, 15 Suppl 2, 197.
Bickmore, T. W., Schulman, D., & Sidner, C. (2013). Automated Interventions for Multiple
Health Behaviors Using Conversational Agents. Patient education and counseling, 92(2),
142–148.
Bickmore, T. W., Schulman, D., & Sidner, C. L. (2011). A reusable framework for health
counseling dialogue systems based on a behavioral medicine ontology. Journal of
Biomedical Informatics, 44(2), 183–197.
Blake, K. D., Ottenbacher, A. J., Rutten, L. J. F., Grady, M. A., Kobrin, S. C., Jacobson, R. M.,
& Hesse, B. W. (2015). Predictors of human papillomavirus awareness and knowledge in
2013: Gaps and opportunities for targeted communication strategies. American journal of
preventive medicine, 48(4), 402–410.
Bodenreider, O. & Stevens, R. (2006). Bio-ontologies: current trends and future directions.
Brieﬁngs in Bioinformatics, 7(3), 256–274.

203

Boehner, C. W., Howe, S. R., Bernstein, D. I., & Rosenthal, S. L. (2003). Viral sexually transmitted
disease vaccine acceptability among college students. Sexually Transmitted Diseas , 30(10),
774–778.
Brabin, L., Roberts, S. A., Farzaneh, F., & Kitchener, H. C. (2006). Future acceptance of
adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine,
24(16), 3087–3094.
Brank, J., Grobelnik, M., & Mladenić, D. (2005). A survey of ontology evaluation techniques. In
Proceedings of the conference on data mining and data warehous (SiKDD 2005).
Brawner, B. M., Baker, J. L., Voytek, C. D., Leader, A., Cashman, R. R., Silverman, R., Peter, N.,
Buchner, B. J., Barnes, C. A., Jemmott, L. S., et al. (2012). The development of a culturally
relevant, theoretically driven hpv prevention intervention for urban adolescent females and
their parents/guardians. Health promotion practice, (pp. 1524839912462389).
Brewer, N. T. & Fazekas, K. I. (2007). Predictors of hpv vaccine acceptability: a theory-informed,
systematic review. Preventive medicine, 45(2), 107–114.
Brewer, N. T., Gottlieb, S. L., Reiter, P. L., McRee, A.-L., Liddon, N., Markowitz, L., & Smith,
J. S. (2011). Longitudinal Predictors of Human Papillomavirus Vaccine Initiation Among
Adolescent Girls in a High-Risk Geographic Area:. Sexually Transmitted Diseas , 38(3),
197–204.
Brooke, J. (2013). SUS: a retrospective. Journal of usability studi , 8(2), 29–40.

204

Brooke, J. et al. (1996). Sus-a quick and dirty usability scale. Usability evaluation in industry,
189(194), 4–7.
Brooks, R. (1986). A robust layered control system for a mobile robot. IEEE journal on robotics
and automation, 2(1), 14–23.
Brooks, R. A. (1991a). Intelligence without reason. In Proceedings of the Twelfth International Joint
Conference on Artiﬁcal Intelligence(IJCAI-91 (pp. 569–595).
Brooks, R. A. (1991b). Intelligence without representation. Artiﬁcial intelligence, 47(1-3), 139–159.
Burgess, D. C., Burgess, M. A., & Leask, J. (2006). The mmr vaccination and autism controversy
in united kingdom 1998–2005: Inevitable community outrage or a failure of risk
communication? Vaccine, 24(18), 3921–3928.
Burke, S. C., Vail-Smith, K., White, D. M., Baker, E., & Mitchell, T. (2010). Getting vaccinated
against hpv: attitudes, intentions and perceived barriers of female undergraduates. College
Student Journal, 44(1), 55.
Burton-Jones, A., Storey, V. C., Sugumaran, V., & Ahluwalia, P. (2005). A semiotic metrics suite
for assessing the quality of ontologies. Data & Knowledge Engineering, 55(1), 84–102.
Bühmann, L., Usbeck, R., & Ngomo, A.-C. N. (2015). ASSESS Automatic Self-Assessment
Using Linked Data. In The Semantic Web-ISWC 2015 (pp. 76–89). Springer.

205

Carlson, A., Betteridge, J., Kisiel, B., Settles, B., Hruschka, E. R., & Mitchell, T. M. (2010a).
Toward an architecture for never-ending language learning. In Twenty-Fourth AAAI
Conference on Artiﬁcial Intelligence: Association for Computational Linguistics.
Carlson, A., Betteridge, J., Wang, R. C., Hruschka Jr, E. R., & Mitchell, T. M. (2010b). Coupled
semi-supervised learning for information extraction. In Proceedings of the third ACM
international conference on Web search and data mining (pp. 101–110).: Association of
Computing and Machinery.
Caskey, R., Lindau, S. T., & Alexander, G. C. (2009). Knowledge and early adoption of the hpv
vaccine among girls and young women: results of a national survey. Journal of Adolescent
Health, 45(5), 453–462.
Castellsague, X., Munoz, N., Pitisuttithum, P., Ferris, D., Monsonego, J., Ault, K., Luna, J., Myers,
E., Mallary, S., Bautista, O., et al. (2011). End-of-study safety, immunogenicity, and e cacy
of quadrivalent hpv (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of
age. British journal of cancer, 105(1), 28–37.
Castle, P. E. & Scarinci, I. (2009). Should hpv vaccine be given to men? British Medical Journal
Publishing Group, (339).
Cates, J. R., Brewer, N. T., Fazekas, K. I., Mitchell, C. E., & Smith, J. S. (2009). Racial di ferences in
hpv knowledge, hpv vaccine acceptability, and related beliefs among rural, southern women.
The Journal of Rural Health, 25(1), 93–97.

206

Centers for Disease Control and Prevention (2008). Hpv vaccine–questions and answers.
http://www.cdc.gov/hpv/parents/questions-answers.html.
Centers for Disease Control and Prevention (2012). Adult vaccination coverage–united states, 2010.
MMWR. Morbidity and mortality weekly report, 61(4), 66.
Centers for Disease Control and Prevention (2014a). HPV vaccine resources for health professions.
http://www.cdc.gov/vaccines/who/teens/for-hcp/hpv-resources.html.
Centers for Disease Control and Prevention (2014b).

Human papillomavirus (hpv).

http://www.cdc.gov/hpv.
Centers for Disease Control and Prevention (2014c). Vaccine information statement: Facts about
VISs - Vaccines - CDC. http://www.cdc.gov/vaccines/hcp/vis/about/facts-vis.html.
Centers for Disease Control and Prevention (2016a). Centers for disease control, genetial hpv
infection-std fact sheet. http://www.cdc.gov/STD/HPV/STDFact-HPV.htm.
Centers for Disease Control and Prevention (2016b). Vaccine Information Statement: Diphtheria,
Tetanus, and Pertussis - Vaccines - CDC. http://www.cdc.gov/vaccines/hcp/vis/visstatements/dtap.html.
Centers for Disease Control and Prevention (2016c).

Vaccine Information

Statement: Haemophilus In uenzae Type b (Hib) - Vaccines - CDC.
http://www.cdc.gov/vaccines/hcp/vis/vis-statements/hib.html.

207

Centers for Disease Control and Prevention (2016d). Vaccine Information Statement: Hepatitis B Vaccines - CDC. http://www.cdc.gov/vaccines/hcp/vis/vis-statements/hep-b.html.
Centers for Disease Control and Prevention (2016e). Vaccine Information Statement: MMR
(Measles, Mumps, Rubella) - Vaccines - CDC. http://www.cdc.gov/vaccines/hcp/vis/visstatements/mmr.html.
Centers for Disease Control and Prevention (2016f).

Vaccine Information Statement:

Pneumococcal Conjugate - Vaccines - CDC. http://www.cdc.gov/vaccines/hcp/vis/visstatements/pcv13.html.
Centers for Disease Control and Prevention (2016g). Vaccine Information Statement: Rotavirus Vaccines - CDC. http://www.cdc.gov/vaccines/hcp/vis/vis-statements/rotavirus.html.
Centers for Disease Control and Prevention (2019). Vaccine information statement: Home page vaccines - cdc. http://www.cdc.gov/vaccines/hcp/vis/index.html.
Centers for Disease Control and Prevention (CDC) (2010). Fda licensure of quadrivalent human
papillomavirus vaccine (hpv4, gardasil) for use in males and guidance from the advisory
committee on immunization practices (acip). MMWR. Morbidity and mortality weekly
report, 59(20), 630.
Centers for Disease Control and Prevention (CDC) (2011). Epidemiology and prevention of
vaccine-preventable diseases. Washington, DC: Public Health Foundation.

208

Centers for Disease Control and Prevention (CDC) (2012). Human papillomavirus-associated
cancers-united states, 2004-2008. MMWR. Morbidity and mortality weekly report, 61, 258.
Centers for Disease Control and Prevention (CDC) (2013a). Cdc fact sheet: incidence, prevalence,
and cost of sexually transmitted infections in the united states. cdc.
Centers for Disease Control and Prevention (CDC) (2013b). Hpv vaccine: safe, e fective, and
grossly underutilized.
Centers for Disease Control and Prevention (CDC) (2013c). Human papillomavirus vaccination
coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring,
2006-2013-united states. MMWR. Morbidity and mortality weekly report, 62(29), 591.
Centers for Disease Control and Prevention (CDC) (2013d). National and state vaccination
coverage among adolescents aged 13-17 years–united states, 2012. MMWR. Morbidity
and mortality weekly report, 62(34), 685.
Centers for Disease Control and Prevention (CDC) (2014). How many cancers are linked with hpv
each year. http://www.cdc.gov/cancer/hpv/statistics/cases.htm.
CervicalCancer.org (2014). Cervical cancer statistics. http://www.cervicalcancer.org/statistics.html.
Cetto, M., Niklaus, C., Freitas, A., & Handschuh, S. (2018). Graphene: Semantically-linked
propositions in open information extraction. In Proceedings of the 27th International
Conference on Computational Linguistics (pp. 2300–2311).: Association for Computational
Linguistics.

209

Chafe, W. L. (1982). Integration and involvement in speaking, writing, and oral literature. Spoken
and written language: Exploring orality and literacy, (pp. 35–53).
Chao, C., Velicer, C., Slezak, J. M., & Jacobsen, S. J. (2010). Correlates for human papillomavirus
vaccination of adolescent girls and young women in a managed care organization.
American Journal of Epidemiolo , (pp. kwp365).
Charo, R. A. (2007). Politics, parents, and prophylaxis—mandating hpv vaccination in the united
states. New England Journal of Medicine, 356(19), 1905–1908.
Chaturvedi, A. K., Engels, E. A., Pfei fer, R. M., Hernandez, B. Y., Xiao, W., Kim, E., Jiang, B.,
Goodman, M. T., Sibug-Saber, M., Cozen, W., et al. (2011). Human papillomavirus and
rising oropharyngeal cancer incidence in the united states. Journal of Clinical Oncolo ,
29(32), 4294–4301.
Chesson, H. W., Dunne, E. F., Hariri, S., & Markowitz, L. E. (2014). The estimated lifetime
probability of acquiring human papillomavirus in the united states. Sexually transmitted
diseas , 41(11), 660–664.
Chou, B., Krill, L. S., Horton, B. B., Barat, C. E., & Trimble, C. L. (2011). Disparities in human
papillomavirus vaccine completion among vaccine initiators. Obstetrics & Gynecolo ,
118(1), 14–20.

210

Chow, S.-N., Soon, R., Park, J. S., Pancharoen, C., Qiao, Y. L., Basu, P., & Ngan, H. Y. S.
(2010). Knowledge, attitudes, and communication around human papillomavirus (hpv)
vaccination amongst urban asian mothers and physicians. Vaccine, 28(22), 3809–3817.
Christel, M. G. (1994). The role of visual delity in computer-based instruction. HumanComputer Interaction, 9(3), 183–223.
Cimino, J. J. (1998). Desiderata for controlled medical vocabularies in the twenty- rst century.
Methods of information in medicine, 37(04/05), 394–403.
Cimino, J. J. & Zhu, X. (2006). The practical impact of ontologies on biomedical informatics.
Yearbook of medical informatics, 15(01), 124–135.
Clore, G. L. & Ortony, A. (2013). Psychological construction in the OCC model of emotion.
Emotion Review, 5(4), 335–343.
Coe, A. B., Gatewood, S. B., Moczygemba, L. R., et al. (2012). The use of the health belief model
to assess predictors of intent to receive the novel (2009) h1n1 in uenza vaccine. Innovations
in pharmacy, 3(2), 1.
Cohen, J. (1960). A coe cient of agreement for nominal scales. Educational and psychological
measurement, 20(1), 37–46.
Cohen, M. H., Cohen, M. H., Giangola, J. P., & Balogh, J. (2004). Voice user interface design.
Addison-Wesley Professional.

211

Cohen, P. A., Kulik, J. A., & Kulik, C.-L. C. (1982). Educational outcomes of tutoring: A metaanalysis of ndings. American educational research journal, 19(2), 237–248.
Colgrove, J., Abiola, S., & Mello, M. M. (2010). Hpv vaccination mandates—lawmaking amid
political and scienti c controversy. New England Journal of Medicine, 363(8), 785–791.
Constantine, N. A. & Jerman, P. (2007). Acceptance of human papillomavirus vaccination among
californian parents of daughters: a representative statewide analysis. Journal of Adolescent
Health, 40(2), 108–115.
Core, M. G., Moore, J. D., & Zinn, C. (2003). The role of initiative in tutorial dialogue.
In Proceedings of the tenth conference on European chapter of the Association for
Computational Linguistics-Volume 1 (pp. 67–74).: Association for Computational
Linguistics.
Craig, S. D., Driscoll, D. M., & Gholson, B. (2004). Constructing knowledge from dialog in an
intelligent tutoring system: Interactive learning, vicarious learning, and pedagogical agents.
Journal of Educational Multimedia and Hypermedia, 13(2), 163–183.
Cunningham, R. M. & Boom, J. A. (2013). Telling Stories of Vaccine-Preventable Diseases: Why it
Works. South Dakota Medicine, (pp.6̃).
Dahlström, L. A., Tran, T. N., Lundholm, C., Young, C., Sundström, K., & Sparén, P. (2010).
Attitudes to hpv vaccination among parents of children aged 12-15 years—a populationbased survey in sweden. International Journal of Cancer, 126(2), 500–507.

212

Daley, E. M., Marhe a, S. L., Buhi, E. R., Vamos, C. A., Hernandez, N. D., & Giuliano, A. R.
(2010). Human papillomavirus vaccine intentions among men participating in a human
papillomavirus natural history study versus a comparison sample. Sexually transmitted
diseas , 37(10), 644.
Daley, M. F., Liddon, N., Crane, L. A., Beaty, B. L., Barrow, J., Babbel, C., Markowitz, L. E.,
Dunne, E. F., Stokley, S., Dickinson, L. M., et al. (2006). A national survey of pediatrician
knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics, 118(6),
2280–2289.
Damianos, L., Loehr, D., Burke, C., Hansen, S., & Viszmeg, M. (2003). The msiia experiment:
Using speech to enhance human performance on a cognitive task. International Journal of
Speech Technolo , 6(2), 133–144.
Damljanovic, D., Agatonovic, M., & Cunningham, H. (2011). Freya: An interactive way of
querying linked data using natural language. In The Semantic Web: ESWC 2011 Workshops
(pp. 125–138).: Springer.
Davido f, F. (1997). Time. Annals of Internal Medicine, 127(6), 483–485.
De La Paz, S. & Graham, S. (1997). E fects of dictation and advanced planning instruction on
the composing of students with writing and learning problems. Journal of Educational
Psycholo , 89(2), 203.

213

Del Corro, L. & Gemulla, R. (2013). ClausIE: clause-based open information extraction. In
Proceedings of the 22nd international conference on World Wide Web (pp. 355–366).:
International World Wide Web Conferences Steering Committee.
Delichatsios, H. K., Friedman, R. H., Glanz, K., Tennstedt, S., Smigelski, C., Pinto, B. M., Kelley,
H., & Gillman, M. W. (2001). Randomized trial of a “talking computer” to improve adults’
eating habits. American Journal of Health Promotion, 15(4), 215–224.
Dempsey, A. F., Abraham, L. M., Dalton, V., & Ru n, M. (2009). Understanding the reasons
why mothers do or do not have their adolescent daughters vaccinated against human
papillomavirus. Annals of Epidemiolo , 19(8), 531 – 538.
Dempsey, A. F., Brewer, S. E., Pyrzanowski, J., Sevick, C., & O’leary, S. T. (2015). Acceptability of
human papillomavirus vaccines among women older than 26 years. Vaccine, 33(13), 1556–
1561.
Dempsey, A. F., Fuhrel-Forbis, A., & Konrath, S. (2014). Use of the Carolina HPV Immunization
Attitudes and Beliefs Scale (CHIAS) in Young Adult Women. PLoS ONE, 9(6), e100193.
Dempsey, A. F., Zimet, G. D., Davis, R. L., & Koutsky, L. (2006). Factors that are associated with
parental acceptance of human papillomavirus vaccines: a randomized intervention study of
written information about hpv. Pediatrics, 117(5), 1486–1493.

214

Deschler, D. G., Richmon, J. D., Khariwala, S. S., Ferris, R. L., & Wang, M. B. (2014). The
“new” head and neck cancer patient—young, nonsmoker, nondrinker, and hpv positive
evaluation. Otolaryngolo –Head and Neck Surgery, 151(3), 375–380.
Dinh, T. A., Rosenthal, S. L., Doan, E. D., Trang, T., Pham, V. H., Tran, B. D., Tran, V. D., Phan,
G. B., Chu, H., & Breitkopf, C. R. (2007). Attitudes of mothers in da nang, vietnam
toward a human papillomavirus vaccine. Journal of Adolescent Health, 40(6), 559–563.
Dividino, R. Q., Romanelli, M., Sonntag, D., et al. (2008). Semiotic-based ontology evaluation
tool (s-ontoeval). In LREC.
D’Mello, S. K., Graesser, A., & King, B. (2010). Toward spoken human–computer tutorial
dialogues. Human–Computer Interaction, 25(4), 289–323.
Donadiki, E., Jiménez-García, R., Hernández-Barrera, V., Sourtzi, P., Carrasco-Garrido, P.,
de Andrés, A. L., Jimenez-Trujillo, I., & Velonakis, E. (2014). Health belief model applied
to non-compliance with hpv vaccine among female university students. Public health,
128(3), 268–273.
Donadiki, E. M., Jiménez-García, R., Hernández-Barrera, V., Carrasco-Garrido, P., de Andrés,
A. L., & Velonakis, E. G. (2012). Human papillomavirus vaccination coverage among greek
higher education female students and predictors of vaccine uptake. Vaccine, 30(49), 6967–
6970.

215

Dorell, C., Yankey, D., & Strasser, S. (2011a). Parent-reported reasons for nonreceipt of
recommended adolescent vaccinations, national immunization survey—teen, 2009.
Clinical Pediatrics, 50(12), 1116–1124.
Dorell, C. G., Yankey, D., Santibanez, T. A., & Markowitz, L. E. (2011b). Human papillomavirus
vaccination series initiation and completion, 2008–2009. Pediatrics, 128(5), 830–839.
Downs, L. S., Smith, J. S., Scarinci, I., Flowers, L., & Parham, G. (2008). The disparity of cervical
cancer in diverse populations. Gynecologic oncolo , 109(2), S22–S30.
Du, P., Camacho, F., McCall-Hosenfeld, J., Lengerich, E., Meyers, C. M., & Christensen, N. D.
(2015). Human papillomavirus vaccination among adults and children in 5 us states. Journal
of Public Health Management and Practice, 21(6), 573–583.
Dubé, E., Gagnon, D., Ouakki, M., Bettinger, J. A., Guay, M., Halperin, S., Wilson, K., Graham,
J., Witteman, H. O., MacDonald, S., et al. (2016). Understanding vaccine hesitancy in
canada: Results of a consultation study by the canadian immunization research network.
PloS one, 11(6), e0156118.
Dunn, A. G., Leask, J., Zhou, X., Mandl, K. D., & Coiera, E. (2015). Associations between
exposure to and expression of negative opinions about human papillomavirus vaccines
on social media: an observational study. Journal of medical Internet research, 17(6).

216

Dunne, E. F., Nielson, C. M., Stone, K. M., Markowitz, L. E., & Giuliano, A. R. (2006).
Prevalence of hpv infection among men: a systematic review of the literature. Journal of
Infectio

Diseas , 194(8), 1044–1057.

Dunne, E. F., Unger, E. R., Sternberg, M., McQuillan, G., Swan, D. C., Patel, S. S., & Markowitz,
L. E. (2007). Prevalence of hpv infection among females in the united states. Jama, 297(8),
813–819.
Eclipse Foundation (2019). Eclipse RDF4J. https://rdf4j.eclipse.org/.
Ekman, P., Friesen, W. V., & Ellsworth, P. (2013). Emotion in the human face: Guidelin for
research and an integration of ﬁndings. Elsevier.
Esposito, S., Bosis, S., Pelucchi, C., Begliatti, E., Rognoni, A., Bellasio, M., Tel, F., Consolo, S., &
Principi, N. (2007). Pediatrician knowledge and attitudes regarding human papillomavirus
disease and its prevention. Vaccine, 25(35), 6437–6446.
Etter, D. J., Zimet, G. D., & Rickert, V. I. (2012). Human papillomavirus vaccine in adolescent
women: a 2012 update. Current Opinion in Obstetrics and Gynecolo , 24(5), 305–310.
Evans, G. & Bostrom, A. (2002). The evolution of vaccine risk communication in the united states:
1982–2002. National Institute of Aller

and Infectio

Diseas , ed. Jordan Report 20th

anniversary: Accelerated Development of Vaccin , (pp. 58–71).
Evens, M. & Michael, J. (2006). One-on-one tutoring by humans and machines. Computer Science
Department, Illino Institute of Technolo .

217

Fabry, P., Gagneur, A., & Pasquier, J.-C. (2011). Determinants of a (h1n1) vaccination: crosssectional study in a population of pregnant women in quebec. Vaccine, 29(9), 1824–1829.
Fader, A., Soderland, S., & Etzioni, O. (2011). Identifying relations for open information extraction.
In Proceedings of the Conference on Empirical Methods in Natural Language Processing (pp.
1535–1545).: Association for Computational Linguistics.
Fang, C. Y., Coups, E. J., & Heckman, C. J. (2010). Behavioral correlates of hpv vaccine
acceptability in the 2007 health information national trends survey (hints). Cancer
Epidemiolo

Biomarkers & Prevention, 19(2), 319–326.

Farzanfar, R., Finkelstein, J., & Friedman, R. H. (2004). Testing the usability of two automated
home-based patient-management systems. Journal of medical systems, 28(2), 143–153.
Feemster, K. A., Winters, S. E., Fiks, A. G., Kinsman, S., & Kahn, J. A. (2008). Pediatricians’
intention to recommend human papillomavirus (hpv) vaccines to 11-to 12-year-old girls
postlicensing. Journal of Adolescent Health, 43(4), 408–411.
Ferris, D. G., Waller, J. L., Miller, J., Patel, P., Jackson, L., Price, G. A., & Wilson, C. (2008). Men’s
attitudes toward receiving the human papillomavirus vaccine. Journal of Lower Genital
Tract Disease, 12(4), 276–281.
Ferris, D. G., Waller, J. L., Miller, J., Patel, P., Price, G. A., Jackson, L., & Wilson, C. (2009).
Variables associated with human papillomavirus (hpv) vaccine acceptance by men. The
Journal of the American Board of Family Medicine, 22(1), 34–42.

218

Fiks, A. G., Grundmeier, R. W., Mayne, S., Song, L., Feemster, K., Karavite, D., Hughes, C. C.,
Massey, J., Keren, R., Bell, L. M., et al. (2013). E fectiveness of decision support for families,
clinicians, or both on hpv vaccine receipt. Pediatrics, 131(6), 1114–1124.
Finlayson, M. (2014). Java libraries for accessing the princeton wordnet: Comparison and
evaluation. In Proceedings of the Seventh Global Wordnet Conference (pp. 78–85).
Fisher, R. A. (1915). Frequency distribution of the values of the correlation coe cient in samples
from an inde nitely large population. Biometrika, 10(4), 507–521.
Fisher, W. A. (2012). Understanding human papillomavirus vaccine uptake. Vaccine, 30, F149–F156.
Forster, A. S., Marlow, L. A., Wardle, J., Stephenson, J., & Waller, J. (2010). Understanding
adolescents’ intentions to have the hpv vaccine. Vaccine, 28(7), 1673–1676.
Fraser, N. M. & Gilbert, G. N. (1991). Simulating speech systems. Computer Speech & Language,
5(1), 81–99.
Freed, G. L., Clark, S. J., Butchart, A. T., Singer, D. C., & Davis, M. M. (2010). Parental vaccine
safety concerns in 2009. Pediatrics, 125(4), 654–659.
Friedman, R. H., Kazis, L. E., Jette, A., Smith, M. B., Stollerman, J., Torgerson, J., & Carey, K.
(1996). A telecommunications system for monitoring and counseling patients with
hypertension: impact on medication adherence and blood pressure control. American
journal of hypertension, 9(4), 285–292.

219

Fu, L. Y., Bonhomme, L.-A., Cooper, S. C., Joseph, J. G., & Zimet, G. D. (2014). Educational
interventions to increase {HPV} vaccination acceptance: A systematic review. Vaccine,
32(17), 1901 – 1920.
Funk, A., Tablan, V., Bontcheva, K., Cunningham, H., Davis, B., & Handschuh, S. (2007). Clone:
Controlled language for ontology editing. In The Semantic Web (pp. 142–155). Springer.
Gallan, A. S., Jarvis, C. B., Brown, S. W., & Bitner, M. J. (2013). Customer positivity and
participation in services: an empirical test in a health care context. Journal of the Academy
of Marketing Science, 41(3), 338–356.
Gangemi, A., Catenacci, C., Ciaramita, M., & Lehmann, J. (2006). Qood grid: A metaontologybased framework for ontology evaluation and selection. In Proceedings of the EON’2006
Workshop.
Garland, S., Hernandez-Avila, M., Wheeler, C., Perez, G., Harper, D., Leodolter, S., Tang, G.,
Ferris, D., Steben, M., Bryan, J., et al. (2007). Females united to unilaterally reduce
endo/ectocervical disease (future) i investigators quadrivalent vaccine against human
papillomavirus to prevent anogenital diseases. N Engl J Med, 356(19), 1928–1943.
Garland, S. & Smith, J. (2010). Human papillomavirus vaccines. Drugs, 70(9), 1079–1098.
Gashteovski, K., Gemulla, R., & Del Corro, L. (2017). Minie: minimizing facts in open
information extraction. In Proceedings of the 2017 Conference on Empirical Methods in
Natural Language Processing (pp. 2630–2640).

220

Gatt, A. & Reiter, E. (2009). Simplenlg: A realisation engine for practical applications. In
Proceedings of the 12th European Workshop on Natural Language Generation (ENLG 2009)
(pp. 90–93).
Gelman, A., Miller, E., Schwarz, E. B., Akers, A. Y., Jeong, K., & Borrero, S. (2013). Racial
disparities in human papillomavirus vaccination: does access matter? Journal of Adolescent
Health, 53(6), 756–762.
Gerend, M. A. & Barley, J. (2009). Human papillomavirus vaccine acceptability among young
adult men. Sexually transmitted diseas , 36(1), 58–62.
Gerend, M. A. & Shepherd, J. E. (2012). Predicting human papillomavirus vaccine uptake in young
adult women: Comparing the health belief model and theory of planned behavior. Annals
of Behavioral Medicine, 44(2), 171–180.
Giede, C., McFadden, L., Komonoski, P., Agrawal, A., Stau fer, A., & Pierson, R. (2010).
Acceptabililty of hpv vaccination among women attending the university of saskatchewan
student health services. Gynecologic Oncolo , 116(3), 598.
Ginzburg, J. & Fernández, R. (2010). Computational models of dialogue. Handbook of
Computational Linguistics and Natural Language, Oxford. Blackwell.
Girardi, R. (2010). Guiding ontology learning and population by knowledge system goals. In
KEOD (pp. 480–484).

221

Giuliano, A. R., Lee, J.-H., Fulp, W., Villa, L. L., Lazcano, E., Papenfuss, M. R., Abrahamsen, M.,
Salmeron, J., Anic, G. M., Rollison, D. E., et al. (2011). Incidence and clearance of genital
human papillomavirus infection in men (him): a cohort study. The Lancet, 377(9769),
932–940.
Glanz, K., Shigaki, D., Farzanfar, R., Pinto, B., Kaplan, B., & Friedman, R. H. (2003). Participant
reactions to a computerized telephone system for nutrition and exercise counseling. Patient
education and counseling, 49(2), 157–163.
Glimm, B., Horrocks, I., Motik, B., Stoilos, G., & Wang, Z. (2014). Hermit: an owl 2 reasoner.
Journal of Automated Reasoning, 53(3), 245–269.
Go f, S. L., Mazor, K. M., Gagne, S. J., Corey, K. C., & Blake, D. R. (2011). Vaccine counseling: A
content analysis of patient–physician discussions regarding human papilloma virus vaccine.
Vaccine, 29(43), 7343–7349.
Goldie, S. J., O’Shea, M., Diaz, M., & Kim, S.-Y. (2008). Bene ts, cost requirements and coste fectiveness of the hpv16, 18 vaccine for cervical cancer prevention in developing countries:
policy implications. Reproductive health matters, 16(32), 86–96.
Gómez-Pérez, A. (2004). Ontology evaluation,[in:] staab s., studer r.(eds.): Handbook on
ontologies.

222

Gomez-Perez, A., Fernández-López, M., & Corcho, O. (2006). Ontological Engineering: with
exampl from the are of Knowledge Management, e-Commerce and the Semantic Web.
Springer Science & Business Media.
Gorenstein, C. (2015). Bill maher’s bizarre anti-vaccine rant: Stop calling these people ”kooks and
liars”. Salon.
Gostin, L. O. & DeAngelis, C. D. (2007). Mandatory hpv vaccination: public health vs private
wealth. Jama, 297(17), 1921–1923.
Gottlieb, S. L., Brewer, N. T., Sternberg, M. R., Smith, J. S., Ziarnowski, K., Liddon, N., &
Markowitz, L. E. (2009). Human papillomavirus vaccine initiation in an area with elevated
rates of cervical cancer. Journal of Adolescent Health, 45(5), 430–437.
Gottlieb, S. L., Low, N., Newman, L. M., Bolan, G., Kamb, M., & Broutet, N. (2014). Toward
global prevention of sexually transmitted infections (stis): the need for sti vaccines. Vaccine,
32(14), 1527–1535.
Gowda, C., Carlos, R. C., Butchart, A. T., Singer, D. C., Davis, M. M., Clark, S. J., & Dempsey,
A. F. (2012). Chias: a standardized measure of parental hpv immunization attitudes and
beliefs and its associations with vaccine uptake. Sexually transmitted diseas , 39(6), 475–
481.

223

Grabiel, M., Reutzel, T. J., Wang, S., Rubin, R., Leung, V., Ordonez, A., Wong, M., & Jordan, E.
(2013). Hpv and hpv vaccines: the knowledge levels, opinions, and behavior of parents.
Journal of community health, 38(6), 1015–1021.
Graesser, A. C. & Olde, B. A. (2003). How does one know whether a person understands a device?
the quality of the questions the person asks when the device breaks down. Journal of
Educational Psycholo , 95(3), 524.
Green Jr, B. F., Wolf, A. K., Chomsky, C., & Laughery, K. (1961). Baseball: an automatic questionanswerer. In Papers presented at the May 9-11, 1961, western joint IRE-AIEE-ACM
computer conference (pp. 219–224).: ACM.
Green eld, K. T. (2010). The autism debate: Who’s afraid of jenny mccarthy? Time Magazine.
Groth, P., Gibson, A., & Velterop, J. (2010). The anatomy of a nanopublication. Information
Servic & Use, 30(1-2), 51–56.
Groth, P., Schultes, E., Thompson, M., Tatum, Z., & Dumontier, M. (2013). Nanopublication
Guidelines. Concept Web Alliance Working Draf .
Group, F. I. S. et al. (2010). Four year e cacy of prophylactic human papillomavirus quadrivalent
vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and
anogenital warts: randomised controlled trial. BMJ: British Medical Journal, 341.
Groza, A., Dragoste, I., Sincai, I., Jimborean, I., & Moraru, V. (2014). An ontology selection
and ranking system based on the analytic hierarchy process. In Symbolic and Numeric

224

Algorithms for Scientiﬁc Computing (SYNASC), 2014 16th International Symposium on (pp.
293–300).: IEEE.
Gruber, T. R. (1995). Toward principles for the design of ontologies used for knowledge sharing?
International Journal of Human-Computer Studi , 43(5–6), 907–928.
Guadagno, R. E., Blascovich, J., Bailenson, J. N., & Mccall, C. (2007). Virtual humans and
persuasion: The e fects of agency and behavioral realism. Media Psycholo , 10(1), 1–22.
Hadzic, M., Chang, E., Dillon, T., & Wongthongtham, P. (2009). Ontolo -based multi-agent
systems. Springer.
Hanson, K. E., McLean, H. Q., Belongia, E. A., Stokley, S., McNeil, M. M., Gee, J., & VanWormer,
J. J. (2019). Sociodemographic and clinical correlates of human papillomavirus vaccine
attitudes and receipt among wisconsin adolescents. Papillomavir

Research, 8, 100168.

Hariri, S., Unger, E. R., Sternberg, M., Dunne, E. F., Swan, D., Patel, S., & Markowitz, L. E.
(2011). Prevalence of genital human papillomavirus among females in the united states,
the national health and nutrition examination survey, 2003–2006. Journal of Infectio
Diseas , 204(4), 566–573.
Harris, S. & Biermann, A. W. (2002). Mouse selection versus voice selection of menu items.
International Journal of Speech Technolo , 5(4), 389–402.
Hat eld, E., Cacioppo, J. T., & Rapson, R. L. (1993). Emotional contagion. Current directions in
psychological science, 2(3), 96–100.

225

Hemminki, K., Dong, C., & Frisch, M. (2000). Tonsillar and other upper aerodigestive tract
cancers among cervical cancer patients and their husbands. European Journal of Cancer
Prevention, 9(6), 433–437.
Henderson, L., Clements, A., Damery, S., Wilkinson, C., Austoker, J., & Wilson, S. (2011). ‘a false
sense of security’? understanding the role of the hpv vaccine on future cervical screening
behaviour: a qualitative study of uk parents and girls of vaccination age. Journal of medical
screening, 18(1), 41–45.
Hendry, M., Lewis, R., Clements, A., Damery, S., & Wilkinson, C. (2013). “hpv? never heard of
it!”: A systematic review of girls’ and parents’ information needs, views and preferences
about human papillomavirus vaccination. Vaccine, 31(45), 5152–5167.
Hernandez, B. Y., Wilkens, L., Thompson, P., Shvetso, Y., Goodman, M., Ning, L., & Kaopua, L.
(2010). Acceptability of prophylactic human papillomavirus vaccination among adult men.
Human vaccin , 6(6), 467–475.
Herzog, T. J., Huh, W. K., & Einstein, M. H. (2010). How does public policy impact cervical
screening and vaccination strategies? Gynecologic oncolo , 119(2), 175–180.
Hilton, S. & Smith, E. (2011). “i thought cancer was one of those random things. i didn’t know
cancer could be caught…”: Adolescent girls’ understandings and experiences of the hpv
programme in the uk. Vaccine, 29(26), 4409–4415.

226

Hongpaisanwiwat, C. & Lewis, M. (2003). Attentional e fect of animated character. Proceedings of
the human-computer interaction. iOS Press, (pp. 423–30).
Hopfer, S. & Clippard, J. R. (2010). College women’s hpv vaccine decision narratives. Qualitative
Health Research.
Hopkins, T. G. & Wood, N. (2013). Female human papillomavirus (hpv) vaccination: global
uptake and the impact of attitudes. Vaccine, 31(13), 1673–1679.
Horridge, M. & Bechhofer, S. (2011). The owl api: A java api for owl ontologies. Semantic Web,
2(1), 11–21.
Horrocks, I., Patel-Schneider, P. F., Boley, H., Tabet, S., Grosof, B., Dean, M., et al. (2004). Swrl:
A semantic web rule language combining owl and ruleml. W3C Member submission, 21(79),
1–31.
Hughes, J., Cates, J. R., Liddon, N., Smith, J. S., Gottlieb, S. L., & Brewer, N. T. (2009).
Disparities in how parents are learning about the human papillomavirus vaccine. Cancer
Epidemiolo

Biomarkers & Prevention, 18(2), 363–372.

Humiston, S. G., Albertin, C., Scha fer, S., Rand, C., Shone, L. P., Stokley, S., & Szilagyi, P. G.
(2009). Health care provider attitudes and practices regarding adolescent immunizations: a
qualitative study. Patient education and counseling, 75(1), 121–127.
InfoWars (2017).

Vaccines exposed: The hidden crime against children.

www.infowars.com/vaccines-exposed-the-hidden-crime-against-children.

227

Ishibashi, K. L., Koopmans, J., Curlin, F. A., Alexander, K. A., & Ross, L. F. (2008). Paediatricians’
attitudes and practices towards hpv vaccination. Acta Paediatrica, 97(11), 1550–1556.
Jain, N., Euler, G. L., Shefer, A., Lu, P., Yankey, D., & Markowitz, L. (2009). Human
papillomavirus (hpv) awareness and vaccination initiation among women in the united
states, national immunization survey—adult 2007. Preventive medicine, 48(5), 426–431.
Janz, N. K. & Becker, M. H. (1984). The health belief model: A decade later. Health Education &
Behavior, 11(1), 1–47.
Jarvis, K. L., Friedman, R. H., Heeren, T., & Cullinane, P. M. (1997). Older women and physical
activity: using the telephone to walk. Women’s Health Issu , 7(1), 24–29.
Javanbakht, M., Stahlman, S., Walker, S., Gottlieb, S., Markowitz, L., Liddon, N., Plant, A., &
Guerry, S. (2012). Provider perceptions of barriers and facilitators of hpv vaccination in a
high-risk community. Vaccine, 30(30), 4511–4516.
Jemal, A., Simard, E. P., Dorell, C., Noone, A.-M., Markowitz, L. E., Kohler, B., Eheman, C.,
Saraiya, M., Bandi, P., Saslow, D., et al. (2013). Annual report to the nation on the status
of cancer, 1975–2009, featuring the burden and trends in human papillomavirus (hpv)–
associated cancers and hpv vaccination coverage levels. Journal of the National Cancer
Institute, (pp. djs491).

228

Jeudin, P., Liveright, E., del Carmen, M. G., & Perkins, R. B. (2014). Race, ethnicity, and income
factors impacting human papillomavirus vaccination rates. Clinical therapeutics, 36(1),
24–37.
Jianliang, X. & Xiaowei, M. (2008). A web-based ontology evaluation system. In Advanced
Language Processing and Web Information Technolo , 2008. ALPIT’08. International
Conference on (pp. 104–107).: IEEE.
Jimborean, I. & Groza, A. (2014). Ranking ontologies in the ontology building competition
boc 2014. In Intelligent Computer Communication and Processing (ICCP), 2014 IEEE
International Conference on (pp. 75–82).: IEEE.
Johnson, W. L., Rickel, J. W., & Lester, J. C. (2000). Animated pedagogical agents: Face-toface interaction in interactive learning environments. International Journal of Artiﬁcial
intelligence in education, 11(1), 47–78.
Jokinen, K. & McTear, M. (2009). Spoken dialogue systems. Synthes Lectur on Human
Language Technologi , 2(1), 1–151.
Jones, M. & Cook, R. (2008). Intent to receive an hpv vaccine among university men and women
and implications for vaccine administration. Journal of American College Health, 57(1),
23–32.

229

Juntasopeepun, P., Suwan, N., Phianmongkhol, Y., & Srisomboon, J. (2012). Factors in uencing
acceptance of human papillomavirus vaccine among young female college students in
thailand. International Journal of Gynecolo

& Obstetrics, 118(3), 247–250.

Jurafsky, D. & Martin, J. H. (2009). Speech and Language Processing. Pearson.
Kabanza, F., Bisson, G., Charneau, A., & Jang, T.-S. (2006). Implementing tutoring strategies into
a patient simulator for clinical reasoning learning. Artiﬁcial Intelligence in Medicine, 38(1),
79–96.
Kaelbling, L. P. & Rosenschein, S. J. (1990). Action and planning in embedded agents. Robotics
and autonomo

systems, 6(1-2), 35–48.

Kahn, J. A., Cooper, H. P., Vadaparampil, S. T., Pence, B. C., Weinberg, A. D., LoCoco, S. J., &
Rosenthal, S. L. (2009). Human papillomavirus vaccine recommendations and agreement
with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide
survey of texas physicians. Cancer Epidemiolo

Biomarkers & Prevention, 18(8), 2325–2332.

Kahn, J. A., Rosenthal, S. L., Tissot, A. M., Bernstein, D. I., Wetzel, C., & Zimet, G. D. (2007).
Factors in uencing pediatricians’ intention to recommend human papillomavirus vaccines.
Ambulatory Pediatrics, 7(5), 367–373.
Kahn, J. A., Xu, J., Zimet, G. D., Liu, N., Gonin, R., Dillard, M. E., Squires, K., for
HIV/AIDS Interventions, A. T. N., et al. (2012). Risk perceptions af er human

230

papillomavirus vaccination in hiv-infected adolescents and young adult women. Journal
of Adolescent Health, 50(5), 464–470.
Kahn, J. A., Zimet, G. D., Bernstein, D. I., Riedesel, J. M., Lan, D., Huang, B., & Rosenthal, S. L.
(2005). Pediatricians’ intention to administer human papillomavirus vaccine: the role of
practice characteristics, knowledge, and attitudes. Journal of Adolescent Health, 37(6),
502–510.
Kamimura, A., Trinh, H. N., Weaver, S., Chernenko, A., Wright, L., Stoddard, M., Nourian,
M. M., & Nguyen, H. (2018). Knowledge and beliefs about hpv among college students
in vietnam and the united states. Journal of infection and public health, 11(1), 120–125.
Kang, H. S. & Moneyham, L. (2010). Attitudes toward and intention to receive the human
papilloma virus (hpv) vaccination and intention to use condoms among female korean
college students. Vaccine, 28(3), 811–816.
Kata, A. (2010). A postmodern pandora’s box: anti-vaccination misinformation on the internet.
Vaccine, 28(7), 1709–1716.
Kata, A. (2012). Anti-vaccine activists, web 2.0, and the postmodern paradigm–an overview of
tactics and tropes used online by the anti-vaccination movement. Vaccine, 30(25), 3778–
3789.

231

Katz, M. L., Krieger, J. L., & Roberto, A. J. (2011). Human papillomavirus (hpv): college male’s
knowledge, perceived risk, sources of information, vaccine barriers and communication.
Journal of men’s health, 8(3), 175–184.
Katz, M. L., Reiter, P. L., Heaner, S., Ru n, M. T., Post, D. M., & Paskett, E. D. (2009).
Acceptance of the hpv vaccine among women, parents, community leaders, and healthcare
providers in ohio appalachia. Vaccine, 27(30), 3945–3952.
Kaufmann, E. & Bernstein, A. (2007). How useful are natural language interfac to the semantic
web for casual end-users? Springer.
Kaufmann, E., Bernstein, A., & Fischer, L. (2007). Nlp-reduce: A naive but domain-independent
natural language interface for querying ontologies. In Proceedings of the 4th European
Semantic Web Conference (ESWC 2007): ESWC Zurich.
Kaufmann, E., Bernstein, A., & Zumstein, R. (2006). Querix: A natural language interface
to query ontologies based on clari cation dialogs. In 5th International Semantic Web
Conference (ISWC 2006) (pp. 980–981).: Citeseer.
Kazama, J., Makino, T., Ohta, Y., & Tsujii, J. (2002). Tuning support vector machines for
biomedical named entity recognition. In Proceedings of the ACL-02 workshop on
Natural language processing in the biomedical domain-Volume 3 (pp. 1–8).: Association
for Computational Linguistics.

232

Kennedy, C. M., Powell, J., Payne, T. H., Ainsworth, J., Boyd, A., & Buchan, I. (2012). Active
Assistance Technology for Health-Related Behavior Change: An Interdisciplinary Review.
Journal of Medical Internet Research, 14(3).
Kessels, S. J., Marshall, H. S., Watson, M., Braunack-Mayer, A. J., Reuzel, R., & Tooher, R. L.
(2012). Factors associated with hpv vaccine uptake in teenage girls: a systematic review.
Vaccine, 30(24), 3546–3556.
Kester, L. M., Zimet, G. D., Fortenberry, J. D., Kahn, J. A., & Shew, M. L. (2013). A national study
of hpv vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination.
Maternal and child health journal, 17(5), 879–885.
Kim, J. J. & Goldie, S. J. (2009). Cost e fectiveness analysis of including boys in a human
papillomavirus vaccination programme in the united states. Bmj, 339.
King, A., Friedman, R., Marcus, B., Napolitano, M., Castro, C., & Forsyth, L. (2003). Increasing
regular physical activity via humans or automated technology: the chat trial. Ann Behav
Med, 25, S111.
Knublauch, H., Hendler, J. A., & Idehen, K. (2011). SPIN - Overview and Motivation.
https://www.w3.org/Submission/spin-overview/.
Ko, E. M., Missmer, S., & Johnson, N. R. (2010). Physician attitudes and practice toward human
papillomavirus vaccination. Journal of lower genital tract disease, 14(4), 339–345.

233

Kobetz, E., Kornfeld, J., Vanderpool, R. C., Finney Rutten, L. J., Parekh, N., O’Bryan, G., &
Menard, J. (2010a). Knowledge of hpv among united states hispanic women: opportunities
and challenges for cancer prevention. Journal of health communication, 15(sup3), 22–29.
Kobetz, E., Mendoza, A. D., Menard, J., Rutten, L. F., Diem, J., Barton, B., Kornfeld, J., &
McKenzie, N. (2010b). One size does not t all: Di ferences in hpv knowledge between
haitian and african american women. Cancer Epidemiolo

Biomarkers & Prevention, 19(2),

366–370.
Konstantinova, N. & Orasan, C. (2012). Interactive Question Answering. Emerging Applications
of Natural Language Processing: Concepts and New Research, (pp. 149–169).
Kontos, E. Z., Emmons, K. M., Puleo, E., & Viswanath, K. (2012).

Contribution of

communication inequalities to disparities in human papillomavirus vaccine awareness and
knowledge. American journal of public health, 102(10), 1911–1920.
Korstanje, M. (2019). SimMetrics. https://github.com/Simmetrics/simmetrics.
Koshiol, J., Rutten, L. F., Moser, R. P., & Hesse, N. (2009). Knowledge of human papillomavirus:
di ferences by self-reported treatment for genital warts and sociodemographic
characteristics. Journal of health communication, 14(4), 331–345.
Krakow, M. M., Jensen, J. D., Carcioppolo, N., Weaver, J., Liu, M., & Guntzviller, L. M. (2015).
Psychosocial predictors of human papillomavirus vaccination intentions for young women

234

18 to 26: Religiosity, morality, promiscuity, and cancer worry. Women’s Health Issu , 25(2),
105 – 111.
Kravitz, L. & Ross, C. (1993). On are you gonna go my way [recorded by henry hirsch (lenny
kravitz). In On Are you gonna go my way [Compact Disc]. Hoboken, New Jersey:
Waterfront Studios.
Krawczyk, A., Stephenson, E., Perez, S., Lau, E., & Rosberger, Z. (2013). Deconstructing human
papillomavirus (hpv) knowledge: Objective and perceived knowledge in males’ intentions
to receive the hpv vaccine. American Journal of Health Education, 44(1), 26–31.
Krupp, K., Marlow, L. A., Kielmann, K., Doddaiah, N., Mysore, S., Reingold, A. L., &
Madhivanan, P. (2010). Factors associated with intention-to-recommend human
papillomavirus vaccination among physicians in mysore, india. Journal of Adolescent
Health, 46(4), 379–384.
Kuhn, T., Chichester, C., Krauthammer, M., & Dumontier, M. (2015). Publishing without
publishers: A decentralized approach to dissemination, retrieval, and archiving of data.
In International Semantic Web Conference (pp. 656–672). Cham: Springer.
Kwan, T. T., Chan, K. K., Yip, A. M., Tam, K., Cheung, A. N., Young, P. M., Lee, P. W., & Ngan,
H. Y. (2008). Barriers and facilitators to human papillomavirus vaccination among chinese
adolescent girls in hong kong: a qualitative–quantitative study. Sexually transmitted
infections, 84(3), 227–232.

235

Lacey, C. J., Lowndes, C. M., & Shah, K. V. (2006). Burden and management of non-cancerous
hpv-related conditions: Hpv-6/11 disease. Vaccine, 24, S35–S41.
Lambert, J. (2019). Is measles here to stay? NPR.org.
Lane, H. C. & VanLehn, K. (2005). Teaching the tacit knowledge of programming to noviceswith
natural language tutoring. Computer Science Education, 15(3), 183–201.
Lau, M., Lin, H., & Flores, G. (2012). Factors associated with human papillomavirus vaccine-series
initiation and healthcare provider recommendation in us adolescent females: 2007 national
survey of children’s health. Vaccine, 30(20), 3112–3118.
Laz, T. H., Rahman, M., & Berenson, A. B. (2012). An update on human papillomavirus vaccine
uptake among 11–17 year old girls in the united states: National health interview survey,
2010. Vaccine, 30(24), 3534–3540.
Laz, T. H., Rahman, M., & Berenson, A. B. (2013). Human papillomavirus vaccine uptake among
18-to 26-year-old women in the united states. Cancer, 119(7), 1386–1392.
Leask, J., Jackson, C., Trevena, L., McCa fery, K., & Brotherton, J. (2009). Implementation of the
australian hpv vaccination program for adult women: qualitative key informant interviews.
Vaccine, 27(40), 5505–5512.
Leddy, M. A., Anderson, B. L., Gall, S., & Schulkin, J. (2009). Obstetrician-gynecologists and the
hpv vaccine: practice patterns, beliefs, and knowledge. Journal of pediatric and adolescent
necolo , 22(4), 239–246.

236

Lenehan, J., Leonard, K., Nandra, S., Isaacs, C., Mathew, A., & Fisher, W. (2008). Women’s
knowledge, attitudes, and intentions concerning human papillomavirus vaccination:
ndings of a waiting room survey of obstetrics-gynaecology outpatients. Journal of
obstetrics and

naecolo

Canada: JOGC= Journal d’obstetrique et

necologie du Canada:

JOGC, 30(6), 489–499.
Lenselink, C., Schmeink, C., Melchers, W., Massuger, L., Hendriks, J., Van Hamont, D., &
Bekkers, R. (2008a). Young adults and acceptance of the human papillomavirus vaccine.
Public health, 122(12), 1295–1301.
Lenselink, C. H., Gerrits, M. M., Melchers, W. J., Massuger, L. F., van Hamont, D., & Bekkers,
R. L. (2008b). Parental acceptance of human papillomavirus vaccines. European Journal of
Obstetrics & Gynecolo

and reproductive biolo , 137(1), 103–107.

Lerner, J. S., Li, Y., Valdesolo, P., & Kassam, K. S. (2015). Emotion and decision making. Annual
review of psycholo , 66, 799–823.
Lewis, J. R. (2016). Standardized Questionnaires for Voice Interaction Design. Voice Interaction
Design, 1(1), 16.
Lewis, J. R. & Hardzinski, M. L. (2015). Investigating the psychometric properties of the Speech
User Interface Service Quality questionnaire. International Journal of Speech Technolo ,
18(3), 479–487.

237

Lewis, J. R. & Sauro, J. (2017). Can i leave this one out?: the e fect of dropping an item from the
sus. Journal of Usability Studi , 13(1), 38–46.
Liddon, N., Hood, J., Wynn, B. A., & Markowitz, L. E. (2010). Acceptability of human
papillomavirus vaccine for males: a review of the literature. Journal of Adolescent Health,
46(2), 113–123.
Liddon, N. C., Hood, J. E., & Leichliter, J. S. (2012a). Intent to receive hpv vaccine and reasons
for not vaccinating among unvaccinated adolescent and young women: ndings from the
2006–2008 national survey of family growth. Vaccine, 30(16), 2676–2682.
Liddon, N. C., Leichliter, J. S., & Markowitz, L. E. (2012b). Human papillomavirus vaccine and
sexual behavior among adolescent and young women. American journal of preventive
medicine, 42(1), 44–52.
Liddy, E. D. (2001). Natural language processing. In Encyclopedia of Library and Information
Science. Marcel Decker, Inc.
Lin, R., Amith, M. �., Liang, C., Duan, R., Chen, Y., & Tao, C. (2018). Visualized Emotion
Ontology: a model for representing visual cues of emotions. BMC Medical Informatics
and Decision Making, 18(2), 64.
Lin, Y., Harris, M. R., Manion, F. J., Eisenhauer, E., Zhao, B., Shi, W., Karnovsky, A., & He, Y.
(2014). Development of a BFO-based informed consent ontology (ICO). Bioinformatics.

238

Litman, D. J., Rosé, C. P., Forbes-Riley, K., VanLehn, K., Bhembe, D., & Silliman, S. (2006).
Spoken versus typed human and computer dialogue tutoring. IJ Artiﬁcial Intelligence
in Education, 16(2), 145–170.
Liu, D., Yang, Y., Chen, Y., Zhu, H., Bayley, I., & Aldea, A. (2016). Evaluating the ontological
semantic description of web services generated from algebraic speci cations. In ServiceOriented System Engineering (SOSE), 2016 IEEE Symposium on (pp. 211–220).: IEEE.
Lopez, V., Pasin, M., & Motta, E. (2005). Aqualog: An ontology-portable question answering
system for the semantic web. In The Semantic Web: Research and Applications (pp. 546–
562). Springer.
Lopez, V., Uren, V., Sabou, M., & Motta, E. (2011). Is question answering t for the semantic web?:
a survey. Semantic Web, 2(2), 125–155.
Lövheim, H. (2012).

A new three-dimensional model for emotions and monoamine

neurotransmitters. Medical hypothes , 78(2), 341–348.
Luperfoy, S. (2004). Retro tting Synthetic Dialog Agents to Game Characters for Lifestyle Risk
Training. In AAAI Fall Symposium on Dialogue Systems for Health Communication.
Washington, DC.
Lustria, M., Brown, L., & Davis, R. (2007). 10 years of consumer health informatics: What
have we learned about how to design successful web-based interventions? In National
Communication Association (pp.1̃).: National Communication Association.

239

Madden, K., Nan, X., Briones, R., & Waks, L. (2012). Sorting through search results: a content
analysis of hpv vaccine information online. Vaccine, 30(25), 3741–3746.
Madhivanan, P., Krupp, K., Yashodha, M., Marlow, L., Klausner, J. D., & Reingold, A. L. (2009).
Attitudes toward hpv vaccination among parents of adolescent girls in mysore, india.
Vaccine, 27(38), 5203–5208.
Maes, P. (1991). The agent network architecture (ana). Acm sigart bulletin, 2(4), 115–120.
Manion, F. (2017). A Life Cycle Approach to the Development and Validation of an Ontolo

of

the U.S. Common Rule (45 C.F.R. §46). PhD thesis, The University of Texas Health Science
Center at Houston.
Manning, C., Surdeanu, M., Bauer, J., Finkel, J., Bethard, S., & McClosky, D. (2014). The stanford
corenlp natural language processing toolkit. In Proceedings of 52nd annual meeting of the
association for computational linguistics: system demonstrations (pp. 55–60).
Markowitz, L. E., Dunne, E. F., Saraiya, M., for Disease Control, C., (CDC), P., et al. (2014).
Human papillomavirus vaccination: recommendations of the advisory committee on
immunization practices (acip). MMWR Recomm Rep, 63(RR-05), 1–30.
Markowitz, L. E., Tsu, V., Deeks, S. L., Cubie, H., Wang, S. A., Vicari, A. S., & Brotherton, J. M.
(2012). Human papillomavirus vaccine introduction–the rst ve years. Vaccine, 30, F139–
F148.

240

Marlow, L. (2011). Hpv vaccination among ethnic minorities in the uk: knowledge, acceptability
and attitudes. British journal of cancer, 105(4), 486–492.
Marlow, L. A., Forster, A. S., Wardle, J., & Waller, J. (2009a). Mothers’ and adolescents’ beliefs
about risk compensation following hpv vaccination. Journal of Adolescent Health, 44(5),
446–451.
Marlow, L. A., Waller, J., Evans, R. E., & Wardle, J. (2009b). Predictors of interest in hpv
vaccination: A study of british adolescents. Vaccine, 27(18), 2483–2488.
Marlow, L. A., Waller, J., & Wardle, J. (2007). Parental attitudes to pre-pubertal hpv vaccination.
Vaccine, 25(11), 1945–1952.
Marlow, L. A., Wardle, J., & Waller, J. (2009c). Attitudes to hpv vaccination among ethnic
minority mothers in the uk: an exploratory qualitative study. Human vaccin , 5(2), 105–
110.
Martone, M. E., Gupta, A., & Ellisman, M. H. (2004). E-neuroscience: challenges and triumphs in
integrating distributed data from molecules to brains. Nature neuroscience, 7(5), 467–472.
Mays, R. M., Sturm, L. A., & Zimet, G. D. (2004). Parental perspectives on vaccinating children
against sexually transmitted infections. Social science & medicine, 58(7), 1405–1413.
McClelland, A. & Liamputtong, P. (2006). Knowledge and acceptance of human papillomavirus
vaccination: perspectives of young australians living in melbourne, australia. Sexual health,
3(2), 95–101.

241

McColl-Kennedy, J. R., Danaher, T. S., Gallan, A. S., Orsingher, C., Lervik-Olsen, L., & Verma, R.
(2017). How do you feel today? managing patient emotions during health care experiences
to enhance well-being. Journal of Business Research, 79, 247–259.
McRee, A.-L., Brewer, N. T., Reiter, P. L., Gottlieb, S. L., & Smith, J. S. (2010a). The carolina hpv
immunization attitudes and beliefs scale (chias): scale development and associations with
intentions to vaccinate. Sexually transmitted diseas , 37(4), 234–239.
McRee, A.-L., Reiter, P. L., & Brewer, N. T. (2012). Parents’ internet use for information about
hpv vaccine. Vaccine, 30(25), 3757–3762.
McRee, A.-L., Reiter, P. L., Chantala, K., & Brewer, N. T. (2010b). Does framing human
papillomavirus vaccine as preventing cancer in men increase vaccine acceptability? Cancer
Epidemiolo

Biomarkers & Prevention, 19(8), 1937–1944.

Michael, M. & Cheuvront, C. C. J. B. (1998). Health communication on the internet: an e fective
channel for health behavior change? Journal of health communication, 3(1), 71–79.
Migneaul, J., Rakowski, W., Friedman, R., Marks, L., & Clark, M. (2005). User engagement with
an automated telephone intervention to improve on-time repeat mammography. Annals of
Behavioral Medicine, D-33, S085.
Migneault, J. P., Farzanfar, R., Wright, J. A., & Friedman, R. H. (2006). How to write health
dialog for a talking computer. Journal of biomedical informatics, 39(5), 468–481.

242

Miller, W. R. & Rollnick, S. (1991). Motivational interviewing: Preparing people to change addictive
behavior. Guilford Press.
Minnen, G., Carroll, J., & Pearce, D. (2001). Applied morphological processing of english. Natural
Language Engineering, 7(3), 207–223.
Montanaro, D. (2017). Despite the facts, Trump once again embraces vaccine skeptics. NPR.org.
Montgomery, K. & Smith-Glasgow, M. E. (2012). Human papillomavirus and cervical cancer
knowledge, health beliefs, and preventive practices in 2 age cohorts: a comparison study.
Gender medicine, 9(1), S55–S66.
Morales-Campos, D. Y., Markham, C. M., Peskin, M. F., & Fernandez, M. E. (2013). Hispanic
mothers’ and high school girls’ perceptions of cervical cancer, human papilloma virus, and
the human papilloma virus vaccine. Journal of Adolescent Health, 52(5), S69–S75.
Moreno, R., Mayer, R. E., Spires, H. A., & Lester, J. C. (2001). The case for social agency
in computer-based teaching: Do students learn more deeply when they interact with
animated pedagogical agents? Cognition and instruction, 19(2), 177–213.
Mortensen, G. L. (2010). Drivers and barriers to acceptance of human-papillomavirus vaccination
among young women: a qualitative and quantitative study. BMC Public Health, 10(1), 68.
Moundridou, M. & Virvou, M. (2002). Evaluating the persona e fect of an interface agent in a
tutoring system. Journal of computer assisted learning, 18(3), 253–261.

243

Müller, J. P. (1996). The agent architecture interrap. The Design of Intelligent Agents: A Layered
Approach, (pp. 45–123).
Mullins, T. L. K., Gri oen, A. M., Glynn, S., Zimet, G. D., Rosenthal, S. L., Fortenberry, J. D., &
Kahn, J. A. (2013). Human papillomavirus vaccine communication: perspectives of 11–12
year-old girls, mothers, and clinicians. Vaccine, 31(42), 4894–4901.
Munoz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K. V.,
& Meijer, C. J. (2004). Against which human papillomavirus types shall we vaccinate and
screen? the international perspective. International Journal of Cancer, 111(2), 278–285.
Musen, M. A. et al. (2015). The protégé project: a look back and a look forward. AI matters, 1(4),
4.
Myers, M. G. & Pineda, D. (2009). Misinformation about vaccines. Vaccin for biodefense and
emerging and neglected diseas , (pp. 255–270).
Narayanan, S., Ananthakrishnan, S., Belvin, R., Ettelaie, E., Gandhe, S., Ganjavi, S., Georgiou,
P. G., Hein, C. M., Kadambe, S., Knight, K., & others (2004). The Transonics spoken
dialogue translator: an aid for English-Persian doctor-patient interviews. In Working Not
of the AAAI Fall symposium on Dialogue Systems for Health Communication (pp. 97–
103).
National Cancer Institute (2012).

Hpv and cancer.

http://www.cancer.gov/cancertopics/factsheet/Risk/HPV.

244

Naylor, M. D., Brooten, D. A., Campbell, R. L., Maislin, G., McCauley, K. M., & Schwartz, J. S.
(2004). Transitional care of older adults hospitalized with heart failure: a randomized,
controlled trial. Journal of the American Geriatrics Society, 52(5), 675–684.
Newmann, S. J. & Garner, E. O. (2005). Social inequities along the cervical cancer continuum: a
structured review. Cancer Caus & Control, 16(1), 63–70.
Niccolai, L. M., Mehta, N. R., & Hadler, J. L. (2011). Racial/ethnic and poverty disparities in
human papillomavirus vaccination completion. American journal of preventive medicine,
41(4), 428–433.
Nicol, C., Duska, L., Hornsby, P., Pannone, A., & Bernheim, R. (2016). HPV vaccination rates and
attitudes: A cross-sectional survey of college men and women. Gynecologic Oncolo , 141,
112.
Noakes, K., Yarwood, J., & Salisbury, D. (2006). Parental response to the introduction of a vaccine
against human papilloma virus. Human Vaccin , 2(6), 243–248.
Obrst, L., Ceusters, W., Mani, I., Ray, S., & Smith, B. (2007). The evaluation of ontologies. In
Semantic Web (pp. 139–158). Springer.
O t, P. A. & Moser, C. A. (2011). Vaccin & your child: separating fact from ﬁction. Columbia
University Press.

245

Ogilvie, G. S., Remple, V. P., Marra, F., McNeil, S. A., Naus, M., Pielak, K., Ehlen, T., Dobson, S.,
Patrick, D. M., & Money, D. (2008). Intention of parents to have male children vaccinated
with the human papillomavirus vaccine. Sexually transmitted infections, 84(4), 318–323.
Olshen, E., Woods, E. R., Austin, S. B., Luskin, M., & Bauchner, H. (2005). Parental acceptance of
the human papillomavirus vaccine. Journal of Adolescent Health, 37(3), 248–251.
Opel, D. J., Diekema, D. S., & Marcuse, E. K. (2011). Assuring research integrity in the wake of
wake eld. BMJ, 342, d2.
Opel, D. J., Heritage, J., Taylor, J. A., Mangione-Smith, R., Salas, H. S., DeVere, V., Zhou, C., &
Robinson, J. D. (2013). The Architecture of Provider-Parent Vaccine Discussions at Health
Supervision Visits. Pediatrics, 132(6), 1037–1046.
Opel, D. J., Mangione-Smith, R., Robinson, J. D., Heritage, J., DeVere, V., Salas, H. S., Zhou, C.,
& Taylor, J. A. (2015). The in uence of provider communication behaviors on parental
vaccine acceptance and visit experience. American journal of public health, 105(10), 1998–
2004.
Opel, D. J., Robinson, J. D., Heritage, J., Kor atis, C., Taylor, J. A., & Mangione-Smith, R.
(2012). Characterizing providers’ immunization communication practices during health
supervision visits with vaccine-hesitant parents: A pilot study. Vaccine, 30(7), 1269–1275.
Ortony, A., Clore, G. L., & Collins, A. (1990). The cognitive structure of emotions. Cambridge
university press.

246

O’connor, M., Knublauch, H., Tu, S., Grosof, B., Dean, M., Grosso, W., & Musen, M. (2005).
Supporting rule system interoperability on the semantic web with swrl. In International
semantic web conference (pp. 974–986).: Springer.
Palefsky, J. M. (2010). Human papillomavirus-related disease in men: not just a women’s issue.
Journal of Adolescent Health, 46(4), S12–S19.
paomedia (2019). User female alt icon. http://www.iconarchive.com/show/small-n- at-icons-bypaomedia/user-female-alt-icon.html. Public Domain. Accessed 23 Apr 2019.
Papirus Development Team (2019).

Gnome robots icon.

http://www.iconarchive.com/show/papirus-apps-icons-by-papirus-team/gnomerobots-icon.html. GNU General Public License v3.0. Accessed 23 Apr 2019.
Parkin, D. M. & Bray, F. (2006). The burden of hpv-related cancers. Vaccine, 24, S11–S25.
Patel, D. A., Zochowski, M., Peterman, S., Dempsey, A. F., Ernst, S., & Dalton, V. K. (2012).
Human papillomavirus vaccine intent and uptake among female college students. Journal
of American College Health, 60(2), 151–161.
Pearce, C. F., Wolfe, L. M., DePasquale, S. E., & Breen, J. M. (2009). Physician knowledge and
opinions about sexually transmitted infections and the human papillomavirus vaccine: a
community based survey. Tennessee medicine: journal of the Tennessee Medical Association,
102(3), 33–5.

247

Perera, R. & Nand, P. (2017). Recent advances in natural language generation: A survey and
classi cation of the empirical literature. Computing and Informatics, 36(1), 1–32.
Perkins, R. B. & Clark, J. A. (2012). What a fects human papillomavirus vaccination rates? a
qualitative analysis of providers’ perceptions. Women’s Health Issu , 22(4), e379–e386.
Person, N. K., Graesser, A., Bautista, L., Mathews, E., Group, T. R., et al. (2001). Evaluating
student learning gains in two versions of autotutor. Artiﬁcial intelligence in education:
AI-ED in the wired and wireless future, (pp. 286–293).
Petosa, R. & Jackson, K. (1991). Using the health belief model to predict safer sex intentions among
adolescents. Health Education & Behavior, 18(4), 463–476.
Petrovic, K., Burney, S., & Fletcher, J. (2011). The relationship of knowledge, health value and
health self-e cacy with men’s intentions to receive the human papillomavirus (hpv) vaccine.
Journal of Health Psycholo , 16(8), 1198–1207.
Pinto, B. M., Friedman, R., Marcus, B. H., Kelley, H., Tennstedt, S., & Gillman, M. W. (2002).
E fects of a computer-based, telephone-counseling system on physical activity. American
journal of preventive medicine, 23(2), 113–120.
Plutchik, R. (2001). The nature of emotions: Human emotions have deep evolutionary roots, a
fact that may explain their complexity and provide tools for clinical practice. American
scientist, 89(4), 344–350.

248

Podolsky, R., Cremer, M., Atrio, J., Hochman, T., & Arslan, A. A. (2009). Hpv vaccine
acceptability by latino parents: a comparison of us and salvadoran populations. Journal
of pediatric and adolescent

necolo , 22(4), 205–215.

Polkosky, M. D. (2005). Toward a social-cognitive psychology of speech technology: A fective
responses to speech-based e-service.
Polkosky, M. D. (2008). Machines as mediators: The challenge of technology for interpersonal
communication theory and research. In Mediated interpersonal communication (pp. 48–
71). Routledge.
Portet, F., Reiter, E., Gatt, A., Hunter, J., Sripada, S., Freer, Y., & Sykes, C. (2009). Automatic
generation of textual summaries from neonatal intensive care data. Artiﬁcial Intelligence,
173(7-8), 789–816.
Pourat, N. & Jones, J. M. (2012). Role of insurance, income, and a fordability in human
papillomavirus vaccination. The American journal of managed care, 18(6), 320–330.
Price, R. & Shanks, G. (2016). A semiotic information quality framework: development and
comparative analysis. In Enacting Research Methods in Information Systems (pp. 219–250).
Cham.: Palgrave Macmillan.
Priest, H. M., Knowlden, A. P., & Sharma, M. (2015). Social cognitive theory predictors of
human papillomavirus vaccination intentions of college men at a southeastern university.
International Quarterly of Community Health Education, (pp. 0272684X15583289).

249

Prochaska, J. O. & DiClemente, C. C. (2005). The transtheoretical approach. Handbook of
psychotherapy integration, 2, 147–171.
Procter, R. (2009).

De nition of health informatics.

https://www.nlm.nih.gov/hsrinfo/informatics.html.
Quinn, G. P., Murphy, D., Malo, T. L., Christie, J., & Vadaparampil, S. T. (2012). A national
survey about human papillomavirus vaccination: What we didn’t ask, but physicians
wanted us to know. Journal of pediatric and adolescent

necolo , 25(4), 254–258.

Quintero Johnson, J., Sionean, C., & Scott, A. M. (2011). Exploring the presentation of news
information about the hpv vaccine: a content analysis of a representative sample of us
newspaper articles. Health communication, 26(6), 491–501.
Racktoo, S. & Coverdale, G. (2009). Hpv? never heard of it. students and the hpv vaccine. British
Journal of School Nursing, 4(7), 328–34.
Rahati, A. (2012). Persuasive and adaptive tutorial dialogu for a medical diagnos tutoring system.
PhD thesis, University of Sherbrooke.
Rahman, M., Islam, M., & Berenson, A. B. (2015). Di ferences in hpv immunization levels among
young adults in various regions of the united states. Journal of community health, 40(3),
404–408.

250

Rahman, M., Laz, T. H., McGrath, C., & Berenson, A. B. (2014). Correlates of human
papillomavirus vaccine series completion among young adult female initiators. Human
vaccin & immunotherapeutics, 10(8), 2163–2167.
Rambout, L., Tashkandi, M., Hopkins, L., & Tricco, A. C. (2014). Self-reported barriers and
facilitators to preventive human papillomavirus vaccination among adolescent girls and
young women: a systematic review. Preventive medicine, 58, 22–32.
Ramelson, H. Z., Bassey, B., & Friedman, R. H. (2003). The use of computer telephony to provide
interactive health information. In AMIA Annual Symposium Proceedings, volume 2003
(pp. 539).: American Medical Informatics Association.
Ratanasiripong, N. T. (2012). A review of human papillomavirus (hpv) infection and hpv vaccine–
related attitudes and sexual behaviors among college-aged women in the united states.
Journal of American College Health, 60(6), 461–470.
Rector, A., Drummond, N., Horridge, M., Rogers, J., Knublauch, H., Stevens, R., Wang, H., &
Wroe, C. (2004). Owl pizzas: Practical experience of teaching owl-dl: Common errors &
common patterns. In International Conference on Knowledge Engineering and Knowledge
Management (pp. 63–81).: Springer.
Reis, L., Eisner, M., Kosary, C., Hankey, B., Miller, B., Clegg, L., Mariotto, A., Feuer, E., &
Edwards, B. (2005). Seer cancer statistics review, 1975–2002. National Cancer Institute,
Bethesda, MD, 6.

251

Reiter, E. & Dale, R. (2000). Building natural language generation systems. Cambridge university
press.
Reiter, P. L., Brewer, N. T., Gottlieb, S. L., McRee, A.-L., & Smith, J. S. (2009). Parents’ health
beliefs and hpv vaccination of their adolescent daughters. Social science & medicine, 69(3),
475–480.
Reiter, P. L., Brewer, N. T., & Smith, J. S. (2010). Human papillomavirus knowledge and vaccine
acceptability among a national sample of heterosexual men. Sexually transmitted infections,
86(3), 241–246.
Reiter, P. L., McRee, A.-L., Kadis, J. A., & Brewer, N. T. (2011). Hpv vaccine and adolescent males.
Vaccine, 29(34), 5595–5602.
Rickenberg, R. & Reeves, B. (2000). The e fects of animated characters on anxiety, task
performance, and evaluations of user interfaces. In Proceedings of the SIGCHI conference
on Human Factors in Computing Systems (pp. 49–56).: ACM.
Riedesel, J. M., Rosenthal, S. L., Zimet, G. D., Bernstein, D. I., Huang, B., Lan, D., & Kahn, J. A.
(2005). Attitudes about human papillomavirus vaccine among family physicians. Journal of
pediatric and adolescent

necolo , 18(6), 391–398.

Rimer, B., Harper, H., & Witte, O. (2014). Accelerating hpv vaccine uptake: urgency for action
to prevent cancer; a report to the president of the united states from the president’s cancer
panel. National Cancer Institute, Bethesda, MD.

252

Robbins, S. C. C., Bernard, D., McCa fery, K., Brotherton, J., Garland, S., & Skinner, S. R. (2010).
“is cancer contagious?”: Australian adolescent girls and their parents: Making the most of
limited information about hpv and hpv vaccination. Vaccine, 28(19), 3398–3408.
Rosenthal, S., Weiss, T. W., Zimet, G. D., Ma, L., Good, M., & Vichnin, M. (2011). Predictors
of hpv vaccine uptake among women aged 19–26: importance of a physician’s
recommendation. Vaccine, 29(5), 890–895.
Rosenthal, S. L., Rupp, R., Zimet, G. D., Meza, H. M., Loza, M. L., Short, M. B., & Succop, P. A.
(2008). Uptake of hpv vaccine: demographics, sexual history and values, parenting style,
and vaccine attitudes. Journal of Adolescent Health, 43(3), 239–245.
Roter, D. L., Erby, L. H., Larson, S., & Ellington, L. (2007). Assessing oral literacy demand in
genetic counseling dialogue: preliminary test of a conceptual framework. Social science &
medicine, 65(7), 1442–1457.
Rowley, J. (2007). The wisdom hierarchy: representations of the dikw hierarchy. Journal of
information science, 33(2), 163–180.
Rubin, D. L., Shah, N. H., & Noy, N. F. (2007). Biomedical ontologies: a functional perspective.
Brieﬁngs in Bioinformatics, 9(1), 75–90.
Russell, J. A. & Mehrabian, A. (1977). Evidence for a three-factor theory of emotions. Journal of
research in Personality, 11(3), 273–294.

253

Saraiya, M., Rosser, J. I., & Cooper, C. P. (2012). Cancers that us physicians believe the hpv vaccine
prevents: ndings from a physician survey, 2009. Journal of Women’s Health, 21(2), 111–117.
Sauro, J. & Lewis, J. R. (2016). Quantifying the user experience: Practical statistics for user research.
Morgan Kaufmann.
Schiller, J. T., Castellsagué, X., & Garland, S. M. (2012). A review of clinical trials of human
papillomavirus prophylactic vaccines. Vaccine, 30, F123–F138.
Schmitz, M., Bart, R., Soderland, S., Etzioni, O., et al. (2012). Open language learning for
information extraction. In Proceedings of the 2012 Joint Conference on Empirical Methods
in Natural Language Processing and Computational Natural Language Learning (pp. 523–
534).: Association for Computational Linguistics.
Schmitz, M. & Thomson, S. (2013). Morpha stemmer. https://github.com/knowitall/morpha.
Schnatz, P. F., Humphrey, K., & O’Sullivan, D. M. (2010). Assessment of the perceptions and
administration of the human papillomavirus vaccine. Journal of lower genital tract disease,
14(2), 103–107.
School of Biomedical Informatics Ontology Research Group, The University of Texas Health
Science Center of Houston (2019). The Time Event Ontology (TEO).
Schwarz, E. & Kurfess, F. (2011). Introduction to Ontologies with Protege. Department of
Computer Science and Sof ware Engineering - Cal Poly, San Luis Obispo.

254

Schwarz, T. F., Spaczynski, M., Schneider, A., Wysocki, J., Galaj, A., Schulze, K., Poncelet, S. M.,
Catteau, G., Thomas, F., & Descamps, D. (2011). Persistence of immune response to hpv16/18 as04-adjuvanted cervical cancer vaccine in women aged 15-55 years. Human vaccin ,
7(9), 958–965.
Searle, J. R. (1976). A classi cation of illocutionary acts. Language in society, 5(01), 1–23.
Sears, R. W. (2011). The vaccine book: making the right decision for your child. Little, Brown.
Shah, N. H., Rubin, D. L., Supekar, K. S., & Musen, M. A. (2006). Ontology-based annotation
and query of tissue microarray data. In AMIA.
Sherris, J., Friedman, A., Wittet, S., Davies, P., Steben, M., & Saraiya, M. (2006). Education,
training, and communication for hpv vaccines. Vaccine, 24, S210–S218.
Shlyapnikova, A. (2019). Brick wall icon. http://www.iconarchive.com/show/toolbar-2-icons-byshlyapnikova/brick-wall-icon.html. CC Attribution 4.0. Accessed 23 Apr 2019.
Siegel, T. (2017). Controversial anti-vaccine doc ’vaxxed’ gets secret cannes screening. The
Hollywood Reporter.
Sirin, E., Parsia, B., Grau, B. C., Kalyanpur, A., & Katz, Y. (2007). Pellet: A practical owl-dl
reasoner. Web Semantics: science, servic and agents on the World Wide Web, 5(2), 51–53.
Smith, B. (2003). Ontology: philosophical and computational. The Blackwell Guide to the
Philosophy of Computing and Information. Blackwell, Oxford.

255

Smith, B., Ashburner, M., Rosse, C., Bard, J., Bug, W., Ceusters, W., Goldberg, L. J., Eilbeck, K.,
Ireland, A., Mungall, C. J., & others (2007). The OBO Foundry: coordinated evolution of
ontologies to support biomedical data integration. Nature biotechnolo , 25(11), 1251–1255.
Smith, B. & Grenon, P. (2019). Basic Formal Ontology (BFO) | Home. http://basic-formalontology.org/.
Songthap, A., Pitisuttithum, P., Kaewkungwal, J., Fungladda, W., Bussaratid, V., Koonsaeng, S.,
et al. (2009). Knowledge, attitudes, and acceptability of a human papillomavirus vaccine
among healthcare providers. Southeast Asian Journal of Tropical Medicine and Public
Health, 40(5), 1048.
Sonntag, D. (2010). Ontologi and Adaptivity in Dialogue for Question Answering, volume 4. IOS
Press.
Sotiriadis, A., Dagklis, T., Siamanta, V., Chatzigeorgiou, K., Agorastos, T., Group, L. S., et al.
(2012). Increasing fear of adverse e fects drops intention to vaccinate af er the introduction
of prophylactic hpv vaccine. Archiv of

necolo

and obstetrics, 285(6), 1719–1724.

Speer, R. & Havasi, C. (2013). ConceptNet 5: A Large Semantic Network for Relational
Knowledge. In I. Gurevych & J. Kim (Eds.), The People’s Web Meets NLP (pp. 161–176).
Berlin, Heidelberg: Springer Berlin Heidelberg.
Speer, R. & Lowry-Duda, J. (2017). Conceptnet at semeval-2017 task 2: Extending word
embeddings with multilingual relational knowledge. arXiv preprint arXiv:1704.03560.

256

Squid Ink (2019). Support icon. http://www.iconarchive.com/show/free- at-sample-icons-bythesquid.ink/support-icon.html. CC Attribution 3.0. Accessed 23 Apr 2019.
Stamper, R., Liu, K., Ha amp, M., & Ades, Y. (2000). Understanding the roles of signs and
norms in organizations-a semiotic approach to information systems design. Behaviour &
Information Technolo , 19(1), 15–27.
Steunebrink, B. R., Dastani, M., & Meyer, J.-J. C. (2009). The OCC model revisited. In Proc. of
the 4th Workshop on Emotion and Computing.
Stokley, S., Cohn, A., Dorell, C., Hariri, S., Yankey, D., Messonnier, N., & Wortley, P. M. (2011).
Adolescent vaccination-coverage levels in the united states: 2006–2009. Pediatrics, (pp.
peds–2011).
Stretch, R., McCann, R., Roberts, S. A., Elton, P., Baxter, D., & Brabin, L. (2009). A qualitative
study to assess school nurses’ views on vaccinating 12–13 year old school girls against human
papillomavirus without parental consent. BMC Public Health, 9(1), 1–6.
Stupiansky, N. W., Alexander, A. B., & Zimet, G. D. (2012). Human papillomavirus vaccine and
men: what are the obstacles and challenges? Current opinion in infectio

diseas , 25(1),

86–91.
Sundström, K., Tran, T. N., Lundholm, C., Young, C., Sparén, P., & Dahlström, L. A. (2010).
Acceptability of hpv vaccination among young adults aged 18–30 years–a population based
survey in sweden. Vaccine, 28(47), 7492–7500.

257

Sussman, A. L., Helitzer, D., Sanders, M., Urquieta, B., Salvador, M., & Ndiaye, K. (2007). Hpv
and cervical cancer prevention counseling with younger adolescents: implications for
primary care. The Annals of Family Medicine, 5(4), 298–304.
Swanson, J. (1992). What does it take to adapt instruction to the individual? a case study of one-toone tutoring. American Education Research Association, San Francisco, CA.
Tannen, D. (1982). Oral and literate strategies in spoken and written narratives. Language, (pp.
1–21).
Tao, C., Wei, W.-Q., Solbrig, H. R., Savova, G., & Chute, C. G. (2010). Cntro: a semantic web
ontology for temporal relation inferencing in clinical narratives. In AMIA annual
symposium proceedings, volume 2010 (pp. 787).: American Medical Informatics Association.
Tariq, S., Bhakta, S., Grimes, A., & Stevens, A. (2009). Attitudes of arkansas’ primary care
physicians toward the hpv vaccine. The Journal of the Arkans Medical Society, 106(5),
113–117.
Tartir, S. & Arpinar, I. B. (2007). Ontology evaluation and ranking using ontoqa. In Semantic
Computing, 2007. ICSC 2007. International Conference on (pp. 185–192).: IEEE.
Tartir, S., Arpinar, I. B., Moore, M., Sheth, A. P., & Aleman-Meza, B. (2005). Ontoqa: Metricbased ontology quality analysis. In IEEE ICDM Workshop on Knowledge Acquisition from
Distributed, Autonomo , Semantically Heterogeneo

258

Data and Knowledge Sourc : IEEE.

Thomas, T. L., Strickland, O., Diclemente, R., & Higgins, M. (2013). An opportunity for cancer
prevention during preadolescence and adolescence: Stopping human papillomavirus (hpv)related cancer through hpv vaccination. Journal of Adolescent Health, 52(5), S60–S68.
Thompson, V. L. S., Arnold, L. D., & Notaro, S. R. (2012). African american parents’ hpv
vaccination intent and concerns. Journal of health care for the poor and underserved, 23(1),
290.
Tielman, M. L., Neerincx, M. A., Bidarra, R., Kybartas, B., & Brinkman, W.-P. (2017). A Therapy
System for Post-Traumatic Stress Disorder Using a Virtual Agent and Virtual Storytelling
to Reconstruct Traumatic Memories. Journal of Medical Systems, 41(8).
Tiro, J. A., Tsui, J., Bauer, H. M., Yamada, E., Kobrin, S., & Breen, N. (2012). Human
papillomavirus vaccine use among adolescent girls and young adult women: an analysis
of the 2007 california health interview survey. Journal of Women’s Health, 21(6), 656–665.
To folon-Weiss, M., Hagan, K., Leston, J., Peterson, L., Provost, E., & Hennessy, T. (2008). Alaska
native parental attitudes on cervical cancer, hpv and the hpv vaccine. International journal
of circumpolar health, 67(4).
Tolk, A., Diallo, S. Y., & Padilla, J. J. (2012). Semiotics, entropy, and interoperability of simulation
systems: mathematical foundations of m&s standardization. In Proceedings of the Winter
Simulation Conference (pp. 243).: Winter Simulation Conference.

259

Tozzi, A. E., Ravà, L., Stat, D., Pandol , E., Marino, M. G., & Ugazio, A. G. (2009). Attitudes
towards hpv immunization of italian mothers of adolescent girls and potential role of
health professionals in the immunization program. Vaccine, 27(19), 2625–2629.
U.S. Cancer Statistics Working Group (2013). United Stat Cancer Statistics: 1999–2009 Incidence
and Mortality Web-based Report. U.S. Department of Health and Human Services,
Centers for Disease Control and Prevention and National Cancer Institute.
US Department of Health and Human Services and O ce of Disease Prevention and Health
Promotion and others (2012). Healthy people 2020.
US Food and Drug Administration (2018). Fda approves expanded use of gardasil 9 to
include individuals 27 through 45 years old. Retrieved from: https://www. fda.
gov/NewsEvents/Newsroom/PressAnnouncements/ucm622715. htm.
US Food and Drug Administration and others (2006). Fda licenses new vaccine for prevention of
cervical cancer and other diseases in females caused by human papillomavirus. FDA News,
10.
Vadaparampil, S. T., Kahn, J. A., Salmon, D., Lee, J.-H., Quinn, G. P., Roetzheim, R., Bruder, K.,
Malo, T. L., Proveaux, T., Zhao, X., et al. (2011). Missed clinical opportunities: provider
recommendations for hpv vaccination for 11–12 year old girls are limited. Vaccine, 29(47),
8634–8641.

260

Valentino, K. & Poronsky, C. B. (2015). Human papillomavirus infection and vaccination. Journal
of pediatric nursing.
Vamos, C. A., McDermott, R. J., & Daley, E. M. (2008). The hpv vaccine: framing the arguments
for and against mandatory vaccination of all middle school girls. Journal of School Health,
78(6), 302–309.
Van Mulken, S., André, E., & Müller, J. (1999). An empirical study on the trustworthiness of lifelike interface agents. In HCI (2) (pp. 152–156).: Citeseer.
VanLehn, K., Graesser, A. C., Jackson, G. T., Jordan, P. W., Olney, A., & Rosé, C. P. (2007). When
are tutorial dialogues more e fective than reading? Cognitive Science, 31(1), 3–62.
Velicer, W. F., Prochaska, J. O., Fava, J. L., Laforge, R. G., & Rossi, J. S. (1999). Interactive versus
noninteractive interventions and dose-response relationships for stage-matched smoking
cessation programs in a managed care setting. Health psycholo

: oﬃcial journal of the

Division of Health Psycholo , American Psychological Association, 18(1), 21.
Verhoeven, V., Baay, M., Colliers, A., Verster, A., Van Royen, P., Avonts, D., & Vermorken, J. B.
(2006). The male factor in cervical carcinogenesis: a questionnaire study of men’s awareness
in primary care. Preventive medicine, 43(5), 389–393.
Villa, L. L., Perez, G., Kjaer, S. K., Paavonen, J., Lehtinen, M., Munoz, N., Sigurdsson, K.,
Hernandez-Avila, M., Skjeldestad, F. E., Thoresen, S., et al. (2007). Quadrivalent vaccine

261

against human papillomavirus to prevent high-grade cervical lesions. New England Journal
of Medicine, 356(19), 1915–1927.
Voorhees, E. M. & Tice, D. M. (2000). Building a question answering test collection. In
Proceedings of the 23rd annual international ACM SIGIR conference on Research and
development in information retrieval (pp. 200–207).: ACM.
Vrandecic, D. (2009). Handbook on ontologies. by A. Staab and R. Studer. Springer Berlin
Heidelberg. Chap. Ontolo

Evaluation, (pp. 293–313).

Walker, T. Y., Elam-Evans, L. D., Singleton, J. A., Yankey, D., Markowitz, L. E., Fredua, B.,
Williams, C. L., Meyer, S. A., & Stokley, S. (2017). National, regional, state, and selected
local area vaccination coverage among adolescents aged 13–17 years—united states, 2016.
MMWR. Morbidity and mortality weekly report, 66(33), 874.
Waller, J., Marlow, L. A., & Wardle, J. (2006). Mothers’ attitudes towards preventing cervical
cancer through human papillomavirus vaccination: a qualitative study. Cancer
Epidemiolo

Biomarkers & Prevention, 15(7), 1257–1261.

Wang, C., Xiong, M., Zhou, Q., & Yu, Y. (2007). Panto: A portable natural language interface to
ontologies. In The Semantic Web: Research and Applications (pp. 473–487). Springer.
Wang, D., Cunningham, R. M., Boom, J., Amith, M., & Tao, C. (2016). Towards a HPV Vaccine
Knowledgebase For Patient Education Content. Studi in Health Technolo
Informatics.

262

and

Watkins, K. L., Reitzel, L. R., Wetter, D. W., & McNeill, L. H. (2015). Hpv awareness, knowledge
and attitudes among older african-american women. American journal of health behavior,
39(2), 205–211.
Watson, D. & Tellegen, A. (1985). Toward a consensual structure of mood. Psychological bulletin,
98(2), 219.
Watson, M., Saraiya, M., Ahmed, F., Cardinez, C. J., Reichman, M. E., Weir, H. K., & Richards,
T. B. (2008a). Using population-based cancer registry data to assess the burden of human
papillomavirus-associated cancers in the united states: Overview of methods. Cancer,
113(S10), 2841–2854.
Watson, M., Saraiya, M., Benard, V., Coughlin, S. S., Flowers, L., Cokkinides, V., Schwenn, M.,
Huang, Y., & Giuliano, A. (2008b). Burden of cervical cancer in the united states, 1998–
2003. Cancer, 113(S10), 2855–2864.
Wei, F., Moore, P. C., & Green, A. L. (2013). Geographic variability in human papillomavirus
vaccination among us young women. American journal of preventive medicine, 44(2),
154–157.
Weinstock, H., Berman, S., & Cates Jr, W. (2004). Sexually transmitted diseases among american
youth: incidence and prevalence estimates, 2000. Perspectiv on sexual and reproductive
health, (pp. 6–10).

263

Weisberg, E., Bateson, D., Skinner, S., McCa fery, K., et al. (2009). Hpv vaccination catch up
program: utilisation by young australian women. Australian family physician, 38(1-2), 72.
Weiss, T. W., Rosenthal, S. L., & Zimet, G. D. (2011). Attitudes toward hpv vaccination among
women aged 27 to 45. ISRN obstetrics and
White, J. (2015).

necolo , 2011.

Robert kennedy jr. warns of vaccine-linked ’holocaust’.

http://www.sacbee.com/news/politics-government/capitol-alert/article17814440.html.
Williams, K., Forster, A., Marlow, L., & Waller, J. (2011). Attitudes towards human papillomavirus
vaccination: a qualitative study of vaccinated and unvaccinated girls aged 17–18 years.
Journal of Family Planning and Reproductive Health Care, 37(1), 22–25.
Williams, W. W., Lu, P.-J., O’Halloran, A., Bridges, C. B., Pilishvili, T., Hales, C. M., &
Markowitz, L. E. (2014). Nonin uenza vaccination coverage among adults-united states,
2012. MMWR. Morbidity and mortality weekly report, 63(5), 95–102.
Williams, W. W., Lu, P.-J., Saraiya, M., Yankey, D., Dorell, C., Rodriguez, J. L., Kepka, D., &
Markowitz, L. E. (2013). Factors associated with human papillomavirus vaccination among
young adult women in the united states. Vaccine, 31(28), 2937–2946.
Wong, L. P. (2008). Young multiethnic women’s attitudes toward the hpv vaccine and hpv
vaccination. International Journal of Gynecolo

& Obstetrics, 103(2), 131–135.

Wong, L. P. (2009). Physicians’ experiences with hpv vaccine delivery: evidence from developing
country with multiethnic populations. Vaccine, 27(10), 1622–1627.

264

Wong, L. P. & Sam, I.-C. (2010). Ethnically diverse female university students’ knowledge
and attitudes toward human papillomavirus (hpv), hpv vaccination and cervical cancer.
European Journal of Obstetrics & Gynecolo

and Reproductive Biolo , 148(1), 90–95.

Wood, D., Wood, H., & Middleton, D. (1978). An experimental evaluation of four face-to-face
teaching strategies. International journal of behavioral development, 1(2), 131–147.
Woodhall, S. C., Lehtinen, M., Verho, T., Huhtala, H., Hokkanen, M., & Kosunen, E. (2007).
Anticipated acceptance of hpv vaccination at the baseline of implementation: a survey of
parental and adolescent knowledge and attitudes in nland. Journal of Adolescent Health,
40(5), 466–469.
Wooldridge, M. (2009). An introduction to multiagent systems. John Wiley & Sons.
Wooldridge, M. & Jennings, N. R. (1995). Intelligent agents: Theory and practice. The knowledge
engineering review, 10(2), 115–152.
Yeganeh, N., Curtis, D., & Kuo, A. (2010). Factors in uencing hpv vaccination status in a latino
population; and parental attitudes towards vaccine mandates. Vaccine, 28(25), 4186–4191.
Ylitalo, K. R., Lee, H., & Mehta, N. K. (2013). Health care provider recommendation, human
papillomavirus vaccination, and race/ethnicity in the us national immunization survey.
American journal of public health, 103(1), 164–169.

265

Young, D., Xiao, C. C., Murphy, B., Moore, M., Fakhry, C., & Day, T. A. (2015). Increase in head
and neck cancer in younger patients due to human papillomavirus (hpv). Oral oncolo ,
51(8), 727–730.
Young, M., Sparrow, D., Gottlieb, D., Selim, A., & Friedman, R. (2001). A telephone-linked
computer system for copd care. CHEST Journal, 119(5), 1565–1575.
Yu, A. C. (2006). Methods in biomedical ontology. Journal of Biomedical Informatics, 39(3),
252–266.
Yu, L. (2011). A Developer’s Guide to the Semantic Web. Heidelberg; New York: Springer, 2011
edition edition.
Zak-Place, J. & Stern, M. (2004). Health belief factors and dispositional optimism as predictors of
std and hiv preventive behavior. Journal of American College Health, 52(5), 229–236.
Zhou, L. & Zhang, D. (2004). Building a misinformation ontology. In Web Intelligence, 2004. WI
2004. Proceedings. IEEE/WIC/ACM International Conference on (pp. 445–448).: IEEE.
Zhou, L. & Zhang, D. (2007). An ontology-supported misinformation model: Toward a digital
misinformation library. IEEE Transactions on Systems, Man, and Cybernetics-Part A:
Systems and Humans, 37(5), 804–813.
Zhou, Y., Freedman, R., Glass, M., Michael, J. A., Rovick, A. A., & Evens, M. W. (1999).
Delivering hints in a dialogue-based intelligent tutoring system. In AAAI/IAAI (pp.
128–134).

266

Zhu, H., Liu, D., Bayley, I., Aldea, A., Yang, Y., & Chen, Y. (2017). Quality model and metrics of
ontology for semantic descriptions of web services. Tsinghua Science and Technolo , 22(3),
254–272.
Zimet, G. D. (2005). Improving adolescent health: focus on hpv vaccine acceptance. Journal of
Adolescent Health, 37(6), S17–S23.
Zimet, G. D., Rosberger, Z., Fisher, W. A., Perez, S., & Stupiansky, N. W. (2013). Beliefs, behaviors
and hpv vaccine: correcting the myths and the misinformation. Preventive medicine, 57(5),
414–418.
Zimet, G. D., Weiss, T. W., Rosenthal, S. L., Good, M. B., & Vichnin, M. D. (2010). Reasons
for non-vaccination against hpv and future vaccination intentions among 19-26 year-old
women. BMC women’s health, 10(1), 27.

267

